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General introduction
8 Chapter 1 
This thesis focuses on practice accreditation as a strategy to improve chronic care 
management in primary care. Practice accreditation is a structured method for assessing an 
organization. The introduction of this thesis starts with an outline of chronic care 
management and the use of audit and feedback to improve quality of care. Accreditation is a 
specific type of audit and feedback. The subsequent section elaborates on two areas of 
research in this thesis, which relate to different aspects in the evaluation of an accreditation 
program. The first concerns the performance measures used in practice accreditation and 
their metric properties. The second concerns the impacts of the Accreditation program on 
chronic care management and the associations of patient characteristics and organizational 
determinants with high quality of care. A total of 6 research questions are formulated which 
have guided the studies presented in this thesis.  
 
CHRONIC CARE MANAGEMENT 
In the Netherlands, as in other countries, chronic conditions place a large burden on the 
healthcare system1. Worldwide, the four leading causes of death are chronic conditions: 
cardiovascular disease, cancer, chronic respiratory disease and diabetes2. It is estimated that 
the prevalence of chronic conditions will increase in the next decades, mainly due to an 
ageing population and a rise in disease-specific risk factors such as obesity3. Furthermore, the 
number of people with multiple chronic conditions will also increase4. The main four chronic 
conditions that are commonly found in patients with high care costs include coronary artery 
disease, diabetes, congestive heart failure and chronic obstructive pulmonary disease 
(COPD). The prevalence of each of these diseases in the population is estimated between 1 
and 10.1%, depending on the type of condition5-8.  
The organization of care for patients with a chronic condition differs across healthcare 
systems. The Chronic Care Model (CCM)9 provides a structured framework to organize chronic 
care management. Several reviews have shown that interventions targeting (aspects of) this 
framework can improve chronic care10,11. For instance, Van Lieshout et al. compared practice 
characteristics of 11 mainly European countries using the CCM12. They found that stronger 
primary care was associated with better management of patients with established 
cardiovascular disease, but not in patients with high cardiovascular risk.  
Since 2000, changes have taken place in the Dutch healthcare system that probably have 
affected several aspects of the organization of chronic care as described in the CCM. In 2006, 
the Dutch health insurance system changed into a more market-oriented health system. 
Although primary care was exempted from this, it was affected indirectly, for example through 
an increased workload due to substitution of hospital care, mainly regarding patients with 
chronic diseases. In the Netherlands, most patients receive treatment in primary care from a 
nurse practitioner (NP) and a family physician (FP)3. With the introduction of the nurse 
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practitioner in primary care, many general practices have restructured their chronic care 
management. Systematic reviews found that there are no differences between care provided 
by an NP (usually with physician backup) or by a physician alone, except that patients were 
more satisfied with care if the NP was involved13,14. Furthermore, interventions have taken 
place to improve chronic care regarding several other aspects mentioned in the CCM, 
including decision support15 and improved registration.  
Given the changes in chronic care management and the importance of this topic as measured 
by the burden on the health system, there is a need to evaluate the quality of care that 
general practices can provide. Based on measures and comparisons over time or between 
practices, suggestions can be made to improve the quality of chronic care management.  
 
AUDIT AND FEEDBACK IN AN ACCREDITATION PROGRAM 
Audit and feedback can be used to assess and improve the quality of chronic care 
management and to set up tailored improvement programs. The key element of audit and 
feedback is the provision of ‘any summary of clinical performance of healthcare over a 
specified period of time, given in a written, electronic or verbal format’16. This summary is 
often based on performance measurement with use of indicators. It can also contain a 
comparison with other performance scores or a benchmark. Ivers et al.17 performed a 
systematic review on the effects of audit and feedback. They found that there are small but 
potentially important improvements in care, including chronic care, albeit with large variation 
in effects across the trials. These effects are possibly larger when baseline performance is low, 
when feedback is provided both verbally and as text and includes explicit targets and an 
action plan. 
Accreditation can be seen as a special type of audit and feedback and is widely used as a 
strategy to improve quality of chronic care management18. A closely related term that is often 
used interchangeably is certification. Accreditation affects the institution or practice and is 
offered more or less voluntary, while certification focuses on a specific norm that should be 
reached by individuals or particular services19,20. Greenfield et al.21 found in their systematic 
review that accreditation can promote change, for example through the opportunity to reflect 
on organizational performance, and that it has an effect on professional development.  
In the Netherlands, a practice accreditation program has been set up to evaluate general 
practices regarding chronic care management, practice organization and patient experiences 
with care; see Box 1 for further details. A crucial feature of this program is that it is primarily 
aimed at stimulating quality improvement in participating practices. This thesis focuses solely 
on the components in the Accreditation program that regard chronic care management. 
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Box 1. The Dutch Accreditation program 
In the Netherlands, general practices can take part in a Dutch Accreditation program since 200522. This program 
strongly focuses on the educational value of audit and feedback and participation is voluntary. However, the 
program does require that specific norms are met, for example on hygiene, first aid equipment and accessibility.  
The program evaluates practice organization, patient opinions and chronic care management. The structured 
program with a three-year cycle starts with a preparatory phase which consists of the collection of data on 
practice management and patient care. The measurement instruments used are previously validated 
questionnaires, including the ‘VIP’, a visitation instrument for practice organization23 and the ‘Europep’ that 
measures patient experiences24. The questionnaires are filled in by family physicians, nurses and patients. 
Furthermore, a trained observer pre-audits the practice. Clinical performance is measured with the use of patient 
information that is extracted from electronic medical records; the family physician or nurse extracts the 
information either automatically or manually with an extraction form. When all data are collected and submitted 
through an online questionnaire system, the practice receives a feedback report that includes information on its 
own performance and the performance of other general practices as benchmarks. This information helps to 
identify which areas could be improved upon. The physicians then write improvement plans with a plan-do-
study-act cycle. The first audit is carried out after the approval of these plans to confirm adequate participation 
and to grant accreditation. After this audit a three-year accreditation cycle starts. At the end of each year the 
practice staff evaluates whether the objectives of improvement programs are met and writes new improvement 
programs for the following year. The prolongation of the accreditation depends on this process. Accreditation is 
not based on the actual quality of care itself but rather on the quality of the improvement initiatives. After three 
years, a new cycle starts with the data collection phase. 
 
PERFORMANCE MEASURES  
In most accreditation programs, performance measures are used to evaluate individual 
practices25. These performance measures need to be tested empirically on their metric 
properties, including validity, reliability and feasibility, before broad implementation26,27. 
Validity and feasibility of performance measures from other programs have been described in 
international literature28,29. Regarding the measurement instruments used to evaluate chronic 
care management in the Dutch Accreditation program, content validity and clinical relevance 
have been assessed during the development of the performance measures used in the Dutch 
Accreditation program22. However, other metric properties have not been examined. In 
chapter 2, we focus on several aspects of validity and reliability: correlation between different 
sets of indicators, internal consistency within each set and precision of the performance 
scores and benchmarks. Types of reliability that are frequently examined in the literature 
include internal consistency and test-retest reliability30,31. However, an important aspect of 
reliability that has not been described extensively is precision. Precision relates to whether 
the estimated performance score is an adequate reflection of the population value32. This 
depends on several aspects such as the variation of scores and the number of data points 
used to calculate performance scores. In chapter 3 we investigate whether performance 
measures used in the Dutch Accreditation program are based on samples of patients which 
are sufficiently large to ensure precision. Which level of precision is acceptable for routine use 
partly depends on the goal of the measurement: discriminative or evaluative33. For 
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discriminative purposes, higher levels of precision are needed. One possible solution to 
achieve higher levels of precision is to create a composite performance measure based on a 
group of related measures. We therefore examine which consequences the creation of a 
composite measure has on the precision. 
 
IMPACTS OF ACCREDITATION 
Alkhenizan et al.19 performed a systematic review on the effects of accreditation programs. 
They found that accreditation had positive effects on processes as well as on clinical 
outcomes; they concluded that accreditation can be an important tool to improve quality of 
care. However, this review focused on accreditation in hospital care; few rigorous evaluations 
of effectiveness of primary care accreditation are available34,35. O’Beirne et al.36 performed a 
review of peer-reviewed and grey literature regarding accreditation in primary care. They 
found indications that accreditation may improve both organization and outcomes of care, 
but conclude that more research is needed. In chapter 4, we examine the effects of the Dutch 
Accreditation program on chronic care management in general practice. 
Insight in participant experiences with practice accreditation can help to identify new 
approaches to improving practice accreditation37. Therefore, we planned a qualitative study 
in participating practices to evaluate the Dutch Accreditation program, which is described in 
chapter 5. 
A vital component of the Accreditation program consists of the provision of feedback to the 
practice. However, in order to derive meaningful interpretations from the performance scores, 
it is important to be aware of factors that may influence these scores. Previous research 
showed that health outcomes of an individual patient are affected by a range of non-
modifiable factors that include age, gender and the duration of the chronic condition38-40. 
Multi-morbidity, defined as any co-occurrence of medical conditions within a person41, can 
also affect chronic care processes and outcomes42. Depending on the goal of measurement 
and strength of the associations found, one can choose to adjust or stratify for these 
influencing factors43. In chapter 6, we investigate whether several patient characteristics (age, 
gender, body mass index (BMI), whether the patient lives in a deprived area) and multi-
morbidities (cardiovascular disease, COPD, depression and anxiety) are associated with 
diabetes care processes and outcomes.  
When the current state of care is evaluated, the next step is to elaborate targeted 
improvement plans and implement changes in the practice. Many interventions to improve 
the quality of care are aimed at practice management aspects44. The Chronic Care Model9 
described earlier offers a useful framework for the domains on which these interventions can 
be focused. Tricco et al.45 performed a systematic review and provided a model that 
incorporates interventions focused on 12 different target areas. They found that interventions 
12 Chapter 1 
aimed at more than one target area are more effective. However, the studies included in this 
review are controlled trials. It is uncertain whether similar effects can be found in routine 
primary care. In chapter 7, we examine which practice characteristics linked with intervention 
strategies are associated with favorable chronic care management. Table 1 presents the 
research questions of studies in this thesis. 
 
Table 1. Overview of research questions of studies in this thesis 
Chapter Research questions 
Chapter 2 To which extent does the domain clinical care of the Visitation Instrument Accreditation (VIA) 
used in the Dutch Accreditation program meet each of four reliability and validity criteria? 
 1. Correlation between the sets of performance indicators  
 2. Internal consistency within each set of performance indicators 
 3. Precision of indicator scores  
 4. Precision of benchmarks  
Chapter 3 What is the relationship between sample size and precision?  
 Can we increase precision with a composite performance score? 
 How many indicators are needed minimally to achieve a certain level of precision? 
Chapter 4  What is the effect of the Dutch Accreditation program on performance scores regarding 
diabetes, COPD and cardiovascular disease? 
Chapter 5 What are the opinions of family physicians regarding the Dutch Accreditation program? 
Chapter 6 Which patient characteristics are associated with performance scores? 
Chapter 7 Which organizational factors are determinants of intermediate patient outcomes in routine 
diabetes care? 
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four reliability and validity issues
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ABSTRACT 
Background To describe four reliability and validity issues regarding the clinical indicators 
from the Visitation Instrument Accreditation (VIA). Based on this information, practices 
needed to develop and implement improvement plans in order to get accredited.  
Methods  An observational study based on data from the medical records of 82 practices.  
Results  The performance indicators that covered chronic care management (diabetes, COPD, 
asthma and cardiovascular risk management), prevention activities (influenza vaccination, 
cervical cancer screening) and prescription of antibiotics were correlated weakly, suggesting 
that the instrument provided a rather broad scope of the practice when it comes to chronic 
care management and prevention. Furthermore, the different subjects were each measured 
by indicators that had sufficient coherence, which suggested that they measured a clear 
underlying concept. To achieve a high indicator score precision (i.e. a confidence limit of 
plus/minus 10 percentage points), data from at least 96 patients were necessary to calculate a 
score. VIA allows to take a sample of 40 patients; in that case the confidence limit increases to 
15 points. To establish a precise benchmark we needed 233 practices to achieve a confidence 
limit of ≤ 5 percentage points.  
Conclusions The clinical indicators of the VIA are reliable and valid and can be used by a 
general practice to gain insight into its performance compared to a benchmark. For practice 
policy on quality improvement a confidence limit of 10-15 percentage points around the 
indicator score on practice level seems to be acceptable. We would be more comfortable with 
a smaller confidence limit in case of accountability or a ‘pay-for-performance’ program. A 
sample of 40 patients would not do in such a case. It therefore remains a continuous search 
to find a balance between feasibility and justice.  
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BACKGROUND  
Clinical performance indicators are needed to measure the quality of care in order to create 
more transparency in healthcare1. To achieve this, general practices can use the Visitation 
Instrument Accreditation (VIA), which maps various aspects of general practice care with 
several indicator sets2.  Since 2005, the VIA has been used in the Dutch Accreditation program 
of the Dutch College of General Practitioners, see Box 1. The instrument consists of the 
following domains: clinical care, practice management and patient experiences. Indicators 
are used to gain more insight into the quality of care, and enable each family physician to 
compare the performance of their practice to a benchmark that is based on performances of 
all participating practices. This feedback method offers family physicians guidance to 
improve the quality of their care. This type of information is increasingly used, for instance for 
internal policy making, multidisciplinary care groups and public information. Because of this, 
questions regarding the validity and reliability of this information are of notable importance. 
The validity and reliability of the domains practice management and patient experiences 
have been described before3,4. However, little is known about the clinical care domain. During 
the development of these performance measures, content validity has been assessed for the 
individual indicators: a panel of experts agreed that the indicators are a good reflection of 
clinical care and can be used to evaluate this domain2,5. Now that data have been collected 
with the instrument, it is also possible to examine other aspects of reliability and validity 6,7. 
 
 
This study examines clinical indicators on the basis of four reliability and validity issues. First, 
the various sets of indicators of the instrument should describe a broad and diverse range of 
clinical activities, which take place in a general practice. This means that the sets of indicators 
should not be too closely connected to each other (low correlation between the sets of 
Box 1. The Dutch Accreditation program (NHG-Praktijkaccreditering®) 
Since 2005, family physicians (FPs) can participate in the Dutch Accreditation program of the Dutch College of 
General Practitioners (NHG). FPs collect data for their accreditation using the Visitation Instrument Accreditation 
(VIA). The VIA consists of performance indicators with regard to clinical care, practice management and patient 
experiences, and measures the quality of (part of) the activities carried out in the general practice. Data are 
extracted from medical records and questionnaires. In addition, observations are made by a consultant of NPA, 
the organization that carries out the independent review on behalf of the Dutch Accreditation program. On the 
basis of the incorporated data the practice is able to compare itself to other practices, and can consequently 
draw up plans for improvement. Accreditation of the practice is based on the development and implementation 
of these improvement plans, provided that certain conditions (minimum requirements) have been met. This is 
checked by the NPA accreditor during an audit. Data are collected using the VIA in the first year. In the following 
two years further audits of the practice take place, in which the accreditor  checks whether the physicians have 
achieved to implement the plans from that year, whether the improvement plans for the upcoming year meet the 
requirements and whether the minimum requirements for that particular year have been met. The cycle repeats 
itself after three years. 
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indicators). Second, it is important that there is a certain amount of coherence between the 
indicators within one set, though the information should not overlap too much (internal 
consistency within a set). Third, the performance score that is calculated from the indicator 
should give an accurate picture of the practice. This means that data should be collected 
from a sufficient number of patients (precise indicator score). Fourth, in order to provide a 
stable and correct reflection of the scores in a population, a benchmark should be based on a 
sufficient number of practices. Moreover, the practices on the basis of which the benchmark is 
calculated, should be representative of the practice that uses the benchmark (adequate and 
precise benchmark). We studied the extent to which the domain clinical care of the VIA meets 
each of these criteria 2.  
 
METHODS 
Study population and measures 
We carried out an observational study based on data from the medical records of 82 practices 
that voluntarily took part in the Dutch Accreditation program during 2005-2006. The practices 
collected data on three widespread chronic conditions (diabetes, chronic obstructive 
pulmonary disease (COPD) and asthma), cardiovascular risk management (CVRM), a number 
of specific prevention activities (influenza vaccination and cervical cancer screening) and 
prescription of antibiotics. The instrument consisted of structure indicators, process 
indicators and outcome indicators8. We mostly concentrated on the process indicators for the 
examination of the criteria, because these are the most reliable in providing information on 
the quality of practice management and care. Table 1 shows an overview of all indicators that 
were included in our study. We used 9 process indicators for diabetes, 8 for CVRM, 5 for COPD, 
4 for asthma, and 1 indicator each for influenza vaccination, cervical cancer screening and 
prescription of antibiotics. We also included 5 outcome indicators (3 diabetes and 2 CVRM 
indicators) for a number of the calculations, in order to gain insight in the effect of this type of 
information on the reliability and validity.  
 
Data collection 
The required data were collected from the medical records by a staff member of the general 
practice. However, it was often not easy to extract data from the electronic medical records; 
for one thing because the software did not offer easy data extraction, but also because data 
had not been registered in a uniform way. Therefore, the practices were offered the choice to 
collect data from a sample of 40 patients. If the total number of patients with the condition 
concerned did not exceed 40, the practices were requested to collect data from all patients. 
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Table 1. Overview of all indicators 
Subject No. Description 
Diabetes 1 % of patients with completed information on risk factors 
Process 
indicators 
2 % of patients with a record of at least 3 glucose measurements in the last 12 months 
3 % of patients with a record of HbA1c measurement in the last 12 months 
 4 % of patients with a record of blood pressure measurement in the last 12 months 
 5 % of patients with a record of total cholesterol measurement in the last 12 months 
 6 % of patients with a record of creatinine measurement in the last 12 months 
 7 % of patients with a record of retinal examination in the last 24 months 
 8 % of patients with a record of feet examination in the last 12 months 
 9 % of patients with a record of a lipid lowering medication prescription 
Outcome 
indicators  
1 % of patients with an Hba1c value of 8.5% or more 
2 % of patients with a blood pressure value within target level (150/85 mm Hg or less) 
 3 % of patients with a total cholesterol value within target level (5.0 mmol/l or less) 
COPD 1 % of patients with a record of a spirometry assessment ever  
 2 % of patients with a record of a spirometry assessment in the last 12 months 
 3 % of patients with a record of a consultation in the last 12 months 
 4 % of patients with a record of smoking status 
 5 % of patients who smoke with a record of smoking cessation advice 
Asthma 1 % of patients with a record of a spirometry or peakflow measurement ever 
 2 % of patients with a record of a consultation in the last 12 months 
 3 % of patients with a record of smoking status 
 4 % of patients who smoke with a record of smoking cessation advice  
CVRM 1 % of patients with a record of blood pressure measurement in the last 12 months 
Process 
indicators 
2 % of patients with a record of cholesterol measurement in the last 12 months 
3 % of patients with a record of a lipid lowering medication prescription 
 4 % of patients with a record of smoking status 
 5 % of patients who smoke with a record of smoking cessation advice  
 6 % of patients with completed information on risk factors 
 7 % of patients with heart disease in their history with a record of a prescription of 
anticoagulants 
 8 % of patients with a record of a glucose measurement in the last 12 months 
Outcome 
indicators 
1 % of patients with a blood pressure value within target level (160/90 mm Hg or less) 
2 % of patients with a lipid lowering medication prescription with a total cholesterol 
value within target level ( 5.0 mmol/l or less) 
Influenza 
vaccination 
1 % of vaccinated high risk patients in the practice or % of vaccinated patients of 65 
years and older* 
Cervical cancer 
screening 
1 % of women from the target cohort with a record of a cervical smear 
Antibiotics 1 % of narrow-spectrum antibiotic prescriptions in relation to all prescriptions of 
antibiotic drugs 
* We decided to use the highest value of these two indicators to serve as indicator score for this item, because 
practices were often not able to fill in both indicators.  
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The Visitation Instrument Accreditation (VIA) requested details to be collected only for that 
part of the patient group that is treated by the family physician (FP). However, reports were 
often made on all patients with the condition concerned. With regards to the prescription of 
antibiotics data, practices were advised to contact the preferential pharmacist. The data 
collection could refer to just one FP, or to more FPs if they shared the patient population. Of 
the 82 practices, we included a total of 97 patient populations; for each population we had 
data on all conditions included in the study. 
 
Analysis 
In order to find out whether the practices in our study were representative of all Dutch 
practices, we compared our study population to all Dutch general practices concerning 
practice type, degree of urbanization and whether practices had a dispensary. Moreover, we 
looked at the number of patients per full-time equivalent (FTE) FP. 
To investigate whether the measurements of the various conditions of clinical care from the 
VIA differed enough from each other, we determined the level of correlation between the 
various subjects (criterion 1) using Pearson’s correlation coefficient. To assess the internal 
consistency (criterion 2) we determined the correlation between the various indicators within 
one subject by using Cronbach’s alpha9. A Cronbach’s alpha between 0.7 and 0.8 is advisable, 
although an alpha higher than 0.6 is also considered to be acceptable for these types of 
indicators10. For each indicator and patient population we calculated the number of patients 
needed in order to achieve a precise score (criterion 3). This calculation was based on the 
indicator score we found. We kept to a 95% significance level and tested for two separate 
confidence limits, of 5 percentage points and 10 percentage points. For each indicator we 
then calculated the maximum, the 75th percentile score, the mean and the standard deviation, 
in order to get a clear picture of the scores and the levels of dispersion. We also used a power 
calculation to estimate the number of patient populations needed to get a precise 
benchmark (criterion 4)11. For this, we also used a 95% significance level and tested for the 
two confidence limits of 5 and 10 percentage points. 
 
RESULTS 
Study population 
Most characteristics of the general practices in our study reasonably correspond to the 
characteristics of all Dutch general practices (Table 2). Yet there seem to be relatively fewer 
single handed practices in our study. Also, the number of patients per FTE FP is higher in our 
study population than the national number of residents per FTE FP.  
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Table 2. Practice characteristics of the study population in comparison with all Dutch practices (2008) 
Practice characteristics Study population Dutch Accreditation 
program, n = 82 practices 
All Dutch general practices* 
n = 4235 practices 
 n %^ %^ 
   Practice type    
Single handed practice 18 22.0 42.3 
Practice with two FPs 18 22.0 31.5 
Group practice or health center 24 29.3 26.1 
HOED◊ 15 18.3 - 
Other type of practice 7 8.5 - 
   Practice location‡    
Urban 33 40.2 46.7 
Partly urban 38 46.3 41.1 
Rural 11 13.4 12.2 
   Dispensary    
Yes 3 3.7 7.3 
No 79 96.3 92.7 
No. of patients per FTE FP 2444   
No. of inhabitants per FTE FP   2322 
* Data provided by NIVEL, 1-1-200812. ◊ HOED: construction where multiple family physicians (FPs) have their 
separate practices under one roof. ‡ A region was defined as urban when the number of addresses per km2 
exceeded 1,500; partly urban regions had 500 - 1.500 addresses per km2; rural regions had less than 500 addresses 
per km2. ^ Because the percentages were rounded off, they do not always add up to exactly 100%. 
 
Criterion 1: low correlation between the indicator sets 
We did not find strong correlations between the various subjects of clinical care (see Table 3). 
The subject prescription of antibiotics did not show coherence with any of the other subjects. 
Although cervical cancer screening turned out to be slightly associated with cardiovascular 
risk management, this correlation was rather weak. Of the other 5 subjects, asthma showed 
the strongest association with the other subjects (diabetes, COPD, cardiovascular risk 
management and influenza vaccination). Furthermore, we noticed a slight correlation 
between diabetes and both cardiovascular risk management and influenza vaccination. 
 
Criterion 2: internal consistency of the indicator sets 
Table 4 shows the average scores on the indicators for each subject, the standard deviation 
and the internal consistency of the indicators for each subject (Cronbach’s alpha). The 9 
process indicators which relate to diabetes proved to have the highest internal consistency. 
These indicators had a Cronbach’s alpha of 0.73. This score can vary between 0 and 1, with a 
score of 0 reflecting no inter-correlation at all and 1 reflecting a perfect inter-correlation. 
When a score is close to 0.9 or higher, the internal consistency is so strong that there is an 
overlap in the information provided by the indicators. An option then would be to leave out 
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indicators. Scores closer to 0 suggest that the indicators deal with different subjects, which 
means that the indicators ought not to be taken together. The 8 process indicators relating to 
cardiovascular risk management had a reasonably strong internal consistency, just as the 5 
indicators relating to COPD (respective alphas of 0.64 and 0.67). The internal consistency of 
the 4 asthma indicators proved to be slightly less strong (alpha = 0.56). Describing the internal 
consistency using Cronbach’s alpha is only possible for subjects with more than one 
indicator. 
 
Table 3. Correlation between the subjects of clinical care (Pearson’s correlation coefficient of the means) 
Subject Diabetes COPD Asthma CVRM Influenza Cancer 
Screening 
Antibiotics 
Diabetes X 0.15 0.31* 0.43* 0.29* 0.19 -0.10 
COPD  X 0.40* 0.09 0.20 -0.13 0.12 
Asthma   X 0.48* 0.30* 0.16 0.06 
CVRM    X 0.08 0.27* 0.19 
Influenza vaccination     X 0.17 0.17 
Cancer screening      X -0.07 
Antibiotics       X 
* Significant correlation, p <0.01.  
 
Table 4. Internal consistency within each subject (Cronbach’s alpha, n = 97) 
Subject No. of indicators Cronbach’s alpha Mean in % SD in % 
Diabetes 9 0.73 72.4 11.2 
COPD 5 0.67 63.1 15.4 
Asthma 4 0.56 49.3 17.1 
CVRM  8 0.64 49.6 11.4 
Influenza vaccination 1 - 85.6 8.4 
Cancer screening 1 - 67.6 16.5 
Antibiotics 1 - 14.3 11.5 
 
Criterion 3: precise performance scores per patient population 
Using the resulting performance scores, we calculated the number of patients needed to 
achieve a certain level of precision for each patient population and indicator separately. 
Table 5 lists the minimum number of patients needed per subject. When subjects consisted of 
more than one indicator we calculated the numbers for each indicator separately; in that case 
Table 5 lists the lowest and the highest number of patients needed for each subject. Looking 
at the achieved performance scores, we needed at least 363 and at most 384 patients to 
calculate a precise score for the 9 diabetes process indicators, with a confidence limit of plus 
or minus 5 percentage points. For many of the subjects, at least 384 patients were needed. If 
we would accept a larger confidence limit of 10 points, we would need to assess data from 96 
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patients to achieve a precise score. The average population size of the participating practices 
was 3,917 patients. This means that we can only calculate precise indicator scores (with a 
confidence limit of ≤ 10 points) for conditions with a minimal prevalence of 2.4%. This is the 
case for diabetes, asthma and cardiovascular risk management (RIVM site13). The prevalence 
of COPD is just below 2.4%. It is probable that not all patients with this condition are 
registered in general practices, which means that through an improved registration we will 
also be able to include enough patients for COPD to achieve precise indicator scores. 
 
Table 5. Number of patients/patient populations needed to achieve  5 or 10 point confidence limits around 
indicators and benchmarks (highest and lowest for each subject) 
Subject (no. of indicators) No. of patients needed 
for each indicator 
No. of populations needed 
for each benchmark 
CL* 5 points CL* 10 points CL* 5 points CL* 10 points 
Diabetes (p◊, 9) 363-384 91-96 8-233 2-58 
Diabetes (o◊, 3) 272-384 68-96 4-35 1-9 
COPD (5) 384-384 96-96 46-146 11-37 
Asthma (4) 384-384 96-96 64-175 16-44 
CVRM (p◊, 8) 384-384 96-96 28-161 7-40 
CVRM (o◊, 2) 384-384 96-96 39-46 10-11 
Influenza vaccination (1) 372 93 11 3 
Cervical cancer screening (1) 384 96 42 10 
Antibiotics (1) 383 96 20 5 
* CL = confidence limit. ◊ p = process indicators, o = outcome indicators.  
 
Criterion 4: precise benchmark 
The number of patient populations needed to calculate a precise benchmark depends on the 
dispersion of the various scores on the indicator concerned. The standard deviation for each 
indicator varied between 5.1 for the diabetes outcome indicator ‘patients with an Hba1c value 
of 8.5% or more’ and 39.0 for the diabetes process indicator ‘patients with completed 
information on risk factors’. Due to the fact that there is a strong dispersion between the 
various indicators, there are also large differences in the number of populations needed for 
each indicator. For instance, the minimum number of patient populations needed for the 
diabetes indicators varies between 8 and 233 with a confidence limit of 5 points (Table 5). To 
calculate a precise benchmark for all indicators, 233 patient populations are needed for a 
confidence limit of 5 points and 58 populations for a confidence limit of 10 points. The 
benchmarks that are currently used as reference material are based on 259 populations, 
which is more than sufficient to maintain a maximum confidence limit of 5 percentage points.  
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DISCUSSION 
The results show that the domain of clinical care, as part of the Visitation Instrument 
Accreditation, consists of a relatively broad and diverse scope of care in general practice. The 
associations between the conditions that have been included are relatively weak. The 
correlations that we found can be explained by the overlap between the various groups. For 
example, a patient who has been included in the indicators concerning cardiovascular risk 
management could also suffer from diabetes. Furthermore, such a patient would also qualify 
for an influenza vaccination. In the future, more subjects can be added to the instrument in 
order to make the evaluation more complete and cover more parts of the field of primary 
care. The subjects that are discussed in the present version are assessed by means of a set of 
indicators which show a reasonable internal consistency. The exception was the Cronbach’s 
alpha score relating to asthma, which showed a rather low correlation. A possible explanation 
for a lower correlation between asthma indicators is the fact that the guidelines for check-up 
consults are less strict for asthma, especially when the patient is on little or no medication. A 
reasonable to good association between indicators serves as an indication that we are 
measuring one underlying concept. With respect to the amount of patients needed to 
establish precise scores, often the same maximum number of patients emerged for the 
various indicators. The reason for this was that with almost all indicators, at least one patient 
population had a score of 50%; with this score the largest number of patients is statistically 
needed to achieve a precise score. The number of patients needed decreases the closer a 
score gets to 0% or 100%. The reliability of the scores is also dependent on the reliability of 
the data that are used for their calculation. The scores will never be reliable when the data 
have not been collected in a reliable way, for instance because of problems with the data 
collection. Uniform reporting is therefore of the utmost importance. Moreover, the data that 
will be included or excluded should be determined in advance. 
The question of how many patients are needed to calculate a precise score and which 
confidence limit would be acceptable, depends to a large extent on the purpose of the 
measurement. The score does not have to be accurate to one percent in order to give a good 
indication of possible points for improvement if it is used for internal quality improvements 
only. Drawing a line with respect to which accuracy level is acceptable is rather arbitrary and 
partly determined by feasibility factors. A general practice only has a limited number of 
patients with a certain condition. There is also a limit to the time investment by the family 
physician. The sample survey of 40 patients which is permitted at the moment in the VIA is 
reliable as long as a confidence limit of 15 percentage points is accepted. For want of larger 
numbers of data, these scores could indeed be used as a reasonable indication for internal 
quality improvement. Stricter demands are put upon the instrument when it should be able 
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to differentiate between practice scores or when it should report scores more accurately. If 
the instrument is used to distinguish between practices, for instance as part of a pay-for-
performance-system, larger numbers of patients will have to be included. A confidence limit 
of 5 percentage points or less is advisable for this purpose, which means a distinction can 
only be made on the level of the care group or between larger practices.  
In our study we did not calculate performance scores on a practice level, but on the level of 
the patient population. In most cases a practice contained only one population. When 
practices supply data for several populations, these data can be taken together in order to 
give a better picture of the practice as a whole. When interpreting data it should be taken into 
consideration that the division between ‘reliable’ and ‘not reliable’ is not as clear as it might 
seem. Even if, on the basis of the number of patients included, the conclusion is that an 
indicator score is not precise enough, such a score could still give a reasonably good picture 
of the practice. However, in this case we are not 95% sure that the score is indeed 
representative, meaning that care must be taken when conclusions are drawn on the basis of 
the scores found. The number of patients or patient populations needed will decrease by 
raising the confidence limit to 15 points. Depending on the purpose, the confidence limit 
chosen and the number of patients included can be varied upon in order to arrive at a score 
which is as precise as possible.  
 
Conclusions 
Our study shows that the domain of clinical care, part of the VIA, is reliable and valid with 
regard to the four criteria studied. However, it is important in this respect to take an 
acceptable confidence interval into account when interpreting data. Uniform reporting is of 
the utmost importance to improve the reliability of the data collection. The instrument is 
valuable for FPs to gain more insight into the medical care they provide, compared with 
national reference figures. On the basis of this instrument, FPs can formulate plans to improve 
the quality of clinical care. The instrument can also be useful when looking at the quality of 
clinical care on a national scale. However, the number of patients that should be included in 
the data collection would then need to be larger than for use of the instrument within the 
practice, due to the higher demands on precision.  
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Precision of individual and composite
performance scores: the ideal number
of indicators in an indicator set
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ABSTRACT 
Background In many countries, quality indicators are used to assess the quality of care of 
general practices. Such assessments need to have an adequate precision, so that the results 
can be interpreted correctly. However, a small sample size per physician can lead to 
inadequate precision. A possible solution could be to create composite performance scores. 
The objective of this study is to evaluate the relationship between sample size and precision. 
We examine whether a composite performance score has an increased precision and how 
many indicators are needed minimally to achieve this level of precision. 
Methods We performed a descriptive statistical study on data from the medical records of 
455 Dutch practices. We included three different conditions: diabetes (12 indicators), chronic 
obstructive pulmonary disease (4 indicators), and cardiovascular disease and risk 
management (9 indicators). 
Results For individual quality indicators, patient samples close to 100 are required to achieve 
even moderate precision (10 percentage points) on the performance scores. This number 
decreases substantially when a composite score is used. A composite derived from 
combining 5 to 7 indicators can provide much the same precision of measurement as one 
made up from a much larger number of indicators. 
Conclusions The added value of a composite score depends on the a priori reasons for 
measuring quality. Our results indicate that especially for formative quality improvement a 
small number of carefully selected indicators can provide a sufficiently precise composite 
measure. 
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BACKGROUND 
Quality indicators provide a tool to assess the quality of primary care; different instruments 
have been developed to measure medical care, practice organization, and patient opinions1-9. 
To ensure meaningful quality evaluations, transparency is critical and assessments using 
indicators should adhere to key attributes that address the properties of the instrument such 
as validity, feasibility, and reliability10-14. However, there has been limited investigation into 
statistical aspects of indicator scores such as precision, particularly where several indicators 
are combined into a ‘composite’ measure. 
Precision is an expression of the closeness of an estimate to the population value15 and is 
typically measured as the width of the confidence interval around the estimated value. A 
related property is the reliability. Reliability is usually defined in terms of measurement 
reproducibility and freedom from random error16, but when operationalized in the form of the 
reliability coefficient, becomes a comparative measure. Thus, whereas precision focuses on 
the accuracy of a performance score for one provider irrespective of the scores for other 
providers, the reliability coefficient compares the precision of an individual provider’s score to 
the variability in scores across providers, as a measure of how distinct the provider scores are 
from one-another. The narrower the variation in scores between providers, the more precise 
the individual provider scores need to be to achieve high reliability. Validity, as a third 
property of a measurement, is essentially concerned with the extent to which a score 
measures what it purports to measure13; however, the current paper is not concerned with 
questions of validity. 
Precision and reliability provide different kinds of information about a quality score. For the 
current paper we will focus mainly on precision, which is the more relevant measure for 
determining if a provider genuinely falls below a benchmark. Where providers receive a 
financial incentive based on their performance scores, poor precision could result in 
considerable overpayment or underpayment. Reliability is more informative where the aim is 
to ensure that the precision of measurement is sufficient to distinguish between different 
providers. 
The precision of a score is dependent on the number of cases included in the sample. This 
poses a problem for routine clinical usage because the larger the patient sample, the more 
time consuming the data collection becomes. Furthermore, the achievable sample size, and 
hence the precision of measurement, depends on the prevalence of the condition and the 
size of the unit of assessment. The larger the unit, such as a region, the easier it is to access 
sufficient data to reach a desired level of precision. However, data at the individual physician 
level are more informative for Continuing Professional Development, and at the practice level 
for external quality assessment and formative practice level quality improvement17. Therefore, 
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it is important to investigate methods that help create more precise scores at finer levels of 
measurement in order for the scores to have clear interpretation (interpretability) and to 
distinguish one score from another score or a benchmark (discriminative ability). 
A strategy that might increase precision at finer levels of measurement is to combine data on 
a number of individual quality indicators into a single ‘composite’ score. Reeves et al.18 
described different methods for creating composite scores and the different benefits and 
drawbacks of each, depending on the objective. Scholle et al.19 looked at the reliability of 
individual versus composite scores and concluded that composite scores can increase 
reliability. Kaplan et al.20 looked at the internal consistency of a composite score and found 
that adequate internal reliability could be achieved when at least 25 patients per physician 
were included. 
This study investigates the relationship between the precision of indicator scores and the 
number of cases used for assessment and also how the latter is affected by creating 
composite scores. We will focus on diabetes, chronic obstructive pulmonary disease (COPD), 
and cardiovascular diseases, which are conditions that are often included in instruments that 
measure quality of primary care, such as the Healthcare Effectiveness Data and Information 
Set (HEDIS) in the United States5 and the Quality and Outcomes Framework (QOF) in the 
United Kingdom1. These conditions have a high incidence and prevalence and account for 
high levels of expenditure and burden on individuals. As the number of quality indicators per 
condition varies across instruments, we will also address the influence of the number of 
indicators on the precision of the composite score. If we can achieve similar precision for a 
composite score based on a smaller subset of indicators, this would lower the burden for 
users of performance scores. 
We address the following research questions: 
1. What is the precision of a single performance score given different sample sizes? 
2. What is the precision of composite performance scores given different sample sizes? 
3. What is the smallest subset of indicators that will provide a composite score of similar 
precision to the full indicator set? 
 
METHODS 
Study population 
A descriptive statistical study was conducted in January 2009, using medical record data from 
455 Dutch general practices out of the 4,235 practices in the Netherlands21. The practices had 
taken part in the Dutch Accreditation program8, on a voluntary basis, and had finished data 
collection between November 2005 and May 2008. The practices were a representative 
sample of all Dutch practices regarding practice size, location, and urbanization although 
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solo practices were slightly underrepresented in our sample. Practice staff collected data 
from electronic medical records using a standardized data abstraction form, taking a sample 
of 40 patients per practice. We removed patients where the medical record was entirely 
empty or the family physician was not the main care provider (see Appendix, excluded data). 
If, after these exclusions, the number of remaining patients for a condition at a practice was 
<20, we excluded the entire practice from the dataset for the condition. This resulted in a 
subset of 350 practices for diabetes, 286 practices for chronic obstructive pulmonary disease 
(COPD), and 342 practices for cardiovascular disease and risk management (CVD/RM). 
 
Data collection 
We extracted data from the patients’ medical records relating to 12 clinical indicators on 
diabetes, 9 on CVD/RM, and 4 on COPD (Table 1). The CVD/RM indicators related to a 
heterogeneous group of people that had elevated risk for CVD: patients with 
hypercholesterolemia, hypertension, heart failure, angina pectoris, peripheral artery disease, 
or with myocardial infarction. Only process indicators were included in the study; such 
indicators are considered to be more sensitive to differences in quality of care compared with 
outcome indicators22. The indicators are based on Dutch guidelines and were developed 
using a consensus technique to ensure high content validity8,23. We required that there be a 
clear record of the indicator having been met in the patient’s medical record, otherwise we 
treated it as not met. 
 
Measures 
For each indicator, a performance score was computed as the number of patients for whom 
the indicator was met, divided by the number of patients eligible for the indicator, expressed 
as a percentage; summary scores are listed in Table 1. A composite score was calculated for 
each of the three conditions as the mean of the individual indicator scores within the 
condition. This ‘indicator average’ method18 forms the basis of many actual quality 
measurement systems3,23. Often these involve some form of weighting system to give 
differential importance to some indicators over others. The UK Quality and Outcomes 
Framework assigns weights to indicators based on expert judgement1. Another approach, 
termed ‘opportunity weighting’ gives each instance of an indicator equivalent impact on the 
composite score by weighting each indicator by its relative denominator (the denominator 
divided by the sum of denominators). The impact of weighting is not examined in detail in this 
paper, as this would add additional complexity to the analysis. 
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Table 1. Overview of indicators with median, 75th percentile and 90th percentile score across practices 
(diabetes n = 350, COPD n = 286, CVD/RM n = 342) 
Condition  No. Description Median  
(%) 
75th  
(%) 
90th  
(%) 
Diabetes 1 % of patients with a record of smoking status  70.5 89.7 97.6 
 2 % of patients with a record of BMI* 75.7 94.4 100 
 3 % of patients with a record of family history 29.9 68.9 94.9 
 4 % of patients with a record of CVR◊ status 53.1 87.4 97.5 
 5 % of patients with a record of at least 3 glucose 
measurements in the last 12 months 
89.3 95.8 100 
 6 % of patients with a record of HbA1c measurement 
in the last 12 months 
95.8 100 100 
 7 % of patients with a record of a blood pressure 
measurement in the last 12 months 
97.1 100 100 
 8 % of patients with a record of cholesterol 
measurement in the last 12 months 
91.9 96.6 100 
 9 % of patients with a record of creatinine 
measurement in the last 12 months 
93.1 96.8 100 
 10 % of patients with a record of retinal examination in 
the last 24 months 
72.3 83.3 92.1 
 11 % of patients with a record of feet examination in 
the last 12 months 
62.3 81.7 91.7 
 12 % of patients with a record of a lipid lowering 
medication prescription 
61.3 72.2 79.5 
COPD 1 % of patients with a record of a spirometry 
assessment ever 
37.1 62.2 83.6 
 2 % of patients with a record of spirometry 
assessment in the last 12 months 
34.5 55.1 75.1 
 3 % of patients with a record of smoking status 83.6 94.6 100 
 4 % of patients with a record of a consultation in the 
last 12 months 
73.9 84.6 92.5 
CVD/RM 1 % of patients with a record of cholesterol 
measurement in the last 12 months 
58.2 70.5 80.0 
 2 % of patients with a record of smoking status 62.5 80.0 92.7 
 3 % of patients with a record of a glucose 
measurement in the last 12 months 
64.6 75.0 85.0 
 4 % of patients with a record of blood pressure 
measurement in the last 12 months 
80.0 87.5 92.5 
 5 % of patients with a record of BMI* 27.5 47.6 70.0 
 6 % of patients with a record of family history 17.5 33.7 57.0 
 7 % of patients with a record of CVR◊ status 24.7 57.5 92.3 
 8 % of patients with a record of a lipid lowering 
medication prescription 
45.0 54.3 65.9 
 9 % of patients with a record of a prescription of 
anticoagulants 
39.0 51.2 77.5 
* BMI = body mass index. ◊ CVR = cardiovascular risk. 
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Analysis 
We express the precision of a score as the 95% confidence limit either side of the mean, 
calculated as 1.96 times the SD15. For example, for a practice that scores 55% on the diabetes 
HbA1c indicator, a precision of 15 points indicates that we are 95% confident that the interval 
of 40% – 70% covers the ‘true’ score. We calculated the number of patient records needed to 
achieve a level of precision of 15, 10, and 5 points. The formulas used to calculate the sample 
size required at each level of precision are given in the Appendix. Inter-indicator Pearson 
correlations were calculated using SPSS 18.0. 
To examine the impact on sample size of relaxing the criteria that performance scores at all 
practices attain the target level of precision, we calculated sample sizes required to achieve 
the target precision at 75% and 90% of all practices. This was to explore the benefit – in data 
collection terms – of reducing the sample by accepting less precise scores for a minority of 
practices. 
To investigate the effect on precision of using fewer indicators, we began with a composite 
score made up of all indicators, and then removed indicators one-by-one. At each step, we 
removed the indicator that maximized the precision of a composite made from the remaining 
subset of indicators. This gave the ‘optimal’ subset of indicators: that is, the subset with the 
highest precision. We then repeated the process, but at each step removing the indicator that 
minimized the precision for the remaining indicators. This identified the least optimal 
indicator subsets (i.e. those with the lowest precision). 
 
RESULTS 
Precision of indicator performance scores 
The sample sizes required to achieve different levels of precision were calculated for each 
practice separately, based on the practice’s own observed scores. Table 2 summarizes the 
results for a selection of indicators that represent the range of findings. For each indicator, the 
first row shows the number of cases needed to achieve the target level of precision for all 
practices. The second and third rows show the sample sizes when a percentage of practices 
(10% and 25%, respectively) is allowed to have less precision than the target level. For 
example, a sample of 43 cases from each practice ensures that all practices will have their 
performance score on diabetes indicator 9 estimated with a precision of 15 points or better. 
This implies that at least 1 practice requires 43 cases, other practices may require fewer than 
43 cases. As the degree of precision becomes greater (i.e. the confidence interval narrows), the 
number of cases needed increases: 384 cases per practice are required for all practices to 
achieve a precision of 5 points. This pattern of results is repeated for all indicators. However, 
when only 90% or 75% of practices are required to have scores within the target precision, 
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there is a substantial reduction in the sample size for some indicators, but very little change 
for others. A sample size of just 19 patients would yield a maximum confidence limit of 15 
points on diabetes indicator 9 for 75% of practices. The corresponding sample size for 
CVD/RM indicator 7 is 42 patients, compared with 43 patients to reach this precision for all 
practices. Indicators where the more relaxed criteria resulted in the biggest reductions in 
sample size were those where most practices had either very high or very low performance 
scores. 
 
Table 2. Number of cases required to achieve different levels of precision (95% confidence limit) 
Condition No. % of practices achieving the 
target precision 
No. of cases required for a target precision of: 
  15 points 10 points 5 points 
Diabetes 3 All practices 43 96 384 
  90% of practices 42 94 375 
  75% of practices 36 81 323 
 9 All practices 43 96 384 
  90% of practices 27 60 239 
  75% of practices 19 42 167 
COPD 1 All practices 43 96 384 
  90% of practices 42 95 380 
  75% of practices 40 90 359 
 3 All practices 43 96 384 
  90% of practices 41 93 373 
  75% of practices 37 84 335 
CVD/RM 2 All practices 43 96 384 
  90% of practices 42 95 380 
  75% of practices 41 92 369 
 7 All practices 43 96 384 
  90% of practices 42 94 376 
  75% of practices 35 79 314 
 
Precision of composite performance scores 
For each practice, a composite score was calculated for each of the three conditions. Practice 
mean composite scores and SDs appear in Table 3, as well as reliability coefficients 
corresponding to each level of precision. For diabetes and COPD, a precision of 15 points 
equates to a reliability coefficient of >0.7, the value generally taken to indicate acceptable 
reliability. However, CVD/RM scores demonstrate less variability between practices; here the 
same level of precision equates to a reliability coefficient of just 0.6. For all conditions, a 
precision of ≤10 points equates to reliability well above the threshold for acceptability. 
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Table 3. Mean composite scores and reliability coefficients corresponding to levels of precision 
Condition Indicator average Mean (SD) Reliability coefficient at a level of precision of: 
15 points 10 points 5 points 
Diabetes 70.2 (15.4) 0.75 0.89 0.97 
COPD 58.1 (14.7) 0.73 0.88 0.97 
CVD/RM 48.8 (12.1) 0.60 0.82 0.96 
 
Table 4. Number of cases required to achieve different levels of precision for composite performance scores 
Condition % of practices achieving the 
target precision 
No. of cases required for a target precision of: 
15 points 10 points 5 points 
Diabetes All practices 19 43 174 
 90% of practices 9 20 81 
 75% of practices 7 15 60 
COPD All practices 25 56 222 
 90% of practices 17 38 152 
 75% of practices 14 32 128 
CVD/RM All practices 40 89 356 
 90% of practices 15 33 133 
 75% of practices 11 25 101 
 
For diabetes and COPD, the number of cases required to achieve a given precision on the 
composite score for all practices is around half the size of the sample required for the 
individual indicator scores (Table 4): for example 19 cases compared with 43 for a precision of 
15 points for diabetes. However, for CVD/RM the reduction is only small (40 patients 
compared with 43). Even so, relaxing the target criteria to 90% or 75% of practices results in 
large reductions in sample size for all three conditions. The sample size gains from using a 
composite score are substantially greater for diabetes; this is related to the generally much 
higher practice performance scores. 
 
Composite scores based on indicator subsets  
Table 5 shows the sample sizes required to achieve a precision of 10 points, for differing 
subsets of indicators. For diabetes, an optimally selected subset of 7 indicators is sufficient to 
achieve a 10 point precision for all practices for a small increase in sample size (45 cases 
compared with 43 when using all 12 indicators). A sample size of just 20 can provide this level 
of precision for 90% of practices. However, other subsets of 7 diabetes indicators require a 
larger sample size to achieve the same precision, up to 34. Results are similar for CVD/RM, 
with subsets of 5 or 6 optimally selected indicators providing the same precision as the full 
indicator set for no appreciable increase in sample size.  
Table 5. No. of cases required to achieve a precision of 10 points for subsets of composite scores (optimal selection - least optimal selection) 
Condition % of practices achieving 
the target precision 
No. of indicators in composite score 
12 11 10 9 8 7 6 5 4 3 2 
Diabetes All practices 43 44-43* 46-42* 46-45* 48-52 45-57 53-65 51-81 54-93 61-95 62-96 
 90% of practices 20 20-22 19-24 20-26 19-29 20-34◊ 21-40 21-46 22-52 22-59 28-73 
 75% of practices 15 14-16 14-17 15-19 15-21 15-24 15-27 15-31 16-35 16-42 18-49 
COPD All practices - - - - - - - - 56 73-73 70-81 
 
90% of practices - - - - - - - - 38 41-49 49-64 
75% of practices - - - - - - - - 32 33-43 40-56 
CVD/RM All practices - - - 89 89-90 90-94 88-94 93-94 92-94 92-94 91-95 
 90% of practices - - - 33 32-39 33-45 31-46 34-48 35-56 34-68 43-85 
 75% of practices - - - 25 25-30 25-35 24-37 26-41 27-47 27-60 34-81 
 
Table 6. Mean composite performance scores and mean inter-indicator Pearson correlation for most optimal and least optimal subsets  
Condition Indicator 
subset 
Practice mean No. of indicators in composite score 
 12 11 10 9 8 7 6 5 4 3 2 
Diabetes Most optimal Composite score 70.2 71.2 72.6 73.1 71.2 72.2 74.3 79.6 78.6 74.7 93.7 
  Correlation 0.24 0.24 0.24 0.26 0.24 0.23 0.28 0.30 0.30 0.22 0.45 
 Least optimal Composite score 70.2 68.0 65.6 62.8 59.6 56.2 55.6 53.1 51.5 47.3 42.4 
  Correlation 0.24 0.24 0.24 0.24 0.26 0.29 0.36 0.44 0.57 0.61 0.66 
COPD Most optimal Composite score - - - - - - - - 58.1 53.2 60.3 
  Correlation - - - - - - - - 0.21 0.17 0.08 
 Least optimal Composite score - - - - - - - - 58.1 51.5 55.8 
  Correlation - - - - - - - - 0.21 0.26 0.38 
CVRM Most optimal Composite score - - - 48.8 47.5 45.0 47.3 47.7 44.5 47.8 32.7 
  Correlation - - - 0.23 0.21 0.20 0.17 0.18 0.16 0.06 -0.07 
 Least optimal Composite score - - - 48.8 49.6 50.2 52.8 58.9 58.4 67.4 62.1 
  Correlation - - - 0.23 0.28 0.33 0.34 0.36 0.41 0.54 0.71 
* For the subsets of 11, 10 and 9 diabetes indicators, the larger sample size for the most optimal subset is a consequence of the results for one practice. Without this 
practice, the number of cases required for the most optimal set were 36, 35 and 36 respectively. ◊ A composite score based on the ‘most optimal’ subset of 7 diabetes 
indicators has a precision of 10 points or less for 75% of the practices when based on a sample of 20 patients. For other subsets of 7 indicators, the required number of 
patients is higher, up to 34 patients.  
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There are only 4 indicators in the full set for COPD; dropping any of these generally results in a 
bigger increase in sample size. When indicator subsets are selected in the least optimal 
manner, the impact varies more highly; in some scenarios (e.g. CVD/RM and 90% of practices) 
removal of just 2 indicators can result in a substantial increase in sample size requirement. 
Table 6 shows the mean composite score and mean inter-indicator correlation across 
practices for each subset. The formula for the variance of the composite indicates that 
variance will be lower for subsets of indicators with smaller inter-indicator correlations and 
with scores closer to 0% and 100% (see Appendix). These characteristics are reflected in Table 
6. For most subset sizes, the mean inter-indicator correlation is smaller for the most optimal, 
compared with least optimal, subset of indicators, with the difference increasing as the size of 
the subset decreases. The difference in mean composite score also increases as the subset 
size decreases. 
 
DISCUSSION 
The interpretation of performance scores requires caution when scores are based on small 
numbers of cases. In this study, for most individual indicators a sample of 96 cases was only 
just enough to compute a performance score with a 95% confidence limit of plus/minus 10 
percentage points for many practices. By using composite scores, the same level of precision 
could be attained for the great majority of practices with samples a fraction of the size 
required for a single indicator. But even for composite scores, to achieve high levels of 
precision (i.e. confidence limits of ≤5 points) at all practices would still require the sampling of 
large numbers of patient records for some conditions. Low precision restricts the 
interpretability of the performance score and the ability to discriminate a performance score 
from a benchmark. However, collecting data on only a small number of indicators per 
condition does not necessarily lead to lower precision. 
 
Strengths and limitations 
We did not examine the impact on the composite score of weighting the indicators. A 
weighted score will have a precision somewhat greater or smaller than the unweighted 
composite, depending upon the variances of the indicators receiving the largest weights. 
However, if the weight assigned to an indicator is unrelated to performance on that indicator, 
then our results in effect represent a general average. Where weights are used to incentivize 
indicators with lower performance (as typically happens) and such indicators generally have 
higher variability, our results are likely to overestimate precision. We made some standard 
statistical assumptions that are detailed in the Appendix. 
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Implications 
We found that the precision of a composite score is a function of both the performance scores 
on the individual indicators in the composite and the inter-correlations between those scores. 
Precision is greater for indicator sets displaying high or low performance scores, and low 
inter-indicator correlations. The effect of low inter-correlations might appear counterintuitive, 
but one way to understand the result is to recognize that a highly correlated indicator does 
not contribute very much additional unique information to the combined score. We would 
clearly not advocate selecting indicators on the basis of their high and low scores to maximize 
the precision of the composite: for assessment purposes it is important that indicators have 
‘room’ to respond to changes in performance. However, where there is a choice among 
indicators with similar levels of performance, selecting a subset with generally smaller inter-
correlations will have advantages in terms of precision. 
Creators of quality indicator sets usually want the indicator performance scores to correlate, 
as an indication of coherence within the set of indicators, implying that the indicators are 
measuring one underlying concept15,18. For this reason one would want to be wary of including 
indicators with no, or only very weak, associations with the rest of the set, but equally the 
inclusion of highly correlated indicators may imply some redundancy. The mean inter-
indicator correlations in this study were just over 0.2 for all the three conditions, this is one 
reason why our composites were so effective in reducing required sample sizes. 
The precision of quality assessment is only weakly related to the number of indicators 
included in the composite score. Judicious selection of subsets of 5 to 7 diabetes or CVD/RM 
indicators generated composite scores with the same precision as the full indicator set 
without noticeably increasing the sample size requirement. However, by precision we mean 
the accuracy with which practice performance on this specific set of indicators is being 
measured. The incorporation of additional indicators may well be necessary to ensure the 
clinical and conceptual validity of the indicator set. In any debate about measuring a few 
conditions extensively or a broad range of conditions with only a few indicators per condition, 
our results would favor the latter. 
In 2009/2010, the Quality and Outcomes Framework in the United Kingdom consisted of 86 
clinical performance scores, with the number of indicators in each clinical area ranging from 2 
for cancer and hypothyroidism to 18 for diabetes1. The HEDIS in the United States commonly 
uses only ≤5 indicators per condition5. Our results show that these smaller numbers of 
indicators per condition do not necessarily pose problems regarding precision. Incorporating 
more indicators might increase the validity of the instrument, but unless these are capturing 
new information they are unlikely to result in a notable benefit to the interpretability or 
discriminative ability of the scores. 
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The most effective way to increase the precision of both individual and composite 
performance scores is to increase the sample size. For smaller practices or conditions with 
low incidence and prevalence, larger sample sizes can be hard to establish. In the United 
States, United Kingdom, and the Netherlands, and indeed throughout Europe, there are many 
solo or small practices. There are 2,340 people in the Dutch population per fulltime-
equivalent physician21. This suggests that for solo practices, reasonably precise performance 
scores (i.e. with a 95% confidence limit of 10 points) for individual indicators can only be 
derived for conditions with a prevalence of >4%. Using composite scores it should be possible 
to reach the same precision for conditions with a prevalence of 2% depending upon the 
condition. Even so, there will be many conditions for which precise measurement is not 
feasible at smaller practices. 
 
Conclusions 
On the basis our findings, policy makers should be cautious when interpreting performance 
scores for individual indicators based on small numbers of cases. A well-designed composite 
measure can provide a more precise measure of performance; a small number of indicators 
included can be sufficient. Data collection demands can be substantially reduced by using a 
sample size that accepts that the precision of measurement will be below target for a small 
minority of practices. 
When selecting indicators it is important to find a good balance between considerations of 
the validity of the composite measure – for which good correlations between indicators might 
be one criterion – and the precision of the score – for which low inter-correlations are 
desirable. Other aspects that should be taken into account include the desired level of 
comprehensiveness and the feasibility of data extraction24. It is crucial to align issues for 
assessment to professional priorities and to issues of clinical relevance to patients and policy 
makers, as this is more likely to influence and change professional behavior25. The degree of 
precision required is also related to the purpose of the assessment; in particular whether 
indicators are being used for external summative judgment or formative internal quality 
improvement18,12. Precision needs to be greatest when there is an external summative 
assessment and where assessment is used as a payment mechanism. Different situations 
(summative, formative, local, national, etc.) may require a different focus. Our results show 
that especially for formative quality improvement, composite scores based on fewer cases 
and a small number of (low-correlated) indicators can provide a precise enough score. 
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APPENDIX 
To compute sample sizes for the present paper, we utilized a number of formulas, described 
below. While the methods used for individual indicators are quite standard, those for 
composite indicators were derived specifically for this paper.  
 
Precision of a performance score for a single indicator 
For a given practice, let p i  be the observed performance score on indicator i, expressed as a 
proportion (i.e. 0 ≤ p i  ≤ 1), and let n be the number of patients (observations) on which p i  is 
based. Then, using the standard Normal approximation to the binomial distribution1, the 
variance of p i  can be estimated in the usual way as: 
 ( ) i ii
p (1 - p )
V p =
n
  (1) 
The distribution of p i  is reasonably Normal for npi  ≥ 5 (Box et al.2, p. 130). 
 
Let C be the desired level of precision (confidence limit) on p i , also as a proportion. Then, the 
number of cases n required to achieve this level of precision is given by: 
 
2
i i
2
p (1 - p )
n =
C
z
  (2) 
Where Z is the standardized Normal variate associated with the required confidence limit. For 
example, Z = 1.96 for a 95% confidence limit. 
 
Precision of a composite performance score 
Let p 1 ,  p 2 , . . .  p k  be the observed practice performance scores on a set of k  indicators, and let 
the composite score, p c , derived from these be the mean of the k  scores: 
 
∑
k
i
i = 1
c
p
p =
k
   (3) 
The variance of p c  is given by: 
 ( ) ( )∑kc i2
i = 1
1
V p = V p
k
  (4) 
Using standard distributional theory and the Normal approximation to the binomial the 
variance of p c  can be estimated as: 
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 ( ) ∑ ∑ ∑
 
  
 
k k -1 k i i j ji i
c i j2
i = 1 i = 1 j = i + 1
i i j
p (1 - p )p (1 - p )p (1 - p )1
V p = + 2 r
k n n n
  (5) 
Where r i j  = observed correlation between indicators i  and j. 
 
In the special case when n i  has the same value, n, for all k  indicators, such as with the present 
dataset:  
 ( ) ( )∑ ∑ ∑k k -1 kc i i i j i i j j2
i = 1 i = 1 j = i + 1
1
V p = p (1 - p ) + 2 r p (1 - p )p (1 - p )
nk
  (6) 
Where r i j  = observed correlation between indicators i  and j. 
 
The sample size required to achieve a precision of size C on the composite score is then given 
by: 
 ( )∑ ∑ ∑   
k k -1 k
2
i i i j i i j j2 2
i = 1 i = 1 j = i + 1
1
n = p (1 - p ) + 2 r p (1 - p )p (1 - p )
k C
z   (7) 
 
We note from equations (6) and (7) that V( p c )  and n are reduced in size when (I) performance 
scores are further away from a value of 0.5, and (II) indicator inter-correlations are small. Thus 
for a given sample size, precision will be higher (i.e. the confidence interval narrower) for a set 
of indicators with high and/or low performance scores and low inter-correlations compared 
to a same-sized set with middling performance scores and larger inter-correlations. 
 
Calculation of reliability 
We let V T( p c ) represent the variance between practices in ‘true’ composite performance 
scores and V O( p c )  the variance in observed practice scores, the coefficient of reliability is then 
defined in the standard way as the ratio of true score variance to observed score variance: 
O c
T cV (p )
V
r
(p
=
)
   (8) 
We previously defined V( p c )  to be the variance of the observed composite score for an 
individual practice. Assuming that V( p c )  is the same for all practices, the variance in observed 
scores across practices is equal to the true variance plus the within-practice variance: 
V O( p c ) =V T( p c ) +V( p c )   (9) 
 
From equations (8) and (9), reliability can be estimated as: 
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O c
O c
cV (p ) - V(pr
V ( )p
=
)
  (10) 
The variance around a practice score can be expressed in terms of the associated precision, C, 
as: 
 
2
c 2V (p = Z
C)    (11) 
Hence the reliability coefficient can be estimated from the precision and the observed 
between-practice variance using: 
 
O c
O c
2
2V (p ) - 
=
)V
r
(p
C
Z   (12) 
We used formula (12) to estimate reliability values for the paper. The formula rests on the 
assumption that V( p c )  is the same for all practices. In practice that will not be so, in which 
case r  is the reliability corresponding to the desired precision C. 
 
Identification of reduced sets of indicators 
We investigated the effect on precision of using fewer indicators in the composite, by first 
constructing the composite using all indicators and then removing indicators one-by-one, at 
each step removing the indicator that minimized the variance of the composite score for the 
remaining subset of indicators. To do this, on the basis of equation (6) above, at each step we 
computed Y i  below for each indicator i. 
 
≠
∑i i i i i i j j j
m
j i
Y = p (1 - p ) + 2 p (1 - p ) r p (1 - p )   (13) 
Where m is the number of indicators in the composite at each step. 
 
We computed a separate Y i  for each practice and summed these across practices. We then 
identified the indicator with the largest sum. Removal of this indicator gave the reduced set of 
indicators with the minimum total sum of within-practice variances for the resulting 
composite score. 
 
This process identified the ‘optimal’ subset of indicators at each step: that is, the subset with 
the smallest possible sum of within-practice variances. We then repeated the process, again 
starting with the full set of indicators, but at each step removing the indicator that maximized 
the sum of practice variances for a composite of the remaining indicators. This identified the 
least optimal indicator subset at each step (i.e. the one with the maximum variance). We used 
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the results to compute the sample sizes required for composites based on the optimal and 
least-optimal indicator subsets at each step to have a precision of 10 percentage points. 
 
Finite population adjustment 
For maximum generalizability, the equations for sample size above assume that the patients 
measured on an indicator at a practice are a random selection from a very much larger – 
effectively infinite – population of potential patients. However, a ‘finite population’ 
adjustment would be appropriate if the goal were to measure performance solely for a fixed 
set of patients who attend the practice. In this case, we regard the patients eligible for an 
indicator at a particular practice as constituting the total population of eligible patients, such 
that if all these patients were assessed the error on the performance score would by definition 
be zero (i.e. perfect precision). For this purpose, the sample sizes reported in the paper can be 
adjusted using the below formula: 
 f
nN
n =
n + N - 1
  (14) 
Where n is the required sample assuming an infinite population, N is the number of patients 
in the finite population, and n f  is the corresponding sample required from this population.  
 
As an example, our paper reports that a sample of 90 patients is required to achieve a 
precision of 10 percentage points for the diabetic care composite score. For a practice with 
150 diabetic patients, the number of these patients that has to be sampled to estimate the 
performance score for the full group of 150 to a precision of 10 points is: 
 f
90 × 150
n =
90 + 150 - 1
= 56  
 
Excluded data 
For each of the conditions a small number of patients were excluded due to a completely 
empty medical record. We excluded substantial numbers of diabetes and COPD patients 
(20.2% and 35.1% respectively) where the main care provider was not the FP but a specialist. 
As a final step practices that, after the above exclusions, had data for less than 20 patients 
with a condition were excluded from the dataset for that condition. We imposed this step to 
reduce the occurrence of poorly estimated indicator performance scores, particularly 
spurious 0% and 100% scores that bias variance estimates (see below). For a large number of 
COPD patients the FP was not the main care provider, resulting in a larger percentage of both 
patients and practices being excluded for this condition. Table 1 summarizes the included 
and excluded data. 
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Table 1. Amount of included and excluded data 
Condition Total amount of data Included in calculations % excluded 
practices patients practices patients practices patients 
Diabetes 392 15033 350 11783 10.7 21.6 
COPD 455 15290 286 8128 37.1 46.8 
CVD/RM 379 14267 342 14158 9.8 0.8 
 
Treatment of performance scores of 0% and 100% 
Some practices had a performance score of 0 or 1 on some indicators. When used with 
equation (1), these scores return a variance estimate of zero. Since zero variance is unrealistic, 
we replaced 0% and 100% scores with a score close to 0 or 100 using the following formulas: 
When p i  = 0 we substituted i
d
p =
n
 
When p i  = 1 we substituted i
n - d
p =
n
 
Where d  = 0,5 and n = number of cases for the practice. 
 
For 5 of the 12 diabetes indicators we applied this to more than 10% of practice scores. This 
was especially the case with diabetes indicator 3, where 94 practices (26%) scored 0%. The 
CVD/RM set also included 3 indicators (indicators 5, 6 and 7) with a large number of 0% or 
100% scores. For COPD, only a small percentage (less than 5 %) of scores were amended. 
 
Statistical assumptions  
The underlying data has a binomial distribution to which we have applied the Normal 
approximation. Using standard criteria related to sample size and score2, the approximation 
is good for the majority of cases we have examined, the main exceptions being for the lowest 
sample size (20 cases) coupled with a performance scores below 25% or above 75%, in which 
case our estimates of precision do not represent the skew in the actual distribution. For 
samples of 40 or more, the approximation is good for performance scores between 12.5 and 
88.5. 
Our approach to estimating precision, reliability, and required sample sizes followed the 
standard statistical methodology of substituting observed practice indicator scores, 
variances, and inter-indicator correlations for the unobserved ‘true’ population scores. Any 
error in the overall results resulting from this will be small however, as over-estimated and 
under-estimated values should be reasonably balanced across practices. 
 
Eﬀect of accreditation on the quality
of chronic disease management:
a comparative observational study
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ABSTRACT 
Background Practice accreditation is widely used to assess and improve quality of 
healthcare providers. Little is known about its effectiveness, particularly in primary care. In 
this study we examined the effect of accreditation on quality of care regarding diabetes, 
chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD). 
Methods A comparative observational study with two cohorts was performed. We included 
138 Dutch general practices that participated in the Dutch Accreditation program for primary 
care. A first cohort of 69 practices was measured at start and completion of the three-year 
Accreditation program. A second cohort of 69 practices was included and measured 
simultaneously with the final measurement of the first cohort. In separate multilevel 
regression analyses, we compared both within-group changes in the first cohort and 
between-groups differences at follow-up (first cohort) and start (second cohort). Outcome 
measures consisted of 24 systematically developed indicators of quality of care in targeted 
chronic conditions. 
Results In the within-group comparison, we found improvements on 6 indicators related to 
diabetes (feet examination, cholesterol measurement, lipid lowering medication prescription) 
and COPD (spirometry measurement, smoking cessation advice). In the between-groups 
comparison we found that first cohort practices performed better on 4 indicators related to 
diabetes (cholesterol outcome) and CVD (blood pressure outcome, smoke status registration, 
glucose measurement). 
Conclusions Improvements of the quality of primary care for patients with chronic conditions 
were found, but few could be attributed to the Dutch Accreditation program. Further 
development of accreditation is needed to enhance its effectiveness on chronic disease 
management. 
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BACKGROUND 
A range of strategies has been developed to assess and improve healthcare for patients with 
chronic conditions1. A widely used strategy is accreditation of healthcare providers2,3. 
Accreditation affects the institution or practice and is offered more or less voluntary, while 
certification focuses on a specific norm that should be reached by individuals or particular 
services4,5. A key element of accreditation is audit and feedback. A Cochrane review suggested 
that an audit and feedback system has a small positive effect on quality of care overall6, but 
the added value of accreditation was not considered. Greenfield et al.7 suggested in their 
systematic review that accreditation can promote change, for example through the 
opportunity to reflect on organizational performance, and that it has an effect on professional 
development. However, they reported inconsistent findings regarding quantifiable effects of 
accreditation on measures of clinical processes and outcomes. Few rigorous evaluations of 
effectiveness of accreditation are available, particularly in primary care8-10. O’Beirne et al.10 
performed a review of peer-reviewed and grey literature regarding accreditation in primary 
care. They found indications that accreditation may improve both organization and 
outcomes of care, but conclude that more research is needed. Szecsenyi et al.11 examined an 
accreditation program that focuses on practice management; they found improvements on 
several quality and safety measures regarding complaint management, analysis of critical 
incidents and quality development. Given the shortage of controlled evaluations, more 
research on the effects of well-defined accreditation programs is required. 
In this study we assessed an accreditation program for primary care practices12,13, set up by 
the Dutch College of General Practitioners in 2005. This program strongly focuses on the 
educational value of audit and feedback and participation is voluntary. However, part of the 
program does require meeting specific norms, for example on hygiene, first aid equipment 
and accessibility. The program addresses clinical care as well as practice management. The 
clinical care section consists mainly of three chronic care conditions: diabetes mellitus, 
chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD). 
In the same period, health insurers developed bundled payment schemes, with an initial 
focus on diabetes (approximate start in 2008), and in later years also on COPD (since 2009) 
and CVD (since 2011)14,15. Bundled payment is suggested as a method to control costs while 
providing more patient-centered, higher quality care16. An international review of different 
types of bundled payment17 suggests that there is weak but consistent evidence for a positive 
effect of bundled payment on healthcare costs, with no tangible impact on quality of care. 
Studies on the effect of bundled payment in the Netherlands show that it improved 
organization and management of care18,19 and potentially also the outcomes of diabetes 
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care20. Nevertheless, a Cochrane review concluded that there is insufficient evidence to draw 
firm conclusions on the effectiveness of different these types of reimbursement schemes21. 
This study is focused on effects of the Dutch Accreditation program in the context of a 
healthcare system, in which provider reimbursement of chronic care was improved 
simultaneously. In the Netherlands, approximately 80% of diabetes patients has the family 
physician (FP) as the principal caregiver. This percentage is slightly lower for COPD and CVD 
patients (50-65%). Generally, patients with the FP as main care provider tend to be stable, 
although not necessarily well controlled. The study aimed to determine whether participation 
in the Accreditation program led to improvements in quality of care regarding diabetes, COPD 
and CVD. We also aimed to assess whether the improved performance was different from the 
performance during pre-assessment of a second group of participants. 
 
METHODS 
Study design 
We performed a comparative observational study with two cohorts of primary care practices. 
A first cohort of practices was followed throughout the three-year program with extended 
measurements at start and after three years. A second cohort was measured at their start of 
the Accreditation program, during the same period of the post-assessment in the first cohort. 
Data collected at the start of the practice accreditation process portrayed practice 
performance prior to the accreditation process: data were collected retrospectively over a 
one-year period prior to the start. We evaluated the effect of practice accreditation in a design 
with two separate comparisons. In the first comparison we assessed improvements over time 
within the first cohort. In the second comparison we assessed differences between the first 
and second cohort by comparing the follow-up measurement of the first cohort with the start 
measurement of the second cohort. Since both of these groups collected data in the same 
period, this comparison could offer additional information on effects of accreditation (3 years 
experience versus start of accreditation). The ethics committee of the Radboud University 
Medical Center provided a waiver for the study. 
 
Study population 
Practices included in the study were Dutch primary care practices that participated in the 
Accreditation program of the Dutch College of General Practitioners between 2006 and 2011. 
We included a group of 69 practices in the first cohort that joined the Accreditation program 
before 2009 and had collected follow-up data. Start measurements took place between 2006 
and 2008; follow-up measurements of this cohort took place between 2009 and 2011.  
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Figure 1. Selection of practices in the second cohort 
 
The average time period between data collection in the first cohort was 4 years and 2 months, 
with a minimal interval of 3 years and 2 months. The second cohort consisted of primary care 
practices that had their start measurement between 2009 and 2011. We used a matched 
design to select an equally large sample of 69 practices (see Figure 1). Matching was based on 
availability of data, practice location (degree of urbanization), visitation date, practice type, 
and practice size. 
 
Practice accreditation 
Practices have been invited to participate voluntarily in the Dutch Accreditation program 
since 2005. The preparatory phase of the program consisted of data collection regarding 
practice management and patient care. The measurement instruments used were previously 
validated questionnaires such as the ‘VIP’, a visitation instrument for practice organization22 
and the ‘Europep’ for patient experiences with care23. The clinical performance indicators 
were derived from the national guidelines valid at the time of measurement24. These 
indicators were measured with the use of patient information that was extracted from 
electronic medical records; the family physician (FP) or nurse extracted the information either 
automatically or manually with a standardized extraction form. After data submission via an 
Practices that registered to start with 
the Dutch Accreditation program 
between 2009 and 2011 
n = 802 
Practices that collected data on 
diabetes, COPD and CVD 
n = 440 
Practices that matched the first cohort 
ranked according to best match 
n = 128 
Second confirmation of no 
participation before 2009; practices 
that matched best to first cohort 
n = 69 
Exclusion n = 362 
no data on diabetes, 
COPD and / or CVD 
Exclusion n = 312 
no match with practices 
in first cohort 
Exclusion n = 59 
less optimal match with 
practice in first cohort 
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online system, the practice received a report that included information on its own 
performance and the performance of other practices as a benchmark. This information could 
be used to identify which areas needed improvement. The FPs wrote improvement plans with 
a plan-do-study-act cycle. The first audit was carried out after the approval of these plans to 
confirm adequate participation and to grant accreditation. After this audit a three-year 
accreditation cycle started. At the end of each year the practice staff evaluated whether the 
objectives of improvement plans were met and wrote new improvement plans for the 
following year. The prolongation of accreditation depended on this process; accreditation 
was not based on the actual quality of care itself, but rather on the quality of the 
improvement initiatives according to a structured program. 
 
Measures 
The primary care practice maintains comprehensive patient records, which includes 
information on all contacts and procedures in primary care, hospital, and several other care 
providers. For this study, we excluded all patients of which the FP was not the main care 
provider. All information used in this study was collected as part of the Accreditation program. 
The prevalence of diabetes and COPD was defined as the number of patients with the 
condition divided by the total number of patients in the practice. Indicators of both processes 
of care and intermediate outcomes were included regarding patients with diabetes, COPD 
and CVD (Table 1). The data that were collected before 2009 on CVD related to a broader 
range of patients; patients with high risk for CVD were also included. Since this made it 
impossible to compare data over time we only included data after 2009, that relate to 
patients with known CVD. During our research period several target levels as described in the 
guidelines shifted for diabetes (relating to indicators 2 and 3) and for CVD (indicator 2). We 
calculated the percentage of patients with a level below target level according to the target 
level that was valid at the time of measurement. Data on practice characteristics were 
collected through the use of online questionnaires which were also part of the Dutch 
Accreditation program. 
 
Analysis 
Descriptive statistics were used to describe the practice population and gain insight in the 
performance scores. For each of the three conditions we calculated a mean score for several 
process indicators. Some indicators could not be included in the mean scores due to low 
internal consistency with other indicators or use of subsamples: diabetes indicator 5, COPD 
indicator 3 and CVD indicators 4, 5 and 6 (Table 1). 
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Table 1. Overview of indicators 
Condition No. Description 
Diabetes   
Outcome 1 % of patients with an HbA1c value within target level (53 mmol/mol or less) 
indicators 2 % of patients with a blood pressure value within target level (2006-2008: 150/80 mm Hg or 
less, 2009-2011: systolic 140 mm Hg or less) 
 3 % of patients with a total cholesterol value within target level (2006-2008: 5.0 mmol/l or 
less, 2009-2011: 4.5 mmol/l or less) 
Process 4 Calculated mean process score based on the following 6 performance measures: 
indicators 4a % of patients with a record of HbA1c measurement in the last 12 months 
 4b % of patients with a record of blood pressure measurement in the last 12 months 
 4c % of patients with a record of cholesterol measurement in the last 12 months 
 4d % of patients with a record of creatinine measurement in the last 12 months 
 4e % of patients with a record of retinal examination in the last 24 months 
 4f % of patients with a record of feet examination in the last 12 months 
 5 % of patients with a current record of a lipid lowering medication prescription 
COPD   
Outcome 1 % of patients that smoke 
Process 2 Calculated mean process score based on the following 2 performance measures: 
indicators 2a % of patients with a record of smoking status 
 2b % of patients with a record of a spirometry assessment in the last 12 months 
 3 % of patients who smoke with a record of smoking cessation advice 
CVD   
Outcome 1 % of patients that smoke 
indicators 2 % of patients with a blood pressure value within target level (2006-2008: 160/90 mm Hg or 
less, 2009-2011: systolic 140 mm Hg or less) 
Process 3 Calculated mean process score based on the following 2 performance measures: 
indicators 3a % of patients with a record of smoking status 
 3b % of patients with a record of blood pressure measurement in the last 12 months 
 4 % of patients who smoke with a record of smoking cessation advice 
 5 % of patients with a record of a glucose measurement in the last 12 months 
 6 % of patients with a current record of a prescription of anticoagulants 
 
In order to examine whether chronic care management improved after the three-year cycle of 
the Accreditation program, we compared the start and follow-up scores of the first cohort in a 
within-subject design. We performed separate multilevel regression analyses for each 
indicator. We accounted for repeated measures per practice and included predictors 
reflecting practice size, practice type and practice location. Practices in the first cohort were 
compared to practices in the second cohort on follow-up and baseline scores respectively, in 
a separate regression analysis. The comparison was corrected for the match criteria practice 
size, practice type and practice location in each model. All analyses were performed with 
SPSS version 2025. 
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Table 2. Practice characteristics of the first and second cohort 
Practice characteristics Practices in first cohort Practices in second 
cohort, 2009-2011  2006-2008 2009-2011 
 n % n % n % 
   Practice type       
Single handed 17 25% 18 26% 19 27% 
Health center 10 14% 11 16% 8 12% 
Other 42 61% 40 58% 42 61% 
   Practice location*       
Urban 23 33% 23 33% 25 36% 
Partly urban 34 49% 34 49% 33 48% 
Rural 12 18% 12 18% 11 16% 
Average no. of patients per practice 4629  4808  4830  
* A region was defined as urban when the number of addresses per km2 exceeded 1,500; partly urban regions had 
500 - 1.500 addresses per km2; rural regions had less than 500 addresses per km2. 
 
RESULTS 
Study population 
Table 2 shows the percentages and means of different practice characteristics in each group. 
There was a slight underrepresentation of practices that were part of a health center in the 
second cohort compared to the first cohort: 8 (12%) versus 11 (16%) practices. They were 
slightly more often located in an urban area (25 (36%) versus 23 (33%) practices). The mean 
number of patients in the practice increased in time; mean practice size was similar in the two 
cohorts. 
 
Within-group comparison 
The first two columns in Table 3 report on scores at start and follow-up of practices in the first 
cohort. The recorded prevalence of diabetes increased from 40 to 50 per 1,000 patients. The 
recorded prevalence of COPD also increased, from 17 to 22 per 1,000 patients. The prevalence 
of CVD/CVRM was not measured. Table 3 also reports results from the multilevel regression 
analyses. Regarding diabetes we found that practices had improved on three performance 
indicators. Practice scores had higher percentages of patients with a recorded cholesterol 
measurement (p = 0.04), feet examination (p = 0.03) and prescription of lipid lowering 
medication (p = 0.009). The percentage of patients with a blood pressure below target level 
was marginally lower at follow up (p = 0.08). Practices in the first cohort had improved on 3 
COPD process indicators. There was an increase in the percentage of patients with a recorded 
spirometry measurement (p = 0.000), which was the sole contributor to the effect on the mean 
process score (p = 0.01). We also found a large improvement in the percentage of patients 
who smoke that received an advice to stop smoking (p = 0.002). 
Table 3. Within-practice comparison of first and second measurement of practices in first cohort and between practice comparison of first and second 
cohort in 2009-2011 
Indicators* 1st cohort Within-group comparison of 1st  2nd cohort Between-groups comparison 1st  
 
2006-2008 2009-2011 cohort◊ 2009-2011 and 2nd cohort 2009-2011‡ 
 Mean (SD) Mean (SD) Estimate (95% CI)  p Mean (SD) Estimate (95% CI)  p 
Diabetes        
Prevalence 0.040 (0.014) 0.050 (0.013) 0.010 (0.006 –  0.015) 0.000 0.051 (0.018) -0.001 (-0.006 –  0.005) 0.79 
   Outcome measures        
HbA1c ≤ target 60.8 (15.9) 63.6 (11.4) 2.6 (-2.6 –  7.9) 0.32 63.6 (11.0) -0.02 (-4.0 –  3.9) 0.99 
Blood pressure ≤ target^ 56.6 (16.7) 52.1 (17.0) -5.4 (-11.4 –  0.7) 0.08 50.8 (16.7) 0.9 (-4.9 –  6.7) 0.76 
Total cholesterol ≤ target^ 50.4 (15.0) 45.2 (20.1) -5.4 (-12.4 –  1.5) 0.12 36.3 (20.7) 8.8 (1.5 –  16.1) 0.02 
   Process measures        
Mean process score 79.2 (10.0) 81.6 (12.7) 2.3 (-1.5 –  6.1) 0.23 79.5 (12.7) 1.8 (-2.5 –  6.2) 0.41 
HbA1c measurement 90.4 (10.2) 92.5 (7.3) 2.1 (-1.1 –  5.4) 0.20 92.4 (6.7) -0.03 (-2.5 –  2.4) 0.98 
BP measurement# 93.7 (7.0) 91.9 (13.3) -1.7 (-5.0 –  1.7) 0.32 92.4 (8.9) -0.7 (-4.7 –  3.3) 0.74 
Cholesterol measurement 81.3 (14.4) 86.1 (12.4) 4.8 (0.2 –  9.4) 0.04 86.6 (9.4) -0.6 (-4.4 –  3.2) 0.74 
Creatinine measurement 82.1 (13.1) 85.3 (17.0) 3.4 (-1.2 –  7.9) 0.14 83.6 (17.3) 1.2 (-4.8 –  7.2) 0.69 
Retinal examination 70.6 (16.4) 66.4 (24.4) -4.5 (-12.0 –  3.1) 0.24 62.3 (26.6) 3.9 (-4.9 –  12.7) 0.39 
Feet examination 57.3 (22.7) 67.1 (26.4) 9.7 (0.9 –  18.5) 0.03 59.7 (27.1) 7.2 (-2.1 –  16.5) 0.13 
Lipid lowering medication 
prescription 
60.5 (16.4) 69.9 (22.6) 9.5 (2.5 –  16.4) 0.009 68.4 (13.1) 1.1 (-5.1 –  7.4) 0.72 
COPD        
Prevalence 0.017 (0.009) 0.022 (0.008) 0.005 (0.003 –  0.008) 0.000 0.023 (0.010) -0.001 (-0.004 –  0.003) 0.65 
   Outcome measure        
Patients that smoke 36.6 (22.9) 31.8 (16.1) -4.9 (-11.5 –  1.8) 0.15 32.2 (20.7) -0.4 (-6.9 –  6.2) 0.92 
   Process measures        
Mean process score 58.5 (17.8) 67.2 (22.1) 8.3 (1.8 –  14.8) 0.01 61.6 (24.9) 5.5 (-2.8 –  13.8) 0.19 
Record of smoke status 76.0 (21.4) 75.4 (23.2) -1.3 (-8.1 –  5.6) 0.71 69.4 (27.0) 6.1 (-2.8 –  15.0) 0.18 
Spirometry measurement 41.2 (23.5) 58.8 (28.7) 17.0 (8.0 –  26.0) 0.000 53.8 (28.5) 4.7 (-5.5 – 14.8) 0.37 
Smoking cessation advice 47.0 (33.9) 69.8 (30.8) 21.8 (8.7 –  34.9) 0.002 65.2 (32.6) 5.1 (-10.1 –  20.2) 0.51 
 
 
Indicators* 1st cohort Within-group comparison of 1st  2nd cohort Between-groups comparison 1st  
 
2006-2008 2009-2011 cohort◊ 2009-2011 and 2nd cohort 2009-2011‡ 
 Mean (SD) Mean (SD) Estimate (95% CI)  p Mean (SD) Estimate (95% CI)  p 
Cardiovascular disease†        
   Outcome measures        
Patients that smoke - 12.6 (8.5) - - 10.5 (7.8) 1.9 (-1.1 –  4.9) 0.20 
Blood pressure ≤ target^ - 41.8 (15.5) - - 35.7 (14.7) 6.3 (0.6 –  11.9) 0.03 
   Process measures        
Mean process score - 61.3 (20.3) - - 54.5 (21.6) 6.5 (-1.2 –  14.1) 0.10 
Record of smoke status - 51.7 (26.6) - - 39.8 (25.5) 11.3 (1.9 –  20.8) 0.02 
BP measurement# - 70.8 (17.9) - - 69.3 (21.3) 1.6 (-5.6 –  8.9) 0.66 
Smoking cessation advice - 66.7 (34.2) - - 51.1 (34.0) 13.2 (-4.6 –  30.9) 0.14 
Glucose measurement - 77.5 (17.6) - - 64.3 (24.3) 12.0 (1.9 –  22.0) 0.02 
Prescription of anticoagulants - 78.8 (15.0) - - 76.5 (20.4) 1.6 (-5.1 –  8.3) 0.64 
* Except for prevalence values, all values in this table report the percentage of patients treated according to the guidelines / for which the indicator was met 
(deviations, estimates and 95% confidence intervals are also reported in number of percentage points). ◊ Results are based on multilevel regression analyses, 
accounting for repeated measures per practice and correcting for practice size, practice type and practice location. ‡ Results are based on regression analyses, 
correcting for practice size, practice type and practice location. ^ In prevailing guidelines, target levels on blood pressure and cholesterol were tightened over time. 
This may partly account for a decrease in these scores regarding diabetes. # BP = blood pressure. † The inclusion criteria for patients with risk for cardiovascular 
disease changed towards the inclusion of patients with known cardiovascular disease only, which made a within-group comparison of the first cohort not justifiable. 
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Between-groups comparison 
The figures for the between-groups comparison are reported in the columns on the right side 
of Table 3. No differences were found in the recorded prevalence of diabetes and COPD. 
Diabetes patients in the second cohort less often had a total cholesterol value within target 
level compared to the patients in the first cohort (p = 0.02). No other differences were found 
between the two cohorts regarding diabetes. We did not find any differences on COPD 
performance indicators. Practices in the first cohort provided higher quality of care than the 
second cohort on 3 CVD performance indicators. A higher percentage of patients had a blood 
pressure within target level (p = 0.03). Furthermore, the number of patients with recorded 
smoke status (p = 0.02) and glucose values (p = 0.02) had increased. 
 
DISCUSSION 
Improvements were found regarding cholesterol measurement, feet examination and the 
prescription of lipid lowering medication (diabetes), spirometry measurement and the 
provision of a smoking cessation advice (COPD). As the follow-up measurement scores on 
these performance measures were similar to the baseline scores in the second cohort, it 
remains uncertain whether the effect can be attributed to the Dutch Accreditation program. 
Compared to the second cohort of newly starting practices, the practices in the first cohort 
performed better regarding achievement of a target cholesterol level (diabetes), blood 
pressure level (CVD) and the registration of smoke status and measurement of glucose levels 
(CVD). These differences could provide evidence for the added value of the Accreditation 
program. 
 
Explanation of findings 
Our results are consistent with previous studies that show that there might be an effect of 
accreditation on quality of care processes and outcomes, although effects are not always 
consistent6,7,10. Furthermore, we mainly found improvements over time on those measures 
that had a lower score at baseline, which is consistent with findings from a systematic review 
on quality improvement strategies26. Several scores, especially regarding diabetes, were 
already quite high, which might be a reflection of the general amount of attention towards 
diabetes care improvement, but it can also be related to the relatively large numbers of 
practices that provide vocational training in our study population, which is associated with 
better quality of care27. In the Netherlands, approximately 30% of all practices have at least 
one family physician that provides training. In our population the percentage of practices with 
training was higher in both cohorts: 61% (42 of 69 practices) and 70% (48 of 69 practices) in 
the first and second cohort respectively. 
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In the Dutch Accreditation program, the practice is accredited if it is actively involved in 
quality improvement through use of improvement plans and can achieve improvements over 
time. An advantage of this approach is that the program is more attractive for health 
professionals; they take ownership of the improvement plans that are tailored to the 
individual practices. Like other accreditation programs, it uses audit and feedback as a 
central mechanism, embedded in a continuous quality improvement process that aims to 
enhance a culture that fosters quality and safety of healthcare4,28. The fact that we did not find 
stronger evidence for an added value of the Accreditation program may be partially explained 
by other developments in the primary care field during our research period. Starting in 2007, 
bundled payment was implemented broadly for diabetes and to a more limited extent for 
COPD; implementation of bundled payment for CVD just started at the end of our research 
period (2011). Although a large part of the practices may currently participate in bundled 
payment schemes15, during our study period, most schemes were only just set up. Bundled 
payment offers audit and feedback and funds for support and education, but offers no other 
interventions to achieve quality improvement. The Dutch Accreditation program is one 
example of an intervention that can complement further implementation through the 
development of improvement plans and continuous support. There are clear similarities 
between participation in bundled payment and the accreditation process as an audit and 
feedback system. Both require data collection and offer feedback; measures used on 
diabetes, COPD and CVD are almost identical. In fact, practices that participate in both 
initiatives often collect data only once and use the data for both purposes. This might explain 
why little added value of the Accreditation program was detected for diabetes and COPD, two 
conditions for which many practices also participate in a bundled payment initiative. It could 
also account for the effect of accreditation on CVD, since implementation of bundled 
payment for this condition only just started during our research period. 
 
Strengths and limitations 
Our study design implied a risk of confounding, because of the absence of random allocation. 
The second cohort was selected out of a possible 802 practices of all 4,917 Dutch practices 
(16.3%)29. At the end of our study period, more than half of all Dutch family physicians (over 
4,600) worked in a practice that took part in the Accreditation program and more than 40% of 
all practices were accredited. It is likely that a substantial part of these practices also 
participated in bundled payment for diabetes and COPD; the lack of exact information on this 
limited this study. In our models, we accounted for practice type, size and location. However, 
there may have been an underrepresentation of practices with a less than average interest in 
quality improvement, especially in the first cohort, since participation in the program was 
voluntary. Both the argument of confounding and of the representation of the study 
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population reflect on the possibility that the effects could be more present in the whole 
population of general practices. 
The increase in diabetes and COPD prevalence between 2006 and 2011 may indicate that 
practices have improved their registration. On the other hand it can also be a result of efforts 
to screen the population for undiagnosed patients. Process indicator scores might decrease 
when registration is better, since there is an association between performing a measurement 
and registering it. This can cause a bias, which may differ when registration improves. 
Outcome scores might increase after active screening of the population, due to the inclusion 
of patients with a mild form of diabetes or COPD. 
 
Conclusions 
General practices improved the quality of provided healthcare for patients with the targeted 
chronic conditions. Nevertheless, only a few improvements could be attributed to the 
Accreditation program, which may be caused by the fact that other programs address quality 
of chronic care at the same time. Expectations of the effects of accreditation were high among 
participants and stakeholders, but the results of this evaluation do not support these fully. 
Continuous monitoring may have been beneficial for practices in order to maintain a high 
level of quality in some areas and improve further in others. After the study was completed, 
adaptations to the program were made, which reduced the burden of work and may improve 
the effectiveness. For instance, these could stimulate practices to not focus solely on the 
measured items30. 
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ABSTRACT 
Background In this study, we describe the opinions of family physicians regarding the Dutch 
Accreditation program of the Dutch College of General Practitioners. 
Methods Using a mixed methods design, data were collected by means of questionnaires and 
interviews from 61 and 29 family physicians respectively, as part of the Dutch Accreditation 
Program in 2006 and 2007. The physicians also took part in a pay-for-performance study, 
where they received a progressive bonus, based on their performance. 
Results  The family physicians chose to participate in the Dutch Accreditation program mainly 
because they wanted to improve the quality of care. While they were positive about the 
insight they gained into their practice management and clinical care, they found that the 
collection of data on clinical care was too time-consuming and that they needed more 
support in preparing a practice improvement plan. They also thought that the assessment 
instruments should put less emphasis on details and more on the underlying processes. 
Conclusions Family physicians are willing to take part in an accreditation program, but the 
process should not be too time-consuming and the instruments used should lend themselves 
to improving quality now and in the future. It is important to find a balance between 
measurability and perceived quality. Some physicians considered the drawbacks of the 
process to outweigh its advantages. 
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BACKGROUND 
Periodic screening of practice performance and accountability are part of a professional 
approach to healthcare. Furthermore, in the (re)organization of the Dutch healthcare system, 
the importance of transparency is emphasized. This has created an increased need to gain 
insight into medical care and practice management, as well as which aspects should be 
improved. Accreditation of general practices offers a method by which to obtain this 
information1,2. In accreditation, dynamic targets are used to assess whether quality of care is 
improved in a correct manner3. This continuous, systematic improvement process fits well 
within the setting of general practice care. In the Netherlands, the Dutch Accreditation 
program has been developed, in which practices can participate since 2005. The Visitation 
Instrument Accreditation (VIA) that is used in the program (see Box 1) covers several domains: 
practice management, clinical care and patient experiences4. The indicators that are used in 
this instrument are sufficiently valid and reliable5-7. 
 
Box 1. Dutch Accreditation program and Visitation Instrument Accreditation (VIA)8-10 
The Dutch Accreditation program is a process with a three-year cycle. The practice collects data using the 
Visitation Instrument Accreditation (VIA) and receives feedback through a feedback report with benchmarks. 
Based on this feedback, the practice develops SMART improvement plans11 and implements these. In order to get 
accredited, the practice must meet certain basic requirements, for example regarding hygiene. In addition, the 
accreditor assesses the quality of the improvement plans and verifies whether the practice is actively improving 
the quality of care. The VIA consists of performance scores in three different domains: clinical care, practice 
management and patient experiences. The data are collected with validated questionnaires filled in by patients, 
family physicians (FPs), practice assistants, nurse practitioners and the consultant who visits the practice. Clinical 
care data are mainly extracted from the medical records. Most clinical care performance measures concern 
diabetes, chronic obstructive pulmonary disease (COPD), asthma and cardiovascular diseases. If the practice is 
not able to extract the data automatically, a randomly selected sample of forty patients per condition can be 
taken instead. Validity and reliability have been assessed during the development of the instrument.5-7 
 
In 2006 and 2007, 65 practices participated in a pay-for-performance program (see Box 2), 
which included participation in the Dutch Accreditation program12. In the pay-for-
performance program, quality of care was compared among the participants. The practices 
received a bonus for participation13,14. As part of the evaluation of the pay-for-performance 
program, the Dutch Accreditation program was also evaluated. Insight in the motivation and 
experiences of the participants is crucial to maximize the effects of a program like the Dutch 
Accreditation program15. Greenfield et al. found that participation of professionals in an 
accreditation scheme within a hospital setting in Australia contributed to a positive change in 
the team climate, which led to an increased focus on quality and safety15. To our knowledge, 
such research has not been done yet in the Dutch primary care setting. With this study we aim 
66  Chapter 5 
to gain insight into the experiences of family physicians who participate in the Dutch 
Accreditation program. 
 
METHODS 
Study design 
We used a mixed methods design16,17 to include a broad range of aspects related to the 
experiences of the family physician (FP). We looked at whether their experiences met their 
expectations through a quantitative questionnaire which can be found in the Appendix. 
Results from the questionnaires were refined and elaborated on through a qualitative 
interview study. 
 
Questionnaires  
As part of the pay-for-performance program, we distributed an evaluative questionnaire 
among 65 practices in the southern part of the Netherlands. All practices collected data in 
2006 and 2007 for the Dutch Accreditation program and participated in the pay-for-
performance program12. An overview of the practice characteristics can be found in Table 1. 
The questionnaires consisted of open-ended and closed-ended questions; part of the 
questions used a 5-point Likert scale. 
 
 
Box 2. The pay-for-performance program12-14 
Family physicians (FPs) in the south of the Netherlands could voluntarily participate in a study on the effects of 
awarding a financial bonus based on performance. A bonus system was used in which practices received points 
for their scores on the performance measures. For each measure, points could vary between 0 and 6; the division 
into groups was based on the percentile scores of all practices. The practice received a financial bonus per 
patient. An average practice received a fee of approximately 7,500 euros. The fee per practice varied from 0 to 
15,000 euros. Costs for participation for an average practice were approximately 6,200 euros. Some of the 
practices received a fee that was lower than the participation costs. At the time of conducting the interviews, not 
every FP knew how high the bonus would be. However, all family physicians were familiar with the bonus system 
used. Participation in the Dutch Accreditation program was a condition for participation in the pay-for-
performance program. Some practices already participated in the Dutch Accreditation program before they 
started the pay-for-performance program. Several practices started participation in the Dutch Accreditation 
program to be able to participate in the pay-for-performance program. However, for most practices no 
information is available on whether they already participated in the Dutch Accreditation program at the start of 
the pay-for-performance program. 
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Table 1. Practice characteristics of the two study populations (questionnaires/interviews) compared to all 
Dutch practices 
Practice characteristics Study population 
questionnaires (n = 65) 
Study population 
interviews (n = 29) 
All practices  
(n = 4321) 
   Practice type    
Single-handed 29.2% 17.9%  43.5%* 
Two FPs 30.8% 39.3%  31.8% 
Group practice or health center 40.0% 42.8%  24.7%*  
   Practice location◊    
Urban 27.9% 31.0%  46.6%* 
Partly urban 60.6% 62.1%  41.1%* 
Rural 11.5% 6.9%  12.3%* 
   Practice size    
Average no. of patients per practice 4596 5076 4283‡ 
   Workload    
Average no. of FTE FPs per 1000 
patients 
0.41 0.42 0.42^ 
* NIVEL, 1-1-200718.  ◊ A region was defined as urban when the number of addresses per km2 exceeded 1,500; partly 
urban regions had 500 - 1.500 addresses per km2; rural regions had less than 500 addresses per km2. ‡ Second 
National Study19. ^ VIA 2006/200720. 
 
Interviews 
Three trained interviewers conducted semi-structured interviews with part of the FPs that 
filled in the questionnaire. We approached all physicians; of the 35 FPs who were willing to 
participate, we approached the 30 FPs who responded first. In this qualitative study, we used 
the framework approach21,22. For the design of the interviews and questionnaires we 
constructed a framework of a number of themes with subthemes in advance (Table 2). No 
new questions were added during the conduction of the interviews.  
 
Analysis 
The completed questionnaires were analyzed using descriptive statistics. In order to 
understand the impact of the financial bonus on the motivation and experiences of the 
participants, we looked at the differences in the scores of two groups, classified according to 
size of their bonus per patient. The data from the interviews were analyzed using a thematic 
analysis16. Not all the subthemes that were established in advance were equally important to 
the participants; new themes emerged during the analysis. We inductively defined these 
themes, see the bold (sub)themes in Table 2. The information from the interviews was placed 
within the framework. Two researchers independently assessed the interviews in order to 
guarantee the reliability of the analysis. Discrepancies were discussed and consensus was 
reached in all cases. 
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Table 2. Overview of themes and subthemes of the interviews and questionnaires; bold (sub)themes have 
been included inductively during data analysis 
Theme Questionnaires Interviews 
Motivation for participation x x 
   Data collection   
Data from medical records  x 
Data from questionnaires  x 
Data from observation  x 
Opinion on data collection in general x x 
Time investment x x 
Contents of the instrument (VIA)  x 
   Improvement plans   
Opinion on improvement plans in general x x 
Time investment x x 
   Support   
Applying for participation   x 
Practice consultant  x 
VIA-consultant  x 
Accreditor  x 
Assistance with data collection  x 
Support in drafting improvement plans  x 
   Benefits for the practice   
Opinion on participation in general x x 
Data collection  x 
Changes in the team  x 
Financial aspects  x 
 
Table 3. Motivation to participate in the Dutch Accreditation program 
Reason for participation No. of FPs (out of 61 FPs) 
Improve patient care 50 
Gain insight into clinical care 47 
Gain insight into practice management 42 
Provide structure to implement changes in the practice 33 
Gain insight into patient experiences 30 
Show others what we do, because we are proud of that (transparency) 27 
Participation was a condition for/to… (with explanation) 21 
Improve market and bargaining power of the practice 16 
Other reason, namely… (with explanation of the practice) 8 
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RESULTS 
Study population 
Out of the 65 practices we approached, 61 family physicians (FPs) from as many practices 
completed the questionnaire. Of the 30 FPs that were approached for an interview, 29 took 
part. For one FP it was not possible to make an appointment for the interview during the 
study period. 
 
Motivation for participation 
In the questionnaires, the FPs gave various reasons for participation in the Dutch 
Accreditation program (see Table 3). The arguments that were mentioned most frequently 
included improving patient care and gaining insight into their clinical care and management. 
Out of 61 practices, 21 indicated that they participated in the Dutch Accreditation program 
because it was a requirement for participation in the pay-for-performance program. The 
amount of the bonus had no effect on the reasons for participation. 
 
Time investment 
Results from the questionnaire showed that the amount of time that physicians had to invest 
in order to collect data was much greater for chronic conditions than for other topics (Table 
4). Even if the FPs were able to extract data from their electronic medical records (EMR), 
practices often needed more than 4 hours to collect data. At the time of this study, the 
practices did not gain time by automated data collection. In the interviews, FPs reported that 
the collection of data on clinical care took a lot of time, especially since it was not possible to 
easily retrieve the data from medical records. Several FPs indicated that EMR software 
suppliers should make adjustments for this purpose. Sometimes the requested information 
was available via a secondary source, but it either turned out to be laborious to provide this 
information, or the information was not accessible to the FPs. FPs also indicated that they felt 
that data collection was not part of their job responsibilities. For example, one of the FPs said: 
‘The quality of care, the actual time spent with patients, is surely the most important. Now 
you have to fill in paperwork. Things that should not really be done by a physician – data 
collection, getting information – Instead of seeing a patient on Monday, I was busy with 
paperwork’. 
 
Table 4. Time investment of the data collection per subject and per practice 
Subject* >4 hours 2-4 hours <2 hours 
Diabetes, COPD, asthma, or cardiovascular diseases 58% 32% 10% 
Medication or prevention 17% 28% 54% 
* Because the percentages were rounded off, they do not always add up to exactly 100%. 
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Contents of the VIA instrument 
In general, results from the interviews show that the FPs were positive about the contents of 
the practice management domain, particularly the inspection of supplies and instruments 
such as the content of the doctor’s emergency bag. However, several of the interview 
participants felt that they were judged on things that they found less important. They were 
afraid that with the scoring of checklists, the underlying concept, the quality of care, would 
disappear into the background. Some physicians thought that several of the indicators were 
not directly related to the quality of care. One of the physicians mentioned an example: ‘The 
date of the ampoules. Of course we have that in order. You just know that they will check that. 
You arrange that a day in advance. Those are all little things that actually do not matter in my 
opinion. What matters is a broader picture... how do you guarantee certain things? You can 
think about improvement now, but how do you guarantee that for the future? After all, you 
have to ensure that you maintain your quality level. And not just make an effort for the sake of 
those improvement plans in one year and then let it slip’. Furthermore, FPs felt that some 
measurements were too strict. For example, practices scored negatively if they followed a 
successful work process but did not have this recorded in a written protocol. One of the 
participants doubted whether the information supplied by the patients was accurate. 
However, results from the interviews showed that physicians felt it was important to include 
measurements from the patient’s perspective. FPs were satisfied with the diversity of the VIA 
instrument, both in terms of the subjects, as well as the sources for data collection. 
Nevertheless, they thought that extra subjects could be added to the instrument, for example 
innovation and cooperation with other practices within the care group.  
 
Improvement plans 
In the questionnaire, the majority of FPs (88%) indicated that it was difficult to write 
improvement plans. 44% of the FPs thought the stated requirements were clear. On average 
they spent 18.5 hours on writing the improvement plans. More than half of the FPs indicated 
in the questionnaire that the improvement plans contributed to the quality of care. The 
interviews revealed that the entire process of writing and approving the improvement plans 
took a lot of time, which stalled the process. FPs would have preferred to spend less time on 
this, but also indicated that it was beneficial for them to make the plans themselves. They 
experienced the process as too bureaucratic and they reported that relatively little attention 
was paid to the content. For example, one FP said: ‘At first I found it rather difficult that there 
was a strong focus on the (required) format. I think the contents are fine. I like to refine things 
further, but in this case I found that sometimes there was a bit too much talk just for the sake 
of it. It wasn’t nonsense, but I did often think that the format sometimes seemed more 
important than our ultimate goal... We’re very pragmatic’. A number of FPs also indicated that 
 Opinions of family physicians regarding the Dutch Accreditation program 71 
a strict method provides the guidance needed to achieve feasible improvement plans. 
However, they did want more support. The only support they could obtain had to be funded 
by themselves. They thought that was not sufficient. 
 
Implementation support 
In the interviews, FPs reported that the accreditation process should be more streamlined 
and that the communication needed improvement. Especially at the start of the accreditation 
the process did not go smoothly. Results from the interviews showed that there were 
differences in the approach of the accreditors, which also applied to the consultants. 
Furthermore, we found that FPs sometimes felt the need to compare themselves with other 
practices in the area. The image that they had of these practices did not always correspond 
with the observation of the accreditor. For example, one FP responded: ‘When I see how easily 
some practices have received their accreditation and I compare our practice with theirs, I 
think that it is not equivalent. We might both be accredited, but the difference in organization 
is apparently not expressed in the accreditation. If you have a lot to improve, then you also 
have improvement plans quickly and you can also improve three things quickly. I think that 
there should be (more) minimum requirements that should be met’. Furthermore, different 
insurers had different compensation systems, which the FPs judged negatively. 
 
Benefits for the practice 
The questionnaire showed that the majority of FPs thought that the time investment to take 
part in the Dutch Accreditation program was worthwhile and for almost all FPs the goal of the 
program was clear. About half of the FPs would recommend a colleague to participate, 20% 
would advise against it. The remaining approximate 30% scored neutral on this question. The 
responses with regards to whether their experiences were consistent with their expectations 
of the Dutch Accreditation program were also very diverse. The relative size of the bonus did 
not influence their opinions. The group with the relatively large bonus seemed to score 
slightly more positive on the questions ‘participation is worth the time investment’ and 
‘would you recommend a colleague to participate?’, in comparison with the group with the 
relatively small bonus. The differences were not significant; however, small numbers of 
physicians were included per group. In the interviews, FPs indicated that during the data 
collection they gained more insight in their own performance. Part of the issues that came up 
could be addressed directly. Several FPs reported that they performed worse than they had 
anticipated. One physician responded: ‘In principle I am excited about the accreditation, 
because it provides insight. You always think you’re already doing very well and then you find 
out that some things really can be improved upon... And there are issues that come up that 
can easily be improved’. The FPs were provided with a broad view of their practice 
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management on paper. This made it easier to start working on concrete improvements. 
According to the FPs, participation also had a positive impact on the cooperation and the 
atmosphere within the team. Some FPs indicated that the enormous amount of work did not 
outweigh the benefits of improvement and insight. Several FPs thought that the accreditation 
could be particularly valuable for FPs who have much to improve. According to them, FPs 
who are already at the forefront in their field have less to improve. Physicians also evaluated 
the recognition of the Dutch College of General Practitioners (which consisted of promotion 
material that included a certificate for each FP in the practice, leaflets and stickers) as very 
poor in comparison with the time and money investment of the practice. However, several 
practices mentioned that they were now more active in quality improvement due to the 
Accreditation program. 
 
DISCUSSION 
The results show that actively working on quality improvement is the main motivation for 
family physicians to participate in an accreditation program such as the Dutch Accreditation 
program. Benefits for the physicians include more insight in their own practice management 
and the possibility to work on quality improvement with improvement plans that are drawn 
up by the practice staff itself. FPs noticed that some things already improved during the 
preparation for the visitation. According to the FPs, the main points to improve upon included 
the amount of time it took to collect data, particularly on clinical care, and the preparation of 
improvement plans. They would have also liked to receive proper and free support. FPs prefer 
to pay less attention to details and more to the underlying processes, so that continuous 
quality improvement is indeed a continuous process. For part of the FPs the disadvantages of 
the process of the Dutch Accreditation program outweigh the benefits of participation. 
 
Strengths and limitations 
The study population consisted of FPs who also took part in the pay-for-performance 
program. Out of 61 practices, 21 practices indicated to participate in the Dutch Accreditation 
program because that was required. The cash bonus possibly gave FPs a greater sense of 
recognition, which may have resulted in a more positive judgment. On the other hand, they 
may have been more critical about the contents of the indicators and the method of 
measurement (self-assessment) because of the increased importance of the measurements. 
In the selection of the FPs for the interviews, we did take into account the size of the financial 
bonus (we made a proportional distribution). We did not find any significant differences 
between these groups, probably because of the small number of participants. The evaluative 
questionnaires and interviews mainly concerned questions regarding the pay-for-
performance program. Also, the main focus of the interviews was on clinical care, which was 
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the most relevant part according to the FPs. Therefore, the other components possibly have 
not been given sufficient attention. There are several limitations to the method that we chose 
for this study. During the period that the interviews took place, we did not add any new 
themes (inductively derived), therefore several themes might not have been sufficiently 
addressed in the interviews. We have conducted the interviews among a limited number of 
FPs; however, during the period of interviewing saturation was reached23. 
 
Implications 
The experiences of FPs are associated with the motivation and commitment to participate, 
and thus with the effects that can be achieved through accreditation. First, good 
communication on the development of indicators and their purpose is vital. Some FPs 
indicated that the instrument came across as a checklist of minor things, that was not 
actually about ‘quality’. A better understanding of the development of an indicator set and its 
background can help participants to better understand what is being measured, which in turn 
might increase their motivation. Regarding several aspects that are related to ‘quality’, such 
as communication with patients, no clear criteria are available. This makes it difficult to 
create measurable indicators for these aspects. There is an area of tension between 
measurability and what is actually perceived as ‘quality’. Performance measures should be 
seen as a tool for quality improvement. Second, the experiences with data collection are 
important. Although data collection is laborious and FPs feel that this is not part of their job 
responsibilities, it can, however, contribute to quality improvement when FPs collect (part of) 
the data themselves. FPs will be less likely to dismiss the results as inaccurate and irrelevant. 
Also, during the data collection FPs often gain insight in their own actions: it regularly turns 
out that reality is less favorable than expected24. A third point concerns the writing of 
improvement plans. Although a SMART approach is used within the Dutch Accreditation 
program to formulate goals for improvement plans25, this approach did not always suit the 
working method of FPs well, which sometimes led to frustration. To keep all FPs motivated 
during an accreditation process, it is important not to focus too much on the methodology, 
but to aim for a substantive and pragmatic approach, without losing the underlying method 
of concrete and comprehensive formulation. Fourth, physicians indicated that the 
assessment by accreditors was not uniform. However, they also suggested that accreditors 
should assess the individual situation, so that alternative solutions that do not comply with 
the guidelines can still get approved. Here is an area of tension: if strict assessment rules are 
set for consultants and accreditors, their assessments will be less diverse, but this also leads 
to less flexibility in the assessment of practices. Within the NPA, the company that manages 
the Dutch Accreditation program, several steps have been taken to standardize their methods 
since conducting the interviews. In the certification scheme, the emphasis remains on 
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systematic quality improvement based on performance measurement. The practice itself is 
responsible to choose a good solution, tailored to the practice, for existing risks of safety and 
quality. 
 
Conclusions 
Family physicians who also participated in the pay-for-performance program were somewhat 
positive about the Dutch Accreditation program. They deem further development of the 
Accreditation program necessary; which is in line with the continuous development of the 
program within the NPA11. We can draw several broader conclusions based on our results. 
Physicians are willing to evaluate their own practice management and clinical care, using an 
accreditation process. It is important that the data collection is not too time consuming – the 
large time investment formed the main barrier in the Dutch Accreditation program. It is also 
important that the instrument that is used encourages real quality improvement, which can 
be ensured in the future. This involves areas of tension between measurability and perceived 
‘quality’, and between flexibility and consistency in assessment. 
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APPENDIX 
This appendix contains a translated version of the written questionnaire that was used in this 
study to evaluate family physician experiences. The instructions can be found in Box 1. 
 
Box 1. Instructions questionnaire 
You have recently participated in the Dutch Accreditation program as part of the pay-for-performance program 
for family physicians. Through this questionnaire, we would like to gain more insight into your personal 
experiences with the Dutch Accreditation program.  
As you may know, the Dutch Accreditation program aims to evaluate: 
 medical care 
 practice organization, operational management and finance 
 patient experiences 
Based on the data collected in these three domains, your practice has received feedback and improvement 
plans have been evaluated by an accreditor. Accreditation is granted in the first year when: 
 the accreditor reports a positive advice 
 the list of basic information regarding the practice is accurate and up-to-date. 
The Accreditation program uses a three-year cycle. After being accredited in the first year, the evaluation of 
quality improvements provides the basis on which a practice can be accredited in the second and third year. 
This questionnaire is intended for the quality coordinator of the practice. We would like to ask you several 
questions regarding the Dutch Accreditation program. The main topics of this questionnaire include motives for 
participation, the registration process, data collection, feedback, improvement plans and support from the Dutch 
College of General Practitioners (NHG/NPA). 
 
1. Personal background 
1) what is your gender: male/female 
2) what is your age:  years 
3) what is your education:  
4) what is your current job function:  
 
2. Motives for participation 
 Which motive(s) did you have to participate in the Dutch Accreditation program? (multiple answers possible) 
□ improve patient care 
□ gain insight into clinical care 
□ gain insight into practice management 
□ gain insight into patient experiences 
□ improve market and bargaining power of the practice 
□ provide structure to implement changes in the practice 
□ show others what we do, because we are proud of that (transparency) 
□ participation was a condition for/to  
□ other reason, namely  
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3. Registration with the Dutch College of General Practitioners 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) the registration process went smoothly □ □ □ □ □ 
2) after reading the information material, the □ □ □ □ □ 
procedure of the program was clear 
3) do you have suggestions for improvement?  
 
4. Data collection 
You have collected data regarding three different domains: medical care, practice organization and patient 
experiences. There were different methods of data collection within each domain, therefore the questions 
are formulated for each of the domains separately. 
 
4.1 Medical care 
1) how many family physicians work in the practice?  physicians 
2) possibly there are several separate patient populations within the practice. Could you clarify which family 
physicians cover the same patient population? 
  patient population 1:  
  patient population 2:  
  patient population 3:  
  patient population 4:  
  patient population 5:  
 
3) how many separate data collections of medical care have taken place within the practice? (in theory, the 
practice should have collected data for each of the patient populations separately in case of more than 1 
patient population)  data collections 
 
4) has the data been collected for a randomly selected sample of all patients, or could data be collected on 
the entire patient population (select both in case different methods were used for different populations) 
Selected sample Complete population 
 Diabetes       □   □ 
 COPD      □   □ 
 Asthma       □   □ 
 Cardiovascular diseases    □   □ 
 Prevention (influenza, cervical screening)  □   □ 
 Medication prescription    □   □ 
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5) which data source was used to collect the data (select both in case different methods were used for 
different populations) 
Practice medical records Other source 
 Diabetes       □   □ 
 COPD      □   □ 
 Asthma       □   □ 
 Cardiovascular diseases    □   □ 
 Prevention (influenza, cervical screening)  □   □ 
 Medication prescription    □   □ 
 
6) how much time was spent in total on data collection? 
 0-1 hour 1-2 hours 2-3 hours 3-4 hours >4 hours 
Diabetes □ □ □ □ □ 
COPD □ □ □ □ □ 
Asthma □ □ □ □ □ 
Cardiovascular diseases □ □ □ □ □ 
Prevention □ □ □ □ □ 
Medication prescription □ □ □ □ □ 
 
7) who was involved in the medical care data collection process? 
 Family 
physician 
Assistant Nurse 
Practitioner 
Other (e.g. 
pharmacist) 
Diabetes □ □ □ □ 
COPD □ □ □ □ 
Asthma □ □ □ □ 
Cardiovascular diseases □ □ □ □ 
Prevention □ □ □ □ 
Medication prescription □ □ □ □ 
 
8) the data collection sheets that needed to be filled in by the practice were clear: 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
□ □ □ □ □ 
 
9) were there any factors that made the data collection regarding medical care more difficult? yes/no 
 If so, which factors?  
 
10) were there any factors that made the data collection regarding medical care easier? yes/no 
 If so, which factors?  
 
11) do you have suggestions for improvement?  
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4.2 Practice organization 
1) how much time was spent in total to fill in all questionnaires regarding practice organization? 
 ,  hours/minutes  
 
2) who was involved in the practice organization data collection process? 
Assistant Nurse Practitioner Family physician VIA consultant 
□ □ □ □ 
 
3) were there any factors that made the data collection regarding practice organization more difficult?  
 yes/no If so, which factors?  
 
4) were there any factors that made the data collection regarding practice organization easier?  
 yes/no If so, which factors?  
 
5) the data collection questionnaires that needed to be filled in by the practice were clear: 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
□ □ □ □ □ 
 
6) do you have suggestions for improvement?  
 
4.3 Patient experiences 
1) how much time was spent in total to hand out and retrieve questionnaires regarding patient opinions? 
 ,  hours/minutes  
 
2) who was involved in the patient questionnaire data collection process? 
Assistant Nurse Practitioner Family physician 
□ □ □ 
3) do you have suggestions for improvement?  
 
5. Feedback 
Based on the data you have collected, a feedback report was sent for all domains in the evaluation. Since 
these reports differ for each domain, the questions are again formulated for each of the domains separately. 
 
5.1 Medical care 
1) the feedback on medical care was appreciated by the practice: 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
□ □ □ □ □ 
2) how much time was spent in total to read the information in the feedback report on medical care?  
 ,  hours/minutes  
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strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
3) the text in the feedback report was clear □ □ □ □  □ 
4) the scores in the feedback report were clear □ □ □ □  □ 
5) the information in the report was complete □ □ □ □ □ 
6) the report provided added insight into your □ □ □ □ □ 
 performance regarding medical care 
7) you intend to make changes based on the  □ □ □ □ □ 
 results from the feedback report 
 
5.2 Practice organization 
1) the feedback on practice organization was appreciated by the practice 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
□ □ □ □ □ 
2) how much time was spent in total to read the information in the feedback report on practice 
organization?  
  ,  hours/minutes 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
3) the scores in the feedback report were clear □ □ □ □ □ 
4) the information in the report was complete □ □ □ □ □ 
5) the report provided added insight into your □ □ □ □ □ 
 performance regarding practice organization 
6) you intend to make changes based on the □ □ □ □ □ 
 results from the feedback report 
 
5.3 Patient experiences 
1) the feedback on patient experiences was appreciated by the practice 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
□ □ □ □ □ 
2) how much time was spent in total to read the information in the feedback report on patient experiences?  
  ,  hours/minutes 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
3) the scores in the feedback report were clear □ □ □ □ □ 
4) the information in the report was complete □ □ □ □ □ 
5) the report provided added insight into  □ □ □ □ □ 
 patient experiences 
6) you feel that feedback on patient experiences □ □ □ □ □ 
 is valuable for quality improvement 
 Opinions of family physicians regarding the Dutch Accreditation program 81 
6. Improvement plans 
Besides the data collection in three different domains, practices had to develop improvement plans as part 
of the Dutch Accreditation program. 
 
 □  the practice has not developed improvement plans → you can continue with section 7. 
 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) the development of improvement plans □ □ □ □ □ 
 was difficult 
2) the requirements that were set for □ □ □ □ □ 
 improvement plans were clear 
 
3) how much time was spent in total on the development of improvement plans?  
  ,  hours/minutes 
 
4) were there any factors that made the development of improvement plans more difficult? yes/no 
 If so, which factors?  
 
5) were there any factors that made the development of improvement plans easier? yes/no 
 If so, which factors?  
 
 6) to which extent did the improvement plans contribute to quality improvement? 
very much much neither much  
nor little 
little very little 
□ □ □ □ □ 
 
7. Support 
The Dutch College of General Practitioners offers support to the practices in several ways. First of all, the 
practice employs a practice consultant who informs the practice on the process of accreditation and helps 
with the development of the improvement plans. Second, there is a VIA-consultant that discusses the 
feedback report with the practice and offers suggestions for topics for improvement plans. And third, the 
accreditor assesses the improvement plans and provides advice to the Dutch College of General Practitioners 
on whether or not a practice should receive accreditation.  
→ If you have not yet been visited by an accreditor, you can skip section 7.3. 
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7.1 Practice consultant 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) it was easy to employ a practice consultant □ □ □ □ □ 
2) the practice consultant that helps with the □ □ □ □ □ 
 development of improvement plans is competent 
3) the practice consultant that helps with the □ □ □ □ □ 
 implementation of improvement plans is competent 
 
7.2 VIA-consultant 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) the VIA-consultant was appointed quickly □ □ □ □ □ 
2) the VIA-consultant was competent in □ □ □ □ □ 
 explaining and discussing the feedback report 
3) the VIA-consultant was competent in □ □ □ □ □ 
 suggesting topics for improvement plans 
 
7.3 Accreditor 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) the accreditor was competent in judging □ □ □ □ □ 
 the improvement plans 
2) the accreditor that offered advice on whether □ □ □ □ □ 
 or not a practice is accredited was competent 
 
8. General questions 
strongly 
agree 
agree neither agree 
nor disagree 
disagree strongly 
disagree 
1) participation was worth the time investment □ □ □ □ □ 
2) the goals of the program were clear □ □ □ □ □ 
3) the experiences of participation were in □ □ □ □ □ 
 accordance with your expectations 
4) you would advise your colleagues to participate □ □ □ □ □ 
 
Other remarks  
Patient characteristics associated with
measurement of routine diabetes care:
an observational study
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ABSTRACT 
Background  Non-modifiable patient characteristics, including age, gender, ethnicity as well 
as the occurrence of multi-morbidities, are associated with processes and outcomes of 
diabetes care. Information on these factors can be used in case-mix adjustment of 
performance measures. However, the practical relevance of such adjustment is not clear. The 
aim of this study was to assess the strength of associations between patient factors and 
diabetes care processes and outcomes.  
Methods We performed an observational study based on routinely collected data of 12,498 
diabetes patients in 59 Dutch primary care practices. Data were collected on patient age, 
gender, whether the patient lived in a deprived area, body mass index and the co-occurrence 
of cardiovascular disease, chronic obstructive pulmonary disease, depression or anxiety. 
Outcomes included 6 dichotomous measures (3 process and 3 outcome related) regarding 
glycosylated hemoglobin, systolic blood pressure and low density lipoprotein-cholesterol. We 
performed separate hierarchical logistic mixed model regression models for each of the 
outcome measures. 
Results  Each of the process measure models showed moderate effect sizes, with pooled 
areas under the curve that varied between 0.66 and 0.76. The frequency of diabetes related 
consultations as a measure of patient compliance to treatment showed the strongest 
association with all process measures (odds ratios between 5.6 and 14.5).The effect sizes of 
the outcome measure models were considerably smaller than the process measure models, 
with pooled areas under the curve varying from 0.57 to 0.61.  
Conclusions  Several non-modifiable patient factors could be associated with processes and 
outcomes of diabetes care. However, associations were small. These results suggest that 
case-mix correction or stratification in assessing diabetes care has limited practical relevance. 
 Patient characteristics associated with routine diabetes care 85 
BACKGROUND 
Many quality programs for diabetes care aim at improving clinical processes and outcomes1. 
An important part of the goals set in these programs is the prevention of cardiovascular risk2,3. 
Relevant intermediate outcomes include glycated hemoglobin (HbA1c), blood pressure and 
serum cholesterol values. These outcome measures are associated with a range of non-
modifiable patient characteristics, including gender, age, ethnicity and other socio-
demographic factors4-7. For example, women in diabetes care have higher blood pressure and 
serum cholesterol levels compared to men7. In order to compare performance measures 
between practices, adjustment is suggested for these factors, as they could be unequally 
distributed in the different populations assessed8. Zaslavsky et al.9 showed that adjustment 
for socio-demographic factors had little impact on most performance measures, but larger 
impact on a few measures, particularly when the measure involved a relatively large 
percentage of patients from a minority ethnic group. However, case-mix adjustment is not 
consistently applied, possibly due to differential perspectives and uncertainties about when 
and how to adjust10. 
Besides socio-demographic factors, differences in the severity of the condition can be 
associated with diabetes control as well. The severity of diabetes mellitus can be defined as 
the co-occurrence of other conditions. In this article we focus on multi-morbidity, which can 
be defined as ‘any co-occurrence of medical conditions within a person’11. The number of 
patients with multi-morbidity has risen enormously in the past decades12. A systematic 
review13 showed that conditions that often occur in diabetes patients include cardiovascular 
diseases (CVD), depression and cancer. These conditions may be directly related to diabetes 
(e.g. CVD) or indirectly related (e.g. chronic obstructive pulmonary disease, COPD)14. Several 
studies have shown that the presence of different types of multi-morbid conditions (in several 
patient groups, including patients with diabetes) can lead to better cardiovascular risk 
control, both regarding processes and outcomes of care15-17. Multi-morbidity may lead to 
lowered patient compliance with treatment and advice18,19. Turner et al.20 found that the 
relationship between multi-morbidity and healthcare outcomes may vary, depending on how 
closely related the conditions are. They suggest that related multi-morbid conditions may 
lead to improved care delivery, whereas unrelated multi-morbid conditions may have a 
negative impact on health outcomes20. Voorham et al.21 specifically looked at the effects of 
multi-morbidity on medication treatment and found that diabetes-related multi-morbidity 
could induce treatment intensification for cardiovascular risk factors. 
Information on multi-morbidity can be used in case-mix adjustment of performance 
measures. However, the strength of the association between multi-morbidity factors, other 
case-mix factors and measures of processes and outcomes of care is not clear. Therefore, the 
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aim of this study was to identify: (I) which patient factors and prevalent multi-morbid 
conditions are related to processes and outcomes of diabetes care, (II) how strong these 
associations are, and (III) the relative importance of the factors identified as predictors.  
 
METHODS 
Study design and study population  
We performed an observational study based on routinely collected data from Dutch primary 
care practices. In the Netherlands, routine diabetes care is primarily provided in general 
practice; therefore, in our study we focus solely on primary care. All data were collected as 
part of a national representative network of practices (LINH), in which data were extracted 
from the electronic medical records. In total, a sample of 12,498 diabetes patients from 59 
general practices was included in this study. All practices extracted their data in the year 2010. 
The extraction included information from all contacts with a time window of one year. This 
time period was based on the fact that all indicators included in the study should be 
measured at least once a year according to the guidelines. 
 
Ethics statement 
The research was conducted under supervision of IQ healthcare, a scientific department 
focusing on quality improvement in healthcare, and as such forms part of the Radboud 
University Medical Center in Nijmegen, the Netherlands. LINH is registered with the Dutch 
Data Protection Authority and data are handled according to the national data protection 
guidelines. The study was conducted in accordance with the Dutch Law for the Protection of 
Personal Data (Wet Bescherming Persoonsgegevens)22 and the Declaration of Helsinki23. 
Based on the Dutch Law for the Protection of Personal Data no medical ethical committee 
approval was required for this study, therefore the medical ethical committee was not 
contacted. All data were anonymized before extraction and analysis. 
 
Measures 
We included demographic patient characteristics and information on prevalent multi-
morbidities in the study. Data were collected on patient age, gender, whether the patient 
lived in a deprived area and body mass index (BMI). A systematic review showed that out of all 
conditions that are commonly treated in primary care, CVD, COPD, depression and anxiety 
most often co-occur with diabetes13. Information on multi-morbidity was based on the ICPC 
codes24, and was included as a dichotomous variable for each condition. CVD included 
ischemic heart disease with or without angina, acute myocardial infarction, heart failure, 
atrial fibrillation, hypertension, transient cerebral ischemia, cerebrovascular disease, stroke 
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and atherosclerosis. Anxiety and depression included the ICPC codes for feeling depressed, 
anxiety disorder or anxiety state and depressive disorder. Furthermore, the number of 
diabetes related consultations per year was included. Whenever the ICPC code for diabetes 
was recorded in the medical record, the consultation was recorded as diabetes related. 
Consultations can be provided by the family physician or other staff in the general practice, 
including a nurse practitioner. In this study, we only included the frequency of the 
consultations; we did not have information on the caregiver that provided the consultation. 
We also recorded whether patients received a prescription of lipid lowering medication, anti-
diabetic medicine (oral, insulin or both) and/or blood pressure lowering medication.  
Outcome measures included 6 dichotomous measures regarding glycosylated hemoglobin 
(HbA1c), systolic blood pressure (BP) and low density lipoprotein-cholesterol (LDL-C). We 
included whether the target level (as set in the Dutch guideline25) was measured during 
consultation (yes/no) and, for those cases with a valid measurement, whether it was achieved 
(yes/no). The most recent valid data for each patient were included in the dataset. 
 
Analysis 
Descriptive statistics were used to describe the patient and practice characteristics. A missing 
data analysis was performed since length and weight (to calculate BMI) were not recorded 
structurally each year. We performed multiple imputation to complete missing values on BMI 
data, using 5 imputation sets. A larger number of imputation sets has been recommended. 
However, since our dataset consisted of a large number of patients, the difficulties of applying 
a large number of imputation sets (>10) in a reasonable amount of time outweighed the 
benefits. Main outcomes and predictors were included in the imputation models. We also 
included practice in the imputation models to account for clustering effects. 
To assess which patient factors were associated with clinical processes and outcomes of 
diabetes care, logistic mixed models were performed on the imputation models in order to 
obtain pooled results, taking into account the clustering of patients within practices. We ran 
six separate hierarchical logistic regression models, one for each of the outcome measures 
(HbA1c, BP and LDL-C measured, HbA1c, BP and LDL-C within target level). Target levels were 
set at 53 mmol/mol, 140 mm Hg and 2.5 mmol/l respectively. In each model, we included 
patient age, gender, number of diabetes related consults (above or below median), whether 
the patient lives in deprived area, BMI and presence of ICPC code related to CVD, COPD 
and/or depression and anxiety (dichotomous measures). We assessed the discriminative 
power of the model by calculating the area under the curve in the imputation sets (pooled 
AUC) and we also calculated pooled fixed effects (OR). In order to assess whether specific 
factors can be left out from the model without decreasing the effect size, we then reduced 
each of the 6 models in accordance with the maximum log-likelihood test (p < 0.10) and again 
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calculated pooled fixed effects and pooled AUCs. The multiple imputation and logistic 
multilevel models were performed in R version 3.03. Descriptive statistics were performed in 
SPSS version 20. 
 
Table 1. Patient characteristics and overall scores on indicators 
Patient characteristics Study 
population 
Dutch diabetes 
population*,◊  
No. of patients 11718 834100 
% of women 49.8% 50.1% 
Mean age (SD) 65.8 (13.3) 67.7 (12.6) 
Mean Body Mass Index (SD) 29.6 (5.3) - 
% of patients with funds for deprived areas 5.9% - 
Mean no. of consultations per year (SD) 7.6 (6.9) - 
Mean no. of diabetes related consultations per year (SD) 2.8 (3.4) - 
   Multi-morbid conditions (% of patients)   
Cardiovascular disease (CVD) 69.8% - 
Chronic obstructive pulmonary disease (COPD) 8.5% 8.4% 
Depression and/or anxiety 13.2% 17.6% 
   Medication prescriptions (% of patients)   
Anti-diabetic medicine   
          No medication 31.3% 22% 
          Oral medication only 52.3% 62% 
          Oral medication and insulin 10.4% 10% 
          Insulin only 6.0% 4% 
Blood pressure lowering medication 69.3% - 
Lipid lowering medication 64.0% 67.0% 
Indicators Study 
population 
Study multi- 
disciplinary care 
% of patients with HbA1c value measured 76.7% 91.4% 
Mean HbA1c value (SD) 50.8 (11.8) - 
% of patients with HbA1c value below target level (53) 67.3% 68.8% 
% of patients with systolic blood pressure measured 79.0% 89.9% 
Mean systolic blood pressure value (SD) 140.3 (18.1) - 
% of patients with systolic blood pressure below target level (140) 49.1% 52.3% 
% of patients with LDL cholesterol level measured 69.4% 85.3% 
Mean LDL cholesterol level (SD) 2.59 (0.93) - 
% of patients with LDL cholesterol level below target level (2.5) 49.6% 53.1% 
* Source data: (I) RIVM website26, (II) publication Zodiac study27, (III) report on care groups28, (IV) report on Dutch 
Accreditation29. ◊ Several characteristics of our study population could not be contrasted with the Dutch population 
or other comparable study populations because no suitable data could be found. 
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RESULTS 
Study population 
11,718 out of 12,498 patients from 59 practices were included in the analyses of process 
measures. 689 patients were excluded because they were in hospital care instead of primary 
care, 91 patients were excluded due to age (younger than 18 years). This population is a 
reasonable representation of all Dutch diabetes patients in primary care, see Table 1.  
Subsets of 8,028, 8,936 and 9,257 patients were included in the analysis of outcome measures 
on LDL cholesterol, HbA1c and systolic blood pressure respectively. The percentage of 
patients with outcomes below target level was slightly lower than the percentages found in a 
Dutch multidisciplinary care study; however, in the latter, practices could exclude particular 
patient groups that are more difficult to treat. Also, the study population scored substantially 
lower on the registration of the patient outcomes. In Table 2, we report the variation on the 
process measures across the 59 practices. We found that for each of the process measures, 
the variation between practices is sufficiently large to show possible effects of patient 
determinants. 
 
Table 2. Variations in clustered scores (per practice) on process indicators 
Indicator outcomes  Study population 
HbA1c value measured Mean 76.0%  
 SD (range) 10.2% (50.8% –  96.7%)  
Systolic blood pressure measured Mean  76.9%  
 SD (range) 15.0% (7.0% –  96.9%) 
LDL cholesterol level measured Mean 67.0% 
 SD (range) 18.3% (2.0% –  93.1%) 
 
In our missing data analysis we found that as expected the main measure with missing data 
was BMI (3,436 missing, 29.3%). Other variables with missing data included age (1 missing, 
0.01%) and whether the patient lives in a deprived area (81 missing, 0.69%). Results from a 
MCAR test showed that the missing data were not completely at random.  
 
Multilevel logistic regression analysis process measures 
Each of the process measure models showed moderate effect sizes, with pooled areas under 
the curve (AUCs) that varied between 0.66 and 0.76. The closer the AUC value approaches 1, 
the better the model can distinguish whether processes are performed or not based on the 
factors included in the model. An AUC of 0.5 would indicate that the model does not perform 
better than chance. A pooled AUC of 0.76 indicates that for each pair of patients (one with 
processes performed and one without processes performed), the model could classify these 
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Table 3. Factors associated with process indicators: measure recorded within study period 
Factor* Complete model Reduced model DM consultation 
only model 
 OR 95% CI OR 95% CI OR 95% CI 
HbA1c       
Age in years 1.03 1.03 – 1.03 1.03 1.02 – 1.03 - - 
Gender male 1.01 0.92 – 1.12 - - - - 
Patient in deprived area 1.03 0.78 – 1.36 - - - - 
CVD  1.15 1.03 – 1.29 1.17 1.05 – 1.31 - - 
Depression and/or anxiety 1.08 0.93 – 1.25 - - - - 
COPD 0.81 0.67 – 0.97 0.81 0.68 – 0.97 - - 
Body mass index in kg/m2 1.01 1.00 – 1.03 - - - - 
DM consultation count >median 14.4 12.3 – 16.7 14.4 12.3 – 16.8 15.4 13.2 – 17.9 
AUC 0.76  0.76  0.71  
n 11718  11718  11718  
Systolic blood pressure       
Age in years 1.03 1.03 – 1.04 1.03 1.03 – 1.04 - - 
Gender male 1.04 0.93 – 1.16 - - - - 
Patient in deprived area 1.11 0.83 – 1.49 - - - - 
CVD 1.75 1.56 – 1.98 1.77 1.57 –  1.99 - - 
Depression and/or anxiety 0.93 0.80 – 1.09 - - - - 
COPD 0.72 0.59 – 0.87 0.72 0.59 –  0.87 - - 
Body mass index in kg/m2 1.01 0.99 – 1.02 - - - - 
DM consultation count >median 14.5 12.3 – 17.1 14.5 12.3 –  17.1 15.5 13.1 – 18.2 
AUC 0.77  0.77  0.71  
n 11718  11718  11718  
LDL cholesterol       
Age in years 1.02 1.01 – 1.02 1.02 1.01 – 1.02 - - 
Gender male 1.17 1.06 – 1.29 1.16 1.06 – 1.27 - - 
Patient in deprived area 0.87 0.66 – 1.13 - - - - 
CVD 1.31 1.18 – 1.46 1.32 1.19 – 1.47 - - 
Depression and/or anxiety 1.03 0.90 – 1.18 - - - - 
COPD 0.81 0.69 – 0.95 0.81 0.69 – 0.95 - - 
body mass index in kg/m2 1.00 0.99 – 1.02 - - - - 
DM consultation count >median 5.60 4.99 – 6.28 5.61 5.00 – 6.30 5.92 5.28 – 6.63 
AUC  0.70  0.69 0.66 
n 11718 11718 11718 
* Reference categories: female, less than median diabetes related contacts per year, without funds for deprived 
area, no multi-morbidities.  
 
correctly in 76% of the cases. The effect sizes could be maintained with a reduced model. In 
the complete models, HbA1c, systolic blood pressure and LDL cholesterol values were 
measured more often in older patients, see Table 3. Furthermore, patients with CVD more 
often  had   their  outcomes   measured,   with  the  largest   odds  for   measurement  of  blood  
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Table 4. Factors associated with outcome indicators: measure outcome within target level 
Factor* Complete model Reduced model 
 OR 95% CI OR 95% CI 
HbA1c     
Age in years 1.00 1.00 – 1.01 1.01 1.00 – 1.01 
Gender male 0.83 0.75 – 0.91 0.83 0.75 – 0.91 
Patient in deprived area 0.84 0.65 – 1.07 - - 
CVD  1.10 0.99 – 1.23 - - 
Depression and/or anxiety 1.19 1.03 – 1.36 1.18 1.03 – 1.36 
COPD 0.95 0.81 – 1.12 - - 
Body mass index in kg/m2 0.97 0.96 – 0.98 0.97 0.96 – 0.98 
DM consultation count >median 0.54 0.48 – 0.60 0.54 0.48 – 0.60 
AUC 0.59  0.58  
n 8936  8936  
Systolic blood pressure     
Age in years 0.97 0.97 – 0.98 0.97 0.97 – 0.98 
Gender male 0.92 0.84 – 1.00 0.92 0.84 – 1.00 
Patient in deprived area 0.92 0.71 – 1.18 - - 
CVD 0.54 0.49 – 0.60 0.54 0.49 – 0.60 
Depression and/or anxiety 1.07 0.94 – 1.21 - - 
COPD 1.13 0.97 – 1.31 - - 
Body mass index in kg/m2 0.97 0.96 – 0.98 0.97 0.96 – 0.98 
DM consultation count >median 1.04 0.94 – 1.16 - - 
AUC 0.61  0.61  
n 9257  9257  
LDL cholesterol     
Age in years 1.01 1.01 – 1.02 1.01 1.01 – 1.01 
Gender male 1.47 1.34 – 1.62 1.45 1.33 – 1.59 
Patient in deprived area 1.44 1.09 – 1.89 1.44 1.10 – 1.90 
CVD  1.19 1.07 – 1.32 1.20 1.08 – 1.34 
Depression and/or anxiety 0.84 0.74 – 0.96 0.84 0.74 – 0.96 
COPD 1.03 0.87 – 1.21 - - 
Body mass index in kg/m2 1.01 1.00 – 1.02 - - 
DM consultation count >median 1.33 1.19 – 1.48 1.33 1.19 – 1.48 
AUC  0.57 0.57 
n 8028 8028 
* Reference categories: female, less than median diabetes related contacts per year, without funds for deprived 
area, no multi-morbidities.  
 
pressure (odds ratio (OR) 1.75, 95% confidence interval (CI) 1.56 – 1.98). In other words, as a 
diabetes patient with CVD as multi-morbidity, the odds of having your blood pressure 
measured were 1.75 times higher than for diabetes patients without CVD. On the other hand, 
patients with COPD had a lower probability to have their blood pressure measured (OR 0.72, 
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95% CI 0.59 – 0.87). COPD patients also had a smaller probability of HbA1c and LDL 
cholesterol measurements compared to patients without COPD. For each of the three process 
measures there was an association of the frequency of diabetes related consultations and the 
probability of the value being measured (ORs vary between 5.6 and 14.5). In fact, this factor on 
its own explained a large part of the effects found in the models (pooled AUC between 0.66 
and 0.71) compared to models that included all factors (pooled AUC between 0.70 and 0.76). 
 
Multilevel logistic regression analysis outcome measures 
The effect sizes of the outcome measure models were considerably smaller than the process 
measure models, with pooled AUCs varying from 0.57 to 0.61. This indicates that the model 
did not perform much better than chance. The probability of achieving the systolic blood 
pressure target level was lower in older patients, while the probability of an LDL cholesterol 
level within target was higher in older patients (Table 4). Gender was also associated with 
outcomes, with lower probabilities of good HbA1c and blood pressure control and a higher 
probability of good LDL cholesterol control in male patients compared to female patients. 
Patients with CVD had a higher probability that the HbA1c level was within target level and a 
lower probability that the blood pressure was within target level. Patients with depression 
and anxiety also had a higher probability of achieving an HbA1c level within target level. 
Furthermore, these patients had a lower probability of achieving good LDL cholesterol 
control. Blood pressure and HbA1c levels were less often below target level in patients with a 
higher BMI. A relatively high number of diabetes consultations was associated with poorer 
HbA1c control and better LDL cholesterol control. 
 
DISCUSSION 
In this study the associations between several non-modifiable patient characteristics and 
prevalent multi-morbidities with processes and outcomes of diabetes care in Dutch general 
practices were explored. We found that the models on processes of care showed moderate 
effects, suggesting that patient factors had some impact on diabetes care indicators. On the 
other hand, effects on outcome measures were small. Measurement of the number of 
diabetes consultations, as a measure of patient health service utilization, was the main 
contributor to the effects found.  
 
Explanation of findings 
Factors incorporated in our study only had small to moderate pooled effects on processes 
and outcomes of care. This is in line with a study by Marceau et al.30, who reported that from 
the 21.1% of variance in diabetes management that could be explained by patient, provider 
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and organizational factors, only 2.2% could be explained by patient factors. The main 
contributor was the diabetes consultation frequency. Since in general all patients receive 
automated invitations for their 3-monthly and yearly consultations, this measure reflects 
patients’ attitudes and compliance. The effects found are in line with other literature that 
shows that poor adherence to treatment plans (such as failure to come to an appointment) 
can have negative effects on processes and outcomes of care31. 
Since effect sizes found are moderate to small, it may be debated whether to take these case-
mix factors into account in the calculation of scores on population level, either through 
correction or stratification. The small changes in scores may not weigh up against the 
troubles of data collection and increased complexity of score interpretation. Furthermore, 
Nicholl32 suggests that correction can actually increase the bias in measurements, especially 
when interactions between factors are not taken into account properly. However, it is 
possible that other patient factors than the factors in this study are relevant for diabetes care 
processes and outcomes, or that the examined factors are relevant for health outcomes that 
were not examined in this study. Also, for the evaluation of individual patients it is important 
to be aware of the possible risk factors, since they may have large influence in a single patient. 
Furthermore, when the total number of diabetes patients in a practice is relatively small, one 
should account for a larger variation in the score33. In such case, we suggest that accounting 
for a larger error margin is better than correcting for multiple factors, since this will only 
increase the bias due to the lower precision of the data.  
Results on measurement of outcomes are in line with previous literature that shows that the 
influence of a multi-morbidity depends on whether the conditions are strongly related to 
each other20. We found that in patients with COPD, a condition that is less strongly related to 
diabetes, processes of care were less often according to the guidelines. It is possible that 
during consultations with COPD patients, priority is given to address those issues that cause 
the highest burden on the patient quality of life the most. These issues are more likely to be 
COPD related rather than diabetes related. On the other hand, patients with a strongly related 
condition, CVD, were more likely to have their blood pressure measured. Results are similar to 
a Dutch study by Nouwens et al., in which better cardiovascular risk treatment in diabetes 
patients but not in COPD patients was reported16. Our findings are also in line with the study 
by Voorham et al.21. They looked at the association between multi-morbidity and treatment 
intensification. In their study, new occurrences of diabetes-related multi-morbidities such as 
cardiovascular disease were related with better risk factor treatment, whereas no effects were 
found for non-diabetes related multi-morbidities.  
Our results show that patients with depression and anxiety have a higher probability to have 
good HbA1c control than others, whereas the probability is lowered that they have good 
cholesterol control. Although literature shows that depression is associated with poorer 
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medication adherence34, evidence regarding the effects on HbA1c, blood pressure and 
cholesterol control is inconclusive35,36. Possibly patients with anxiety are more sensitive for 
side-effects of lipid lowering medication, resulting in poor cholesterol control.  
 
Strengths and limitations 
In this observational study, there were several factors associated with diabetes care that we 
could not take into account. These include hereditary factors and lifestyle factors, which have 
known associations with development of diabetes37. We also did not include duration and 
severity of the illness in our study, which is an important limitation. Furthermore, medication 
compliance may have varied between patients, which may have also influenced the scores. 
Other studies show that longer diabetes duration is associated with more diabetes 
complications such as retinopathy38 and coronary heart disease39. These factors may explain 
part of the variation that we could not account for with our model. Poor outcomes of care 
may be accounted for by factors that we did not include in our dataset, including presence of 
pancreatic illnesses or issues with medication tolerance. However, these factors only regard 
small parts of the population of diabetic patients seen by the family physician. Therefore, we 
expect that this has not had a large influence on our study. 
Our study was performed on a large dataset that formed an adequate reflection of the 
diabetes patients treated in primary care. There were several limitations to the use of this 
dataset. We could only analyze the outcomes of care for those patients that had a 
measurement of the outcome, i.e. scored positively on the process measure. This can cause a 
bias in our study. It may be the case that physicians are more likely to perform measurements 
when they expect that patients need treatment; leading to a slightly lower percentage of 
patients with a measurement within target level compared to those without a measurement. 
On the other hand, there may have been an underrepresentation of patients that show higher 
noncompliance to treatment. It is to be expected that outcomes are not within target level for 
this group of patients, which may cause a bias in the opposite direction. However, we argue 
that this bias also occurs in routine care. Since our aim was to develop a model of 
determinants that approaches everyday care, the large study population that we used was 
valid for its purpose.  
Since data were collected through an automated extraction of medical records, it is likely that 
there is an effect of poor registration. This is reflected by the large difference in measurement 
of outcomes in our study population compared to the report on multidisciplinary care. In the 
latter study, the practices collected data from their registrations themselves, which meant 
that they could retrieve misplaced information more easily. The registration bias in our study 
may have led to a bias in our study population. Although poor registration may have led to 
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lower scores on processes of care, in general our population was reasonably well controlled. 
This may have decreased the likelihood of finding associations in this study. 
 
Conclusions 
Several non-modifiable patient factors could be associated with processes and outcomes of 
diabetes care. The main contributor to improved processes of care was the frequency of 
diabetes consultations. However, especially regarding the outcomes of care, associations 
were small. Therefore, our results do not support the need for case-mix correction or 
stratification suggested in previous literature. Accounting for a certain margin of error around 
the scores without further correction may be more beneficial for users in practice. 
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ABSTRACT 
Background Randomized trials showed that changes in healthcare organization improved 
diabetes care. This study aimed to identify which organizational determinants were 
associated with patient outcomes in routine diabetes care.  
Methods We performed an observational study, in which multilevel regression analyses were 
applied to examine the impact of 12 organizational determinants on diabetes care as 
separate measures and as a composite score. We included 11,751 patients with diabetes in 
354 general practices in the Netherlands. Main outcome measures included patients’ 
recorded glycated hemoglobin (HbA1c), systolic blood pressure, and serum cholesterol levels.  
Results A higher score on the composite measure of organizational determinants was 
associated with better control of systolic blood pressure (p = 0.017). No effects on HbA1c or 
cholesterol levels were found. Exploration of specific organizational factors found significant 
impact of use of electronic medical records on HbA1c (OR = 1.80, 95% CI 1.12 – 2.88), 
availability of patient leaflets on systolic blood pressure control (OR = 2.59, 95% CI 1.06 – 6.35), 
and number of hours nurse education on cholesterol control (OR = 2.51, 95% CI 1.02 – 6.15).  
Conclusions In routine primary care, it was found that favorable healthcare organization was 
associated with a number of intermediate outcomes in diabetes care. This finding lends 
support to the findings of trials on organizational changes in diabetes care. Notably, the 
composite measure of organizational determinants had most impact. 
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BACKGROUND 
Improving diabetes care has been on the agenda for several decades in many countries. In 
their systematic review of 142 trials, Tricco et al. examined the effects of various 
organizational changes on glycated hemoglobin (HbA1c), blood pressure, and serum 
cholesterol levels1. They identified 12 target areas (Table 1) in three domains: the local 
healthcare system, the healthcare providers, and the patients. 
The results suggested that in particular the combination of intervention components 
targeting the health system and patient-mediated interventions contributed to better 
outcomes. Since the amount of different intervention components varied among the studies 
and the relationship between components was often not investigated, considerable 
uncertainty remained associated with these findings. Similar results were found in a recent 
review by Stellefson et al.2. This study showed that interventions related to each of the six 
Chronic Care Model (CCM) components3,4, ‘community resources and policies’, ‘healthcare 
organization’, ‘self-management support’, ‘delivery system design’, ‘decision support’, and 
‘clinical information systems’, contributed to quality improvement. However, there was not 
one particular component that proved to be a key component to achieve improvements. 
They also suggest that a multifaceted program could facilitate better implementation. Most 
evaluative studies are randomized controlled trials, which involve optimized support for 
achieving change. Although this offers obvious advantages regarding risk of bias, there is 
inconclusive evidence on whether effects can be replicated in daily practice5,6. 
In this contribution, we focus on the impact of organizational determinants on (intermediate) 
patient outcomes in routine diabetes care for type 2 diabetic patients. In the Netherlands, this 
is largely provided in primary care. We aimed to identify organizational determinants of the 
following outcomes: HbA1c, blood pressure, and cholesterol levels. As the quality of diabetes 
care generally has improved over the last decades7-11, we wondered whether organizational 
determinants identified in trials had been implemented and whether they contributed to 
increased control in routine diabetes care in the Netherlands. 
Since several studies suggested that a combination of determinants rather than individual 
determinants contribute most to quality improvement1,2, we also examined the impact of a 
composite measure of organizational factors. 
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Table 1. Measures included in the study related to the target areas for improvement strategies 
Tricco taxonomy  Included measure 
Health systems   
Team changes 1 Nurse practitioner volume: the amount of FTE (full-time equivalent) NP (nurse 
practitioner) per 1,000 patients 
Continuous QI  Continuous quality improvement in the form of written plans with plan-do-
study-act cycles was present in all practices since this was required in the Dutch 
Accreditation program 
 2 Annual report: dichotomous measure of whether the practice evaluates 
quality in a written report (for internal use) at least once a year 
 3 Complaints procedure: percentage of patients aware of the complaints 
procedure in the practice 
Electronic medical 
records 
4 Use of Electronic Medical Records (EMR), sum score of 7 dichotomous items: 
 a) Family physicians (FPs) always use the EMR to create prescriptions 
  b) Incoming lab results are processed automatically 
  c) Hospital referrals are completely created in the EMR 
  d) Referrals to other disciplines (e.g. physiotherapy) are completely created 
in the EMR 
  e) Application forms for diagnostic procedures are generated in the EMR 
  f) Contra-indications and intolerances are systematically recorded in the 
EMR 
  g) FPs have the support of an electronic referral system during visiting 
hours 
Case management 5 Diabetic clinic available in the practice (dichotomous) 
Facilitated relay of 
information to 
clinicians 
6 Consultation with partners, sum score of five dichotomous items: 
 a) Practice has regular consultations with local district nurses 
 b) Practice has regular consultations with local physiotherapists 
  c) Practice has regular consultations with local dieticians 
  d) Practice has regular consultations with local pharmacists 
  e) Practice has regular consultations with local social workers 
 7 Collaboration with partners, sum score of 2 dichotomous items: 
  a) Practice collaborates with local physiotherapists 
  b) Practice collaborates with local social workers 
Healthcare 
providers 
  
Financial incentives  - 
Clinician education 8 FP education: dichotomous measure, amount of accredited education less 
than 50 hours per year or exactly/more than 50 hours. The cutoff point was 
based on the approximate median score in our dataset. 
 9 Nurse education: dichotomous measure, amount of education less than 15 
hours per year or exactly/more than 15 hours. The cutoff point was based on 
the approximate median score in our dataset. 
 10 Electronic guidelines are available in every treatment room (dichotomous) 
Clinician reminders  - 
Audit and feedback  The Dutch Accreditation program was an audit and feedback system in itself, in 
which all practices participated 
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Table 1. (continued) 
Tricco taxonomy  Included measure 
Patients   
Education of patients 11 Patient leaflets, composite score of two dichotomous items: 
 a) Patient leaflets regarding cardiovascular diseases are available in the 
practice 
  b) All patient leaflets are kept in an area that is clearly visible and accessible 
for patients 
Promotion of self-
management 
 - 
Reminder systems 12 Patient reminder system available in the practice (dichotomous) 
 
METHODS 
Study design and study population 
We analyzed electronic patient record data from 362 general practices that participated for 
the first time in the Dutch Accreditation program between 2006 and 2009 (Box 1). These 
practices manually extracted information from a random sample of 40 medical records, using 
a structured protocol and data-extraction tool to ensure the selected sample was unbiased. 
Data were collected retrospectively during the preparatory phase of the accreditation 
process. The practice was instructed to select records on only those patients that were 
diagnosed with diabetes and had a family physician (FP) as main diabetes care provider. In 
effect, practices mainly included diabetes type 2 patients. 
 
Box 1. Dutch Accreditation program for general practices 
Since 2005, general practices can voluntarily take part in the Dutch Accreditation program. The preparatory 
phase of this program consists of the collection of data on practice management and patient care. The 
measurement instruments used are previously validated questionnaires such as the ‘VIP’, a visitation instrument 
for practice organization and the ‘Europep’ that measures patient experiences12,13. The questionnaires are filled 
in by family physicians (FPs), nurses and patients. There are also questionnaires for a trained consultant that pre-
audits the practice. Clinical performance is measured with the use of patient information that is extracted from 
electronic medical records; the FP or nurse extracts the information either automatically or manually with an 
extraction form. 
When all data are collected and submitted through an online questionnaire system, the practice receives a 
report that includes information on its own performance and the performance of other practices as benchmarks. 
This information helps to identify which areas could be improved upon. The FPs then write improvement plans 
with a plan-do-study-act cycle. The first audit is carried out after the approval of these plans to confirm adequate 
participation and to grant accreditation. After this audit a three-year accreditation cycle starts. At the end of each 
year the practice staff evaluates whether the objectives of improvement plans are met and writes new 
improvement plans for the following year. The prolongation of the accreditation depends on this process. 
Accreditation is not based on the actual quality of care itself but rather on the quality of the improvement 
initiatives according to a structured program. After three years, a new cycle starts with the data collection phase. 
In our current study, we have excluded these repeated measurements; we have only included data from the first 
cycle. 
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Measures 
Our outcome measures were recorded HbA1c, systolic blood pressure, and total cholesterol 
values. Organizational determinants related to high-quality diabetes care, derived from a 
review of trials1, were linked to specific items from validated questionnaires12. FPs, other 
practice staff, patients, and trained observers filled in these questionnaires as part of the 
Dutch Accreditation program. We composed 12 measures, some with multiple items (see 
Table 1), and their composite score (see Appendix 1). Furthermore, we gathered data from 
these questionnaires on practice type, size and urbanization, the number of diabetes patients 
per 1,000 patients, and the volume of FP per 1,000 patients (expressed as a full-time 
equivalent, FTE). Patients’ age and gender were extracted from the patients’ medical record, 
as well as the year of data collection (2006/2007/2008/2009). Patients’ age was considered as 
a proxy for comorbidity. 
 
Analysis 
We used means and percentages as appropriate to summarize patient and practice 
characteristics and establish whether determinants were implemented in our study 
population. Correlations of all measures (Pearson’s correlation coefficient or Spearman’s 
correlation coefficient as appropriate) were calculated to check for multicollinearity; the 
cutoff point for exclusion was set at r > 0.15. We performed separate multilevel regression 
analyses on each of the three outcome measures: HbA1c, total cholesterol, and systolic blood 
pressure in SPSS (version 20). We examined the effect of the composite score of the 12 
determinants, while controlling for patient characteristics (age and gender) and practice 
characteristics (practice type, year of data collection). Other practice characteristics were not 
included in the model because of correlations above r = 0.15 with practice type. In order to 
explore which underlying determinants of the composite score were related to outcomes, we 
repeated the multilevel regression analyses on each of the 12 determinants in Table 1 
separately. As effects may be smaller in patient populations with higher baseline control1, we 
also performed logistic regression analyses while comparing the extremes, that is the 
practices that performed in the highest and lowest quartiles. 
 
RESULTS 
Study population 
Patients who were mainly under specialist care during the study period were excluded. Data 
on 11,751 diabetes patients from 354 practices remained (mean value of 33.2 patients per 
practice, minimally 10 patients per practice). The study population contained slightly more 
large practices in urban regions compared with the Dutch population (Table 2). Practices that 
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offer vocational training were overrepresented, as it was already known that the Accreditation 
program would become mandatory for them in the ensuing years. 
 
Table 2. Description of participating practices and scores on determinants  
Description Study population  
(2006 – 2009) 
Dutch population 
(2008)14-16 
Practice characteristics  % or value† % or value† 
Practice type* (% of practices)   
Single handed practice 20.2% 42.3% 
Non - single handed, not in health center 57.6%  
Practice with 2 FPs 23.6% 31.5% 
Group practice (>2 FPs) 13.8% 26.1% 
Other practice type 20.2%  
Practice within primary health center 22.2%  
Practice size: no. of patients 4961 3888 
Number of FTE◊ FP per 1000 patients 0.43 0.43 
Practice location‡   
Rural 12.6% 12.2% 
Partly urban  38.2% 41.1% 
Urban 49.2% 46.7% 
At least one of the FPs in the practice provides vocational 
training 
48% 30% 
Total % of FPs that provide vocational training 31% 19% 
No. of diabetic patients per 1000 patients 43 43 
Year of participation   
2005/2006 22.9%  
2007 42.2%  
2008/2009 34.8%  
Scores on determinants % or mean (SD) 
Volume of NP (FTE per 1000 patients)^ 0.14 (0.06)  
Availability of annual report 48%   
% of patients familiar with the complaints procedure 51.1 (12.5)  
Sum score EMR# (score between 0 and 7) 5.38 (1.03)  
Availability of diabetic clinic 88%   
Sum score consultation partners (score between 0 and 5) 3.77 (1.18)  
Sum score collaboration partners (score between 0 and 2) 0.46 (0.69)  
FP education (hours per year) 51 (12.9)  
Nurse education (hours per year) 17 (17.2)  
Availability of guidelines (score between 0 and 1) 0.95 (0.17)  
Sum score patient leaflets (score between 0 and 2) 1.68 (0.56)  
Availability of patient reminder system 78%   
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Table 2. (continued)  
Description Study population  
(2006 – 2009) 
GIANTT 200717 
Patient characteristics  % or mean (SD)  % or mean (SD)  
Patient age 65.9 (12.1) 66.6 (12.3) 
Patient gender, male 51%  48% 
HbA1c value % / mmol/mol 6.8 (1.0) / 51 (10.9) 6.9 (1.0) / 52 (10.9) 
Total cholesterol value mmol/l 4.7 (1.1) 4.4 (1.1) 
Systolic blood pressure value mm Hg 140 (18) 142 (20) 
HbA1c within target value (7.0) 67.4%  61% 
Total cholesterol within target value (5.0) 63.2%   
Systolic blood pressure within target value (150) 70.9%   
Within 140 46.9%  44% 
Within 160 84.0% 87%  
Aggregated average and percentile scores on practice 
level 
25th percentile Average 75th percentile 
HbA1c value % / mmol/mol 7.0 / 53 6.8 / 51 6.5 / 48 
Total cholesterol value mmol/l 4.9 4.7 4.5 
Systolic blood pressure value mm Hg 144 140 136 
* The figures based on the Dutch population distinguish between solo, duo and group practices. In our study there 
were also the options ‘part of health center’, which can be either solo, duo or group, and ‘other practice type’, which 
consists mostly of duo or group practices within a cooperation construction other than a health center. ◊ FTE = Full-
time equivalent. ‡ A region was defined as urban when the number of addresses per km2 exceeded 1,500; partly 
urban regions had 500 - 1.500 addresses per km2; rural regions had less than 500 addresses per km2. ^ NP = Nurse 
practitioner. # EMR = Electronic medical records. † Because the percentages were rounded off, they do not always 
add up to exactly 100%. 
 
Measures 
Table 2 gives the mean scores and standard deviations (SD) or percentages (in case of 
dichotomous measures) on the measures included in the study. The percentage of patients 
with a value below the target for HbA1c, cholesterol, and blood pressure was relatively high 
(between 63% and 71%). However, 68.4% of all patients had at least one intermediate 
outcome that was above the target, i.e. diabetes control was not according to guidelines on 
all aspects. 
 
Organizational determinants 
The included practices had high scores on the organizational determinants, indicating 
favorable conditions for high-quality diabetes care (see Table 2). Determinants that were 
implemented on a broad scale included the diabetic clinic, a patient reminder system, and 
guideline availability. Also, in most practices (89%) a nurse practitioner (NP) was part of the 
practice team. More possibilities for further implementation were found on collaboration with 
partners and the familiarity of patients with the complaints procedure. 
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Table 3. Multilevel models (cluster measure = practice, data on patient level) on continuous outcomes of 
HbA1c, cholesterol and blood pressure for determinant composite score 
Parameter* HbA1c (%), n = 7281 Total cholesterol 
(mmol/l), n = 7122 
Systolic blood pressure 
(mm Hg), n = 7320 
 Estimate (95% CI) p Estimate (95% CI) p Estimate (95% CI) p 
Intercept 6.77 (6.53 − 7.01) .000 4.54 (4.30 − 4.77) .000 118.8 (114.9 − 122.7) .000 
Sum score 
determinants 
.008 (-.018 − .035) .546 .005 (-.020 − .030) .698 -.50 (-.91 − -.09) .017 
Patient age -.002 (-.004 − -.000) .049 -.001 (-.003 − .001) .419 .34 (.31 − .38) .000 
Patient gender .028 (-.017 − .074) .221 -.354 (-.402 − -.306) .000 -.53 (-1.33 − .28) .199 
Year data 
collection 
      
2007 .071 (-.042 − .185) .217 -.014 (-.122 − .095) .804 2.39 (.61 − 4.18) .009 
2008 .079 (-.038 − .196) .187 -.170 (-.282 − -.059) .003 2.30 (.46 − 4.13) .014 
2009 .149 (-.028 − .325) .098 -.091 (-.258 − .076) .284 1.68 (-1.08 − 4.43) .231 
Practice type       
Single handed -.020 (-.134 − .094) .729 -.026 (-.134 − .083) .638 -1.39 (-3.18 − .39) .125 
Health center .076 (-.042 − .194) .206 .149 (.037 − .262) .010 .02 (-1.82 − 1.87) .981 
* Reference categories: patient gender male, data collection in 2006, practice with more than 1 FP that is not part of 
a health center. 
 
Impact of composite organizational measure 
Table 3 shows that systolic blood pressure levels were lower in practices with a higher 
determinant sum score (p = 0.017). The additional implementation of one determinant led to 
a decrease of 0.5 in the systolic blood pressure, with a maximum estimated decrease of six 
points. No effects were found regarding HbA1c or cholesterol levels. 
 
Impacts of organizational items 
Of 36 possibilities (12 items x 3 outcomes) we found three significant effects. HbA1c levels 
were lower in practices that made more use of their electronic medical records (B = -0.088, p < 
0.000). HbA1c levels were higher in practices with a diabetic clinic (B = 0.327, p < 0.000), and 
practices that wrote an annual report (B = 0.103, p = 0.032). None of the 12 measures was 
found to have an influence on total cholesterol or systolic blood pressure, see Appendix 2. 
 
Comparison highest and lowest quartile practices  
Of the 34 measured effects, three effects were significant. Practices that made more use of 
their electronic medical records (increase of one on a scale of seven) were more likely to score 
in the highest quartile (OR = 1.8), see Table 4. If the amount of nurse education was relatively 
high (above the median), there was a higher likelihood that the practice performed within the 
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highest quartile on total cholesterol (OR = 2.51). Regarding the average systolic blood 
pressure, better availability of patient leaflets increased the odds (OR = 2.59) that practices 
comprised part of the ‘best practices’. 
 
Table 4. Logistic regression comparison practices in highest and lowest quartile, corrected for patient age, 
gender, practice type and year of data collection  
Parameter HbA1c, n = 109 Total cholesterol, n = 120 Systolic blood pressure,  
n = 122 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Volume of NP*  .031 (.00 − 11.94) .253 6.25 (.00 − 18334.95) .653 29.62 (.03 − 33804.60) .345 
Annual report .40 (.14 − 1.13) .083 .68 (.25 − 1.83) .442 .66 (.22 − 1.94) .447 
Complaints policy 1.02 (.98 − 1.07) .294 .99 (.95 − 1.03) .481 .98 (.94 − 1.03) .403 
Use of EMR◊ 1.80 (1.12 − 2.88) .014 .97 (.64 − 1.48) .892 1.65 (.95 − 2.85) .074 
Diabetic clinic ‡ ‡ .55 (.08 − 4.01) .554 .37 (.06 − 2.07) .255 
Consultation 1.40 (.91 − 2.16) .126 1.00 (.70 − 1.43) .992 1.20 (.81 − 1.78) .359 
Collaboration 1.19 (.57 − 2.51) .643 1.27 (.62 − 2.63) .512 1.40 (.68 − 2.88) .363 
FP education .75 (.31 − 1.82) .519 .80 (.32 − 1.99) .636 1.62 (.65 − 4.05) .301 
Nurse education 1.13 (.45 − 2.82) .800 2.51 (1.02 − 6.15) .045 1.15 (.43 − 3.11) .778 
Guidelines ‡ ‡ 1.01 (.06 − 17.40) .997 .34 (.01 − 14.76) .571 
Patient leaflets .40 (.16 − 1.01) .051 1.11 (.41 − 3.04) .833 2.59 (1.06 − 6.35) .037 
Reminder system 1.03 (.30 − 3.57) .958 .66 (.23 − 1.89) .443 1.39 (.44 − 4.41) .579 
* NP = Nurse practitioner. ◊ EMR = electronic medical records. ‡ The determinants diabetic clinic and guidelines could 
not be included in the analysis regarding HbA1c because these variables were a constant in one of the quartile 
groups. 
 
DISCUSSION 
In this study, targeted organizational determinants were broadly implemented in routine 
primary care. A higher score on the composite measure of healthcare organization was 
associated with better systolic blood pressure control. Exploration of specific organizational 
factors identified only three significant effects in 36 combinations. Comparison of highest and 
lowest quartiles yielded similar results (three significant effects out of 34). These results from 
daily practice suggest that implementation of a combination of organizational determinants 
(rather than individual organizational items) is crucial for high-quality diabetes care1,2,18. 
 
Strengths and limitations 
The current study monitored ongoing care in an average Dutch practice, as opposed to a 
controlled trial setting where active changes are made to practice management. Most 
organizational determinants were broadly implemented in routine care, reflecting a 
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longstanding process of improving diabetes care in the Dutch primary care setting. Perhaps 
the voluntariness of participation in this study contributed to this fact. 
Outcomes were similar in the Dutch GIANTT study17, in which all diabetic patients from 
general practices were included. This suggests that the selected patient samples formed an 
adequate reflection of the practice population. The relatively well-controlled population and 
the small amount of variation within the organizational measures decreased the potential 
impact of organizational items19. Although other individual studies have used similar items to 
operationalize constructs20, there were some constructs that were based solely on one 
dichotomous item, which could have affected the representation of the model. 
 
Explanation of findings 
Our observational study showed that, similar to trials, a multifaceted approach to improve 
the quality of care involving a combination of organizational interventions can be expected to 
achieve larger effects than single interventions1,2. Ose et al. found that a practice management 
program had a positive effect on quality of life outcomes21. Coleman et al. evaluated the 
effects of implementation of the Chronic Care Model (CCM) and concluded that an integrated 
approach was positively associated with improvements in organization and outcomes of 
care22. Compared with other studies, effect sizes in our study were moderate, as was their 
clinical relevance. Nevertheless, the differences between practices with highest and lowest 
quartile organizational performance were substantial. Further research is required to unravel 
whether multiple favorable organizational determinants imply additive or multiplicative 
effects. On average, the outcome measures in our study met the standard levels as described 
in the diabetes guidelines, but the composite measure for organizational determinants still 
showed a significant effect regarding blood pressure. This is probably due to the fact that 
blood pressure offered the largest room for improvement17,23,24. 
Regarding the individual organizational determinants we found few and small effects. There 
was a positive effect of the use of the Electronic Medical Records (EMR) on diabetes care, 
which is consistent with the research evidence from the trials25. The positive relation between 
the availability of patient leaflets and blood pressure has been suggested in other studies as 
well26. Less clear was the unexpected negative association of the availability of a diabetic 
clinic and an annual report with HbA1c. However, in the Netherlands both features are related 
to large practices, which in turn have a negative association with quality of care27,28. The data 
supported this argument, as practice size was somewhat larger for practices with an annual 
report (5,279 versus 4,526 patients) as well as for practices with a diabetes clinic (5,086 versus 
3,910 patients). 
In our study we used the target values as described in the diabetes guidelines at the time of 
measurement. However, in daily practice, these are influenced by patient values and 
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preferences and should not be handled strictly. It is likely that FPs might have deviated from 
the guidelines when they thought strict treatment was not preferred. For instance, in our 
dataset the percentage of people with a blood pressure above target was higher for the 
elderly (70 and above) than the younger population (39% versus 30%). 
 
Conclusions 
In line with previous research a combination of determinants of practice organization was 
more strongly related to meeting the targets on diabetes management than a single 
determinant1,2,22. On average the targets for the management of diabetes care as described in 
the diabetes guidelines were met, but improvement on intermediate diabetes outcomes 
could still be reached by introducing more structured practice organization. 
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APPENDIX 
Appendix 1. Creator of composite scores 
Twelve organizational determinants were identified in this study. To create a composite 
measure out of these 12 determinants we transformed six measures into dichotomous 
measures. These determinants were nurse practitioner volume, patient awareness of the 
complaints procedure, use of the electronic medical records, consultation with partners, 
collaboration with partners, and use of patient leaflets. We based the division into two groups 
on the median score within our dataset. Since in several cases the median score equaled 
either the highest or lowest score, we looked at the average to determine in which group the 
median score should be included. If the average was lower than the median, we coded all 
median or higher scores as 1 and the others as 0, and vice versa. For example, 61% of all 
practices scored 0 on the determinant consultation with partners, 24% scored 1 and 11% 
scored 2. We recoded this into ‘0’ for all practices with a 0 score, and ‘1’ for all other practices. 
The other six measures were already dichotomous and coded as 0 or 1. All 12 items were then 
combined into a sum score that indicated the extent of implementation of all determinants. 
This score could in theory vary between 0 (none of the determinants implemented) and 12 (all 
determinants implemented). 
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Appendix 2. Multilevel models (cluster measure = practice, data on patient level) on continuous 
outcomes of HbA1c, cholesterol and blood pressure for separate determinants 
Parameter* HbA1c (%), n = 7281 Total cholesterol (mmol/l), 
n = 7122 
Systolic blood pressure 
(mm Hg), n = 7320 
 Estimate (95% CI) p Estimate (95% CI) p Estimate (95% CI) p 
Intercept 7.28 (6.84 − 7.72) .000 4.54 (4.08 − 5.00) .000 119.8 (112.3 −127.3) .000 
Volume of NP◊ .083 (-.518 − .684) .786 -.088 (-.712 − .535) .780 -5.30 (-15.39 − 4.78) .301 
Annual report .103 (.009 − .197) .032 .019 (-.078 − .117) .703 -.23 (-1.81 − 1.35) .774 
Complaints policy -.002 (-.005 − .002) .409 .001 (-.003 − .005) .614 .02 (-.04 −.08) .521 
Use of EMR◊ -.088 (-.130 − -.045) .000 .007 (-.037 − .051) .759 -.56 (-1.27 − .15) .124 
Diabetic clinic .327 (.173 − .480) .000 .056 (-.103 − .214) .489 .81 (-1.77 − 3.38) .538 
Consultation  -.013 (-.048 − .023) .482 -.003 (-.040 − .034) .872 -.41 (-1.00 − .19) .181 
Collaboration  -.042 (-.109 − .025) .215 -.006 (-.075 − .063) .867 -.13 (-1.26 − .99) .816 
FP education .020 (-.063 − .103) .639 -.001 (-.087 − .086) .991 -.51 (-1.91 − .88) .470 
Nurse education -.027 (-.115 − .061) .542 -.034 (-.125 − .057) .464 -.79 (-2.27 − .68) .292 
Guidelines .152 (-.093 − .397) .222 -.008 (-.261 − .245) .949 .34 (-3.77 − 4.45) .870 
Patient leaflets .053 (-.031 − .138) .215 -.012 (-.100 − .075) .784 -1.07 (-2.49 − .345) .137 
Reminder system -.005 (-.113 − .103) .928 .047 (-.065 − .158) .410 -1.35 (-3.16 − .-46) .144 
Patient age -.002 (-.004 − -.000) .034 -.001 (-.003 − .001) .431 .34 (.31 − .37) .000 
Patient gender .028 (-.018 − .073) .230 -.353 (-.402 − -.305) .000 -.53 (-1.34 − .27) .195 
Year data 
collection 
      
      2007 .056 (-.056 − .168) .325 -.001 (-.117 − .114)) .986 2.69 (.80 − 4.58)  .005 
      2008 .062 (-.056 − .180) .299 -.155 (-.277 − -.032 .014 2.53 (.54 − 4.51) .013 
      2009 .129 (-.046 − .303) .148 -.072 (-.252 − .108) .431 2.15 (-.78 − 5.08) .149 
Practice type       
      Single handed .045 (-.072 − .163) .447 -.042 (-.164 − .080) .495 -1.51 (-3.49 − .46) .132 
      Health center .115 (-.010 − .241) .070 .133 (.003 − .263) .045 .00 (-2.10 − 2.10) 1.00 
* Reference categories dichotomous measures: amount of nurse education below median, amount of family 
physician (FP) education below median, no diabetic clinic, practice does not produce an annual report, no reminder 
system available, patient gender male, data collection in 2006, practices with more than 1 FP that are not part of a 
health center. ◊ NP = Nurse practitioner, EMR = electronic medical records. 
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BACKGROUND 
This thesis focuses on the improvement of chronic care management in primary care, using 
practice accreditation for audit and feedback. Audit and feedback gives an opportunity to 
reflect on clinical and organizational performance by comparing current performance with 
best practices or prior performance. Despite several decades of research, the heterogeneity of 
effects of this strategy remains large and not well understood1. Practice accreditation is a 
specific type of audit and feedback, in which results are used to grant accreditation to the 
practices2. The research on the effectiveness is hindered by the major differences in the 
content of the various programs3. In this thesis, one component of the Dutch Accreditation 
program for general practices is studied, namely the indicators and feedback concerning 
clinical processes and outcomes of general practice care for patients with chronic diseases. 
Little was known about the metric properties of these clinical quality indicators based on 
national guidelines. We therefore examined the reliability and validity of the audit 
instruments, as well as the relation between sample size and precision. Subsequently, the 
clinical indicators were used to analyze the impact of the Dutch Accreditation program on 
chronic care management. This study was complemented by a qualitative study to learn 
more about the factors and processes related to change. Another issue that needed to be 
addressed was the influence of the specific characteristics of each practice population on the 
impact of the Accreditation program. In the calculation of clinical performance scores, it has 
been suggested to account for patient characteristics that can be distributed differently 
between practices4,5. As the practical relevance of risk adjustment for patient characteristics is 
unknown, we investigated its impact on the scores. To conclude the thesis, an in-depth 
analysis was performed on the organizational determinants that affect chronic care 
management in primary care. Most of these factors have been studied in controlled trials6, but 
it was questioned whether they had impact in routine diabetes care as well.  
 
MAIN FINDINGS 
Reliability and validity of the measurement instruments 
 The clinical quality indicators used in the Dutch Accreditation program measure a 
number of conditions and topics that show low to moderate correlations (Pearson 
correlations up to 0.48), suggesting that they measure a broad scope of provided care. 
Indicators on a single condition show reasonable internal consistency (Cronbach’s alpha 
between 0.56 and 0.73), which suggests that the indicators measure one underlying 
concept. These results indicate that the instruments used in the Accreditation program 
are valid for their purposes: formative evaluation and self-directed learning.  
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 Given the sample of 40 patients used in the Dutch Accreditation program, a confidence 
limit of 15% needs to be taken into account around performance scores. For example, 
the underlying true score of a practice could be anywhere between 52% and 82% when 
the measured score is 67%. Current confidence limits around benchmarks are smaller, 
around 5%. These confidence limits seem to be acceptable for the purpose of internal 
quality performance. However, in case of summative assessment or pay-for-performance, 
higher levels of precision are required and sample sizes should be increased. Given the 
measurement goal, a balance should be found between an acceptable level of precision 
and the increased burden of data collection. The aggregation level (practice or group of 
practices) is also relevant in this context. 
 
Precision of the measurement instruments 
 The number of cases required to achieve a certain level of precision can be reduced by 
creating a composite score that is based on several single indicator performance scores. 
Whereas for a single indicator a sample size of 96 cases is required to achieve a 10% 
precision level, this sample size can be reduced to between 43 and 89 cases for a 
composite performance score. The size of the reduction is dependent on the strength of 
the correlations between the indicators in the composite and on their scores. But even 
for composite scores, the sampling of large numbers of patient records would be 
required to achieve high levels of precision, that is a confidence limit of 5% or less. 
 Collecting data on only a small number of indicators per condition does not necessarily 
lead to lower precision. A composite score based on an optimally chosen subset of 5 or 6 
indicators can have the same level of precision as a composite score that is based on the 
full set of 9 to 12 indicators. 
 
Impact of participation in the Accreditation program 
 Participants in the Dutch Accreditation program that were measured with 24 indicators at 
start and completion of a three-year period had improved on 6 process indicators related 
to diabetes (feet examination, cholesterol measurement, lipid lowering medication 
prescription) and COPD (spirometry measurement, smoking cessation advice). 
Compared to practices that had just started in the Accreditation program, they also 
performed better on 4 indicators related to diabetes (cholesterol outcome) and 
cardiovascular disease (blood pressure outcome, smoke status registration, glucose 
measurement).  
 However, the improvements could not be directly related to participation in the Dutch 
Accreditation program, possibly due to the effects of other quality improvement 
initiatives that were applied simultaneously. 
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Experiences of participants in the Accreditation program 
 Family physicians primarily chose to participate in the Dutch Accreditation program 
because they wanted to improve the quality of care. They were positive about the insight 
they gained into the clinical care they provided and their practice management. The 
main drawback of the process mentioned by the physicians was the amount of time and 
effort it took to collect data. Furthermore, they suggested that they needed more support 
in preparing a practice improvement plan.  
 Some physicians considered the drawbacks of the process to outweigh its advantages. In 
order to optimize quality of care measurement, the findings suggest that it is crucial to 
find a balance between measurability and perceived relevance.  
 
Patient characteristics associated with performance scores 
 Several patient characteristics were associated with indicators of diabetes care. 
Moderate effects of patient characteristics were found on processes of diabetes care 
(measurement of HbA1c, blood pressure and LDL cholesterol), with areas under the curve 
that varied between 0.66 and 0.76. The main contributor to these effects was the 
frequency of diabetes related consults, that can be seen as a measure of patient 
compliance to the treatment process. 
 Regarding the intermediate outcomes of diabetes care (HbA1c, blood pressure and LDL 
cholesterol values within target levels) we found considerably smaller effect sizes, with 
areas under the curve between 0.57 and 0.61. These results suggest that correction or 
stratification of patient characteristics may have limited practical relevance. 
 
Organizational determinants associated with performance scores 
 Most investigated organizational determinants were broadly implemented in routine 
care, but only a few (3 out of 36) showed significant effects on intermediate diabetes 
outcomes. Associations were found between the use of electronic medical records and 
HbA1c, the availability of patient leaflets and blood pressure control and the number of 
hours of nurse education and cholesterol control. 
 A higher score on the composite measure of several practice determinants was 
associated with better systolic blood pressure control. These results from an 
observational study of routine primary care support the findings of trials on 
organizational changes in diabetes care. 
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STRENGTHS AND LIMITATIONS 
The research in this thesis was mainly based on the data collected in the Dutch Accreditation 
program. These data specifically lend themselves for observational studies. Whereas 
randomized, controlled trials (RCTs) have obvious advantages over observational studies in 
terms of risk of bias, observational studies can be used to complement evidence from trials to 
enhance the generalizability. Results from observational studies in daily practice can be more 
easily translated to this setting. Although some studies show that effect sizes in RCTs tend to 
be smaller than in observational studies7, Anglemyer et al. found little evidence for differences 
in effect sizes in their systematic review8. Nevertheless, there were several limitations in our 
studies that relate to the use of observational data. During the data collection period, 
changes were made to the instruments as a reflection of changes in guidelines and policy. 
This led to issues with comparability of the data, especially in our study of impacts of practice 
accreditation. Furthermore, it is likely that practices with a less than average interest in quality 
improvement may have been underrepresented in our sample, although practice 
characteristics of participating practices were comparable to all Dutch practices. Some of the 
practices participated in a pay-for-performance program, which was run parallel in time; 
Kirschner et al. showed that these practices had improved on both process and outcome 
measures of chronic care management9. However, in our study of impacts, we did not find any 
differences between the pay-for-performance participants and the other practices that took 
part in the Dutch Accreditation program. For the study on the experiences of the practices, 
data collection took place in collaboration with the project on pay-for-performance, meaning 
that only practices that participated in both studies were included. This may have biased the 
results, although it is unclear in which direction.  
Our dataset was extracted retrospectively from the electronic medical records. In most 
studies, we addressed the issue of missing values by selecting a subsample of completed 
data. This extra sampling process was checked on loss of validity by comparing the patient 
and practice characteristics of the selected samples with the total dataset. However, in the 
study on the impact of patient characteristics we used multiple imputation to account for the 
missing data due to the large amount of missing data on some of the variables.  
In our study population, the overall quality of chronic care management in the practices that 
participated was already reasonably high, especially regarding diabetes. This may have been 
caused by previous improvement initiatives or by the voluntariness of the program. Possibly, 
the high levels of quality may have hindered finding significant effects in our study on impacts 
of accreditation and the studies on the association of patient and practice characteristics, 
because it becomes more difficult to establish significant effects when baseline scores are 
relatively high6.  
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PERFORMANCE MEASURES 
Feedback in the Accreditation program is provided through performance scores calculated 
from clinical quality indicators. One of the goals of this thesis was to gain better insight in the 
reliability and validity of the instruments. In this section, we address several aspects that are 
of importance in the evaluation of the measurement instruments and what conclusions can 
be drawn from performance scores. We found that electronic record data are sufficiently 
reliable to measure quality of chronic care management for internal assessment. This is 
supported by Green et al.10, who found that information from electronic medical records is 
especially useful to evaluate performance measures of technical quality of care such as 
chronic care management. Nevertheless, Parsons et al.11 showed that information derived 
automatically from the electronic medical records can be biased towards lower performance 
scores. Measured effects may be a reflection of the quality of registration rather than the 
quality of care. In the Dutch Accreditation program, physicians often extracted data from their 
medical records manually. This meant that information that was recorded incorrectly, i.e. in 
other record fields than it was expected to be recorded in, could still be retrieved and 
included. Therefore, in our study manual extraction has probably decreased the bias 
described by Parsons. On the other hand, this option to manually extract data also meant 
that smaller samples of patients were included per practice. As we have shown in our study 
on the precision of data, smaller samples lead to an increase in the confidence limit around 
the scores. In other words, the sample may be a less adequate reflection of the practice 
population because of larger random error. This is important information that can be used to 
improve the interpretability of the performance scores. 
Regarding the evaluation of the measurement instruments, physicians were instructed in the 
data collection protocol to leave out patients that had a medical specialist as their main care 
provider. To judge chronic care management fairly, it makes sense to only include those 
patients for which the family physician (and nurse practitioner) make the main decisions 
regarding treatment. However, this may have caused bias, systematic error in the reflection of 
the population, because the patients that are treated by a specialist tend to have a more 
severe or less stable condition12. Although a written protocol was used to insure random 
selection of patients, there may also have been a bias in patient selection with a preference 
for well-controlled patients. However, in comparing our performance scores on diabetes to 
data from the Dutch GIANTT study13 – a study in which all diabetes patients were included 
that have the FP as their main diabetes care provider – similar results were shown. This 
suggests that in our study, selected patient samples were an adequate reflection of the 
practice population.  
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Another point of discussion relates to our studies on the impact of various patient 
characteristics on processes and outcomes of care. In this thesis, we found that the impact of 
these factors was small to moderate. Other studies have shown that effects can be small for 
most but large for a few practices5,14. Correction or stratification of performance scores can 
increase their face validity and thereby the acceptance among professionals and 
stakeholders15. However, it is debatable whether, for an individual practice, the benefit of 
correction outweighs the disadvantages of case-mix, which include complex calculation 
methods and more difficult interpretation of scores. Whichever choice is made, it is important 
to provide adequate information for users to interpret performance scores correctly16. 
We used classical (frequentistic) statistics to analyze our data in this thesis. In addition, one 
could also use Bayesian methods. A Bayesian analysis is based on several probability 
statements: a prior distribution that is subjective, and a posterior distribution that is based on 
the prior distribution and the observed data17. The probability of whether the blood pressure 
of a diabetes patient is within target level in a certain practice can be estimated, for example 
based on guidelines. These probabilities are then adjusted with the incorporation of the 
observed data, after which the fit of the model can be assessed. One advantage of Bayesian 
methods is that it allows for expert or stakeholder judgments in an explicit way; conclusions 
of an analysis may vary depending on the context of the study and who is conducting it18. This 
may be beneficial, for example when you want to incorporate the different viewpoints of 
various stakeholders. Several separate prior distributions can be included that correspond 
with each stakeholder. Another advantage of Bayesian models is that small sample sizes (per 
family physician or per practice) do not have to pose a problem, since the model is fit by 
pooling data across all physicians or practices19.  
 
Implications 
This thesis includes a number of studies that aim to enhance our knowledge on the use of 
performance scores and their interpretation in practice. Several implications can be derived 
for practical use of performance scores. The current performance scores are based on 
relatively small sample sizes; an acceptable level of error needs to be taken into account. 
Although precision can be increased by the creation of a composite score, the extent of this 
increase is highly variable between practices. Precision can also be increased by collecting 
data from larger samples; improved registration and facilitation of data extraction can 
contribute to achieve larger samples from individual practices. Or data can be collected on a 
larger scale, for example on care trust level. However, for an individual practice, the key is to 
accept a level of uncertainty around each performance score. Knowledge on the issues raised 
in this thesis can help to draw correct conclusions from the performance scores. While insight 
in the impact of case-mix factors and organizational determinants is important, based on this 
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insight one may choose not to incorporate these factors into practice. Instead, uncorrected or 
non-stratified scores may be acceptable for internal quality improvement since the impact of 
these factors is limited. Further studies on validity and reliability of performance scores, based 
on frequentist or Bayesian statistics, can be beneficial to gain more knowledge. Statistics can 
be an important tool to support decisions on which quality indicators to include and what 
conclusions can be drawn from performance scores. However, the means should not exceed 
the goal. It is crucial to align statistical issues of assessment to issues of clinical relevance to 
professionals, patients and policy makers, to increase the chances to influence professional 
behavior20. Bayesian statistics may offer a solution by combining the input from experts and 
statistical models, and thereby it may provide interesting additional information to evaluate 
performance measures.  
 
AUDIT AND FEEDBACK IN AN ACCREDITATION PROGRAM 
The Dutch Accreditation program uses audit and feedback as a central mechanism, 
embedded in a continuous quality improvement process21. This process aims to enhance a 
culture that fosters quality and safety of healthcare22. Literature shows that audit and 
feedback can have positive effects on processes and outcomes of care, although effect sizes 
are heterogeneous and overall small to moderate23. In this thesis, we found several 
improvements on processes and outcomes of care, but the association with the Accreditation 
program was not obvious and effect sizes were small. We also found mixed results in our 
qualitative study. Therefore we did not find support for an added value of the Dutch 
Accreditation program to the effects of audit and feedback, as compared to usual care and 
other ongoing programs, that could be expected on the basis of some previous research23. 
Our findings are in line with systematic reviews on the effects of accreditation on quality of 
chronic care21. However, there may be more indirect effects of the Accreditation program that 
we have not measured with our instruments and within the timeframe of the study. Nouwens 
et al.24 also investigated the effects of the Dutch Accreditation program; they specifically 
looked at the added value of the improvement plans on cardiovascular risk management. 
They found no effects on the outcomes, but found improvements on six processes of care: 
recorded smoking status, exercise control, diet control, registration of alcohol intake, 
measurement of waist circumference and fasting glucose. In an additional qualitative study, 
Nouwens et al. found that physicians did not perceive any direct effects of the Accreditation 
program on patient care. However, they did report positive effects on team climate and on 
the commitment to improve quality of care25. 
A systematic review on audit and feedback states that effects can be larger when feedback is 
provided more intensively, when providers are actively involved and have specific and formal 
responsibilities for implementing change23. One of the key features of the Dutch Accreditation 
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program is that the practice is accredited if it is actively involved in quality improvement 
through use of improvement plans and can achieve improvements over time. This approach 
should aid in creating active involvement among the health professionals; they can take 
ownership of the improvement plans that can be tailored to the individual practices. 
However, results from our qualitative effect study do not support that this was the case. 
Although physicians felt positive about the opportunity to individualize the improvement 
plans to their practice, they did not take ownership of the improvement plans; one of the 
reasons being that they felt that the methods used to develop the plans did not suit their 
pragmatic way of thinking. Possibly, other barriers on the level of the healthcare provider, 
team or organization (such as a less than optimal team climate or lack of leadership) may 
have hindered the implementation of practice changes as well26. In their qualitative study25, 
Nouwens et al. investigated which determinants were perceived to facilitate implementation 
of the Dutch Accreditation program. These include a heightened enthusiasm for improving 
quality of care, clear communication and designation of one person to take responsibility for 
the program. 
 
Accreditation programs vary widely in their content. The Dutch Accreditation program has 
been developed for internal quality assessment. However, there is an increasing request to 
disclose quality data for the general public. Enhancing transparency has been a key element 
in changes in various healthcare systems in the past decade27 and remains high on the 
agenda in the current decade. Transparency can be used to prove that care is provided 
according to the standards and may help to give confidence that quality is high in certain 
areas. Furthermore, it is thought to have an effect on improvement through the mechanism 
that patients choose for higher scoring practices28. A systematic review29 that is mainly based 
on studies performed in hospitals shows mixed results on publishing patient care data. Given 
the issues on validity and precision of performance scores mentioned in the section on 
performance scores, we suggest that additional testing of the indicators is necessary before 
data can be used for public disclosure and external comparisons. Furthermore, it is 
questionable whether the benefits of transparency outweigh the costs and effort to collect 
data when the direct association with improved processes and outcomes of care is not clear.  
Information can also be used in a pay-for-performance scheme. Kirschner et al.30 have looked 
at effects of the Dutch Accreditation program on chronic care, but with an additional financial 
incentive provided based on performance. They found that practices had improved their care 
within the time period measured. It is not certain whether effects can be sustained over a 
longer time period9. However, there can also be negative consequences to financial 
incentives. The implementation of the Quality Outcomes Framework (QOF) in the UK provides 
a good example of what can happen when there is a strong focus on outcomes in 
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combination with relatively large incentives. Researchers found that there were several 
unintended consequences, including gaming, a lack of improvement on non-incentivized 
indicators and a slight decrease in scores after incentives stopped. Other aspects such as 
accessibility also worsened in some cases31,32. They conclude that part of these unintended 
consequences were caused by the large incentives that were involved. These issues will be 
more prominent in external summative assessment compared to internal quality 
improvement.  
 
Implications 
Since we performed this study, changes have been made to facilitate the process and make it 
easier to tailor the programs to the practice, which may have helped to broaden the support 
among physicians. The focus of the program has also shifted: whereas the aim used to be to 
achieve the highest indicator scores possible, currently practice scores are compared to 
certain benchmark levels that indicate a minimum level of good quality of care. In the future, 
the program would benefit from further facilitation of data collection. Also, chronic care 
management has been divided into separate modules that can be spread over several years. 
This decreases the amount of data collection in one year and offers the physicians the option 
to focus on one or a few topics at a time. Further efforts should be made to enhance the 
chances for the Accreditation program to be effective, including taking into account barriers 
and facilitators in improvement that have not been taken into account in the current 
program, for example team climate and motivation to change26. Furthermore, it is important 
to work towards one measurement instrument that different stakeholders can use to gain 
insight in performance. Currently, in the Netherlands several different indicator sets are used 
in care trusts, the Accreditation program and other initiatives to accumulate data for 
stakeholders such as the health inspection and insurers. The practices would benefit from 
one indicator set that is sufficient to provide data for all these different purposes. A standard 
that aims to promote this is under development at the Netherlands Care Organization 
(Zorginstituut Nederland).  
Guidelines, from which performance scores are derived, have increasingly become a golden 
standard. Each deviation needs to be accounted for by the professional. It is important to be 
aware of the original and primary goal of a practice guideline: to guide the physician, rather 
than to enforce strict rules. As a professional, the physician is responsible to provide the best, 
tailored, treatment for an individual patient. They can take an active role in quality 
improvement; they are also the most suitable person to decide in individual cases whether to 
deviate consciously from a guideline or not. Indicators on the percentage of patients treated 
according to guidelines are meant to indicate and should not be used in black-and-white 
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comparisons. Instead of the strong focus on the actual outcomes, the Dutch Accreditation 
program was designed to facilitate systematic quality improvement in practices. 
 
CHRONIC CARE MANAGEMENT 
This thesis focuses on chronic care management. Performance of primary care practices is 
measured with indicators that are based on national guidelines33-35. In our study on the 
impact of accreditation, processes of care were in accordance with guidelines in 
approximately 50-90% of the patients (highest scores on diabetes indicators and lower scores 
on chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) 
indicators). On the other hand, guideline recommendations were met in 35-65% of the 
outcome measures. These findings are in line with other national studies13,36. These 
percentages show that there is room for improvement, especially on the outcomes. However, 
the exact improvement ratio is unclear: for most indicators it is not desirable to strive for 
100% scores, i.e. treatment according to the guideline in each patient. There are several 
reasons for lower guideline adherence. First of all, the guidelines themselves vary in the 
amount of evidence and the urgency of the recommendations. For example, the guidelines 
state that periodic control of diabetes patients that are not fully under control should occur 
(at least) 4 times per year33. However, scientific evidence for this recommendation is lacking. 
In this thesis, the study on impact of patient characteristics shows that higher visiting 
frequencies are associated with better processes of care, which would suggest that one 
should increase the number of consultations when patients are not under control properly. 
Another reason for lower guideline adherence is that throughout the years several changes 
have been made to the guidelines. For instance, target levels have changed for diabetes and 
CVD outcomes. Other changes have also been implemented as the evidence changed. For 
example, whereas previously spirometry was suggested as a tool for both diagnosis and 
follow up, it is now suggested mainly as a diagnostic tool and to measure large changes in 
lung function37. Treatment itself is guided mostly by patient complaints rather than clinical 
parameters. Given these changes in guidelines, indicators are adjusted as well. Although this 
offers some challenges in the interpretation and comparability of the collected data, 
performance scores should reflect the guidelines as closely as possible in order to achieve the 
most optimal reflection of good quality of care given the evidence at the time of 
measurement. However, it takes time to change the guidelines and performance measures 
according to the available evidence, so that at any moment in time, the most recent 
information may not be taken into account yet. 
A systematic review38 reports that poor guideline adherence can also be associated with 
barriers on patient and physician level, including their attitudes, beliefs and their knowledge. 
In individual cases, guideline adherence may be lower because physicians may choose to 
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deviate consciously from the guideline for clinical reasons. For example because further 
intensification of medical treatment would make the situation worse, despite the fact that 
treatment targets were not achieved. On the other hand, physicians may also deviate from 
guidelines to achieve better patient compliance (e.g. patients are more easily motivated to 
aim for a weight loss of 5 kilos than 30 kilos). Treatment can also be guided by the severity of 
the symptoms and preferences of the patients, which can also lead to deviations from the 
guidelines. 
The interpretation of performance scores on chronic care management can be challenging. 
Literature shows that several patient characteristics are associated with processes and 
outcomes of care39,40. In this thesis, we found small associations of several patient 
characteristics with performance scores. Given these influences we suggest that indicator 
scores may be adjusted for these factors through stratification rather than correction. The 
benefit of stratified scores is that physicians gain additional information on whether they 
deviate from the guidelines in a particular group of patients. In addition, continued 
explanation of the limitations of performance and outcome data to relevant stakeholders 
may be required. 
 
The performance measures on chronic care management are based on the guidelines and 
validated with expert panels41. However, there are other aspects of quality that we have not 
measured with our set of performance scores. Indicators only form a snapshot of the care at 
one moment in time, whereas good quality of care also encompasses timeliness42. 
Sidorenkov et al.43 investigated the differences in guideline adherence for commonly used 
indicators, such as those in this thesis, versus clinical pathways in diabetes care. They found 
that the quality of care processes was substantially reduced when looking at clinical 
pathways compared to process indicator scores. For example, in their study 86% of all 
diabetes patients received a blood pressure measurement. However, they found that only 
53% of all diabetes patients were adequately managed in response to this measurement (i.e. 
received treatment intensification when indicated and had a timely evaluation of their 
response to treatment). Porter takes the idea of clinical pathways even further and argues 
that accountability should be shared among the providers involved44. The focus should be on 
all care for a medical condition, including its complications; involving hospital an general 
practice, but also other care providers such as physiotherapists and district nurses. 
Furthermore, he provides a hierarchical model of outcomes with three tiers: retained or 
achieved health status, process of recovery and sustainability of health. Each condition may 
require different outcomes on the three tiers. The relevance of each tier may also vary: for 
example, in advanced cancer stages providers may have limited effects on survival and other 
outcomes related to retained or achieved health status44. Whichever method is used to 
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measure quality of care, it will always be a simplified version – an indication – of reality. This 
offers challenges in whether measures are an adequate reflection of care. In our interview 
study, some physicians commented that the instruments of the Accreditation program on 
practice organization did not capture actual quality of care. In order to increase the support 
among users, the instruments in the accreditation are regularly updated, in accordance with 
the latest evidence.  
Another aspect of chronic care that has not been measured is the actual functioning of the 
patient in daily life. Although patient-reported outcome measures (PROMs) are most often 
used when a clear comparison can be made, for example before and after a surgical 
procedure, they can also be beneficial for quality measurement of chronic care45. For 
example, a self-reported quality of life questionnaire may offer insight in the patient’s fears of 
going into a hypoglyceamic coma and its effect on everyday life46.  
In recent years, personalized medicine has been proposed as an important future perspective 
of healthcare47. Recently developed guidelines include variable targets, for example with a 
HbA1c target level in diabetes patients that varies according to age, duration of the disease 
and treatment intensity, as opposed to a fixed target that is valid for all patients33. However, 
others suggest that guidelines should be adjusted further, by incorporating patient 
preferences such as their beliefs, expectations and goals48. This causes some issues for 
mechanisms such as accreditation, which strives for standardization of treatment, a 
minimum standard or an optimal treatment to strive for in each patient. In some cases a 
higher diversity in treatment, resulting in higher practice variation, is actually an indication of 
good quality of care. With the current quality indicators, we are not able to distinguish 
between intentional deviation in order to benefit the patient and unintentional deviation (i.e. 
lack of good quality care). However, they can still offer evaluative information that can form 
the basis to discuss the processes that take place within the practice. 
 
Implications 
Given the fact that the translation of performance measures into improvements in chronic 
care management is not straightforward, there are several implications for practice. Striving 
for 100% scores may not always be in the patient’s best interest, so indicator scores should be 
assessed with a view on this. It is also important to continuously develop the guidelines and 
measurement instruments according to the latest evidence and to allow for conscious 
deviation from the guidelines in individual cases. For physicians, the challenge is to be 
prepared for these changes that will affect patient management. This may be particularly 
challenging if certain procedures were previously implemented in the guideline, but are later 
on discarded. For this was the case with spirometry as a measure to guide treatment of COPD. 
It is sensible to use performance measurements purely as an indication. 
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The increased administrative burden that comes with accreditation and other improvement 
initiatives that require data collection may have a negative effect on patient experiences with 
the consultation. Shachak et al.49 found that patient-doctor communication was hindered by 
the use of a computer to fill in electronic medical records during consultations. The benefits 
of the program should be weighed against these issues. The aim should be that physicians 
can collect data that they would normally collect to provide good quality of care, with a 
minimum extra impact from improvement schemes. Extra efforts are put in to ensure better 
possibilities for automatic data extraction in the future. 
With the increasing focus on personalized medicine, deviations from the guidelines that are 
well thought out may become more frequent, thus potentially increasing practice variation. In 
the development of new indicators this should be taken into account. As an addition to the 
existing indicator sets on diabetes, COPD, CVD and asthma, we could develop indicators for 
other common diseases such as depression. Furthermore, patient reported outcome 
measures (PROMs) may offer insight in the impact of the chronic disease on everyday life. 
Also, in line with patient-centered care, indicators could be developed regarding multi-
morbidity or collaborative care.  
 
CONCLUSIONS 
Although the effects of accreditation found in this thesis are limited, an accreditation program 
remains a suitable tool for quality improvement. Our research on the properties of the 
indicators and effects of patient and practice characteristics provides evidence on the impact 
of a specific accreditation program. We should strive for the optimal balance between the 
creation of accurate and reliable performance measures versus acceptable amounts of 
investments to collect data. Formative usage of the Accreditation program can be 
recommended; after further evaluation, the program as a whole could be suitable for a 
summative evaluation, in which for example the impact of improvement actions are assessed. 
Guidelines and indicators are aimed to do nothing more or less than to guide and to indicate, 
so technical knowledge as well as wisdom is required in the use for quality improvement.  
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This thesis examines practice accreditation as a strategy to improve chronic care 
management in primary care. Practice accreditation is offered in many countries, but little is 
known on its effectiveness. Evaluation of chronic care management is often an important part 
of these accreditation programs. In this thesis the measurements themselves are discussed as 
well as the impact of the Dutch Accreditation program on the performance improvement. 
 
Chapter 1 provides a general introduction of chronic care management and practice 
accreditation programs. Chronic care management increasingly becomes a more important 
part of the care provided by general practices. It is predicted that the prevalence of chronic 
conditions, as well as the number of people with multiple chronic conditions, will increase in 
the coming years mainly due to an aging population. This will lead to a higher burden on the 
healthcare system. Several interventions have taken place to improve chronic care 
management in general practices. Audit and feedback can promote change through the 
opportunity to reflect on performance. Practice accreditation, a specific form of an audit and 
feedback system, can help evaluate the quality of care provided by the practice and can be 
used to set up tailored improvement programs. In the Netherlands, primary care practices 
can take part in the Accreditation program developed by the Dutch College of General 
Practitioners. In this thesis, we focus on the evaluation of part of the Accreditation program 
that regards chronic care management. We describe several measurement aspects of the 
instrument that is used in the Accreditation program. Furthermore, we examine the impact of 
practice accreditation on chronic care management. The research questions of this thesis are 
summarized in Table 1. 
 
Table 1. Overview of research questions of studies in this thesis 
Chapter Research questions 
Chapter 2 To which extent does the domain clinical care of the Visitation Instrument Accreditation (VIA) 
used in the Dutch Accreditation program meet each of four reliability and validity criteria? 
 1. Correlation between the sets of performance indicators  
 2. Internal consistency within each set of performance indicators 
 3. Precision of indicator scores  
 4. Precision of benchmarks  
Chapter 3 What is the relationship between sample size and precision?  
 Can we increase precision with a composite performance score? 
 How many indicators are needed minimally to achieve a certain level of precision? 
Chapter 4  What is the effect of the Dutch Accreditation program on performance scores regarding 
diabetes, COPD and cardiovascular disease? 
Chapter 5 What are the opinions of family physicians regarding the Dutch Accreditation program? 
Chapter 6 Which patient characteristics are associated with performance scores? 
Chapter 7 Which organizational factors are determinants of intermediate patient outcomes in routine 
diabetes care? 
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To derive meaningful conclusions from performance scores, it is important that the validity 
and reliability of the instrument used to evaluate chronic care management are adequate. In 
chapter 2, we examine four reliability and validity issues of the instrument: the correlation 
between the indicator sets, the internal consistency of each set, the precision of the 
performance scores and the precision of the benchmarks. We performed an observational 
study based on medical record data from 82 practices that participated in the Dutch 
Accreditation program. We included data on diabetes (9 indicators), chronic obstructive 
pulmonary disease (COPD, 5 indicators), asthma (4 indicators), cardiovascular disease (CVD, 8 
indicators), influenza vaccination (1 indicator), cervical cancer screening (1 indicator) and 
prescription of antibiotics (1 indicator). Results show that correlations between these 7 sets of 
indicators were weak, which indicates that the chronic care section of the instrument 
provides a relatively broad representation of care. Furthermore, internal consistency of the 
sets with more than 1 indicator was adequate, which suggests that each set measures a 
coherent underlying concept. Regarding the precision of the performance scores we found 
that in order to achieve a maximum confidence limit of 10% (the true value of the population 
score lies between +10 and -10 percentage points from the measured score) we should base 
the score on records from 96 patients. To decrease the confidence limit to 5%, the number of 
patient records needed to calculate a score increased to 384. A sample of 233 practices was 
sufficient to achieve a maximum confidence limit of 5% around each benchmark. Given that 
practices are mainly interested in those scores that show the largest deviation from the 
benchmark to assess in which areas they can improve their care, a margin of 10% around 
their own score and 5% around the benchmark score is acceptable. However, when the 
intention is to use performance scores for other purposes, for example to rank practices, 
precision criteria become more stringent and current sample sizes are not sufficient. 
 
In chapter 3 we examine a possible solution for sample size issues with individual 
performance scores. We evaluated precision, which is expressed as the closeness of the 
estimated score to the ‘true’ population value. Typically, larger precision is achieved by 
including a larger sample of patients on which scores are based. However, there is a limit to 
the sample that can be included in routine clinical usage, based on time restrictions and 
prevalence of the condition measured. We examined the precision of individual performance 
scores and compared the results with precision of a composite performance score. We also 
looked at how many single performance scores should be included into the composite 
minimally to achieve an acceptable level of precision. We performed a descriptive statistical 
study using medical record data from 455 Dutch general practices that had taken part in the 
Dutch Accreditation program. We included indicators regarding diabetes, CVD and COPD and 
calculated performance scores per indicator and composite performance scores per topic, all 
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on practice level (the percentage of patients that met the indicator divided by the number of 
patients eligible for the indicator). Results show that for individual performance scores, a 
sample of 96 patients needs to be included to achieve a precision of 10 percentage points. 
When the scores are combined into a composite score, a sample of 43 (diabetes) to 89 (CVD) 
patients is sufficient to achieve a similar precision. The variation in required sample sizes 
between the different conditions was caused by the variability in scores within a condition, 
the closeness of the indicator mean scores to the maximum/minimum score of 100%/0% and 
the correlations between the performance scores included in the composite score. 
Furthermore, if it was accepted that a small percentage of practices (e.g. 10%) would not 
achieve the targeted level of precision, required sample sizes decreased further. We also 
found that a composite score derived from a relatively small set of 5 to 7 indicators could 
provide the same precision of measurement as a composite score made up from a larger 
number of indicators. We therefore conclude that the creation of a composite score based on 
a small number of indicators can provide sufficient precision. However, which level of 
precision is sufficient depends on the a priori reasons for measuring quality. Statistically, 
higher precision can be achieved by selecting indicators with lower inter-correlations and 
indictors that are closer to the maximum or minimum score level (100% or 0%). However, for 
assessment purposes it is important that scores do not approach a maximum level so that 
there is room for improvement in the indicator scores. Also, high inter-correlations of 
indicators are often favorable when one wants to achieve high validity of an indicator set. 
Careful consideration of measurement purposes and all aspects related to measurement and 
calculation of scores is advised. Precision needs to be greatest when there is an external 
summative assessment or when it is used in a payment mechanism. For formative quality 
improvement, such as the Dutch Accreditation program, current precision of single 
performance scores and precision of a composite score is sufficient. 
 
In chapter 4, we present a comparative observational study in which we examine the impact 
of the Dutch Accreditation program on the quality of chronic care management. Although 
accreditation is widely used to assess and improve quality of healthcare providers, little is 
known about its effectiveness, particularly in primary care. The Dutch Accreditation program 
uses a 3-year cycle with extended measurements at the start of the first year. A first cohort of 
69 practices was followed throughout the program with measurements at start and after 
three years (the start of the next cycle). A second cohort of 69 practices was measured at their 
start of the Accreditation program, during the same period of the post-assessment in the first 
cohort. Data were collected retrospectively over a one year period prior to the start. We 
evaluated the effect of practice accreditation in a design with two separate comparisons. In 
the first comparison we assessed improvements over time within the first cohort. In the 
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second comparison we assessed differences between the first and second cohort by 
comparing the follow-up measurement of the first cohort with the start measurement of the 
second cohort. We included measurements on diabetes, COPD and CVD. Results show that 
practices in the first cohort had improved on cholesterol measurement, feet examination and 
the prescription of lipid lowering medication (diabetes), spirometry measurement and the 
provision of a smoking cessation advice (COPD). As the follow-up measurement scores on 
these performance measures were similar to the baseline scores in the second cohort, it 
remains uncertain whether the effect can be attributed to the Accreditation program. 
Compared to the second cohort of newly starting practices, the practices in the first cohort 
performed better regarding achievement of a target cholesterol level (diabetes) and blood 
pressure level (CVD) and the registration of smoke status and measurement of glucose levels 
(CVD). These differences could provide evidence for the added value of the Accreditation 
program. The evidence for an added value of the Accreditation program was not as strong as 
expected by participants and stakeholders. This may be partially explained by other 
developments in the primary care field during our research period, such as the 
implementation of bundled payment. Both require data collection and offer feedback; 
measures used on diabetes, COPD and CVD are almost identical. However, we did find that 
general practices improved the quality of care for patients with the targeted chronic diseases. 
Continuous monitoring may have been beneficial for practices in order to maintain a high 
level of quality in some areas and improve further in others. 
 
Chapter 5 presents a study on the opinions of family physicians regarding the Dutch 
Accreditation program. Evaluation of participant opinions can provide added insight in the 
mechanisms underlying the program and the impact of accreditation. A mixed methods 
design was used in which data from written questionnaires was combined with information 
gathered in interviews. All family physicians took part in the Dutch Accreditation program 
between 2006 and 2007 and also participated in a pay-for-performance study. The 
questionnaire contained open-ended and closed-ended questions. We used a framework 
approach in the interviews; the main themes and subthemes of the questionnaires and 
interviews were selected in advance, but some sub-themes were inductively derived during 
the analysis. The themes included motives for participation in the program, data collection, 
content of the measurement instrument, writing practice improvement plans, support and 
what the practice gained from participating. Results showed that family physicians mainly 
participated because they had a special interest in quality improvement and wanted to gain 
insight in their performance. While they were positive about the insight they gained into their 
practice management and clinical care, they found that the collection of data on medical 
practice was too time-consuming. Because of the lack of uniform registration, extraction from 
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electronic medical records was difficult. Regarding the content of the measurement 
instrument they were generally quite positive. However, they mentioned that the assessment 
instruments should put less emphasis on details and more on the underlying processes. 
Furthermore, physicians indicated that they needed more support in preparing a practice 
improvement plan. Overall, we found that family physicians are willing to take part in an 
accreditation program, but the process should not be too time-consuming and the 
instruments used should lend themselves to improving quality now and in the future. There 
needs to be a balance between measurability and perceived quality. Some physicians 
considered the drawbacks of the process to outweigh its advantages. 
 
Patient characteristics may influence the performance scores measured in the Accreditation 
program. Chapter 6 focuses on the relationship between patient characteristics and 
measurement of processes and outcomes of diabetes care in general practices. Patient age, 
gender, ethnicity and other socio-demographic factors are associated with diabetes 
outcomes. Furthermore, differences in the severity of the condition, defined as multi-
morbidity, can also affect diabetes control. In order to compare performance measures 
between practices, adjustment or stratification is suggested for these factors. The strength of 
the association between multi-morbidity factors, other case mix factors and measures of 
processes and outcomes of care is not clear. Therefore, we investigated the associations of 
several patient factors (gender, age, body mass index (BMI), whether patient lives in a 
deprived area) and three multi-morbid conditions (cardiovascular disease (CVD), chronic 
obstructive pulmonary disease (COPD) and depression/anxiety) with diabetes care processes 
and outcomes. We included a total of 6 measures on whether HbA1c, systolic blood pressure 
and LDL cholesterol were measured and whether the measurement was within the target 
level described in the guidelines. We found that the models on processes of care showed 
moderate effects, with pooled areas under the curve (AUCs) that varied between 0.66 and 
0.76. This suggests that patient factors had some impact on diabetes care indicators. 
Measurement of the number of diabetes consultations, as a measure of patient health service 
utilization, was the main contributor to the effects found (odds ratios between 5.6 and 14.5). 
Effects on outcome measures were small (AUCs varying from 0.57 to 0.61), which indicates 
that the model did not perform much better than chance. Our results do not support the need 
for case-mix correction or stratification suggested in previous literature. Therefore, we 
conclude that accounting for a certain margin of error around the scores without further 
correction may be more beneficial for users in practice. 
 
The impact of accreditation on outcomes of care may vary between practices due to 
variations in organization that can be related to improved care. In chapter 7 we examine 
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which organizational determinants are associated with improved diabetes care outcomes. 
Organizational determinants related to high-quality diabetes care, derived from a review of 
trials, were linked to specific items from validated questionnaires that were used in the Dutch 
Accreditation program. We included data from 362 practices that participated in the program 
between 2006 and 2009. We composed twelve measures and a composite score and 
examined the association of these measures with three diabetes outcomes: HbA1c, total 
cholesterol and systolic blood pressure. Results show that most organizational determinants 
were broadly implemented in our study population, indicating favorable conditions for high-
quality diabetes care. A higher score on the composite measure of healthcare organization 
was associated with better systolic blood pressure control. Exploration of specific 
organizational factors identified only 3 significant effects in 36 combinations. These results 
from daily practice suggest that implementation of a combination of organizational 
determinants (rather than individual organizational items) is crucial for high-quality diabetes 
care.  
 
Chapter 8 provides a general discussion of this thesis. All studies were based on observational 
data, which can be used to complement evidence from trials to enhance the generalizability. 
However, there were also several limitations to the use of retrospectively collected 
observational data, including the existence of missing values and possible selection bias. 
Also, practices already scored relatively high on many indicators of chronic care 
management, which may have limited the possibility of finding significant effects. In this 
chapter, we address three areas of discussion: (I) performance scores, (II) audit and feedback 
and accreditation, and (III) chronic care management. Regarding the performance scores we 
discuss whether they should be corrected or stratified for patient and practice characteristics. 
On the one hand it will increase face validity; on the other hand the associations that we 
found were small. It is debatable whether, for an individual practice, the benefit of correction 
outweighs the disadvantages (complex calculation methods and difficult interpretation of 
scores). We also suggest that Bayesian methods of analysis may provide interesting 
additional information to evaluate performance measures. These methods offer a solution to 
align statistical issues of assessment with issues of clinical relevance for the different 
stakeholders.  
In the section on audit and feedback and accreditation, we discuss that whereas we found 
limited effects of accreditation on the processes and outcomes of chronic care management, 
the Accreditation program can also be of value to the general practice by means of creating 
more transparency. However, the costs and efforts to collect data should be in balance with 
the benefits. Since there is an increasing request to disclose quality data for the general 
public, we discuss the effects of public disclosure and pay-for-performance reported in other 
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studies: they may increase effects on outcomes, but there can also be more unintended 
consequences such as gaming and a lack of improvement in non-incentivized indicators. 
Also, there are several issues with validity and precision, since the requirements become more 
stringent for external summative assessment. To increase the chances of finding effects, the 
Dutch Accreditation program should be continuously tailored; data collection should be 
facilitated and existing barriers and facilitators to change should be addressed. The Dutch 
Accreditation program has been under development since the studies in this thesis were 
performed to address several of these issues. 
Regarding chronic care management we discuss the use of guidelines. Performance scores 
that are used in the Dutch Accreditation program are derived from these guidelines. However, 
it is not desirable to strive for 100% scores. Not all guidelines are based on equally strong 
evidence, and in individual cases, deviation from the guideline may be beneficial for the 
patient. With the increasing focus on personalized medicine, deviations from the guideline 
may become more frequent. Also, guidelines are adjusted as the evidence is growing. This 
requires that physicians are flexible and willing to adjust their patient management. It is 
sensible to use performance measurements purely as an indication. 
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In veel landen wordt praktijkaccreditatie aangeboden als strategie om de organisatie en 
uitvoering van zorg te verbeteren. Over de effectiviteit van praktijkaccreditatie is echter weinig 
bekend. In Nederland is in 2005 een accreditatieprogramma voor de huisartsenzorg gestart, 
de NHG-Praktijkaccreditering. In dit proefschrift onderzoeken we de impact van deze 
praktijkaccreditatie op de zorg voor chronische patiënten in de huisartspraktijk. 
 
Hoofdstuk 1 bevat een algemene introductie over de kwaliteit van zorg voor chronische 
patiënten in de huisartspraktijk. Chronische zorg vormt een steeds groter aandeel van alle 
zorg geleverd door de huisartspraktijk. Er wordt verwacht dat zowel de prevalentie van de 
chronische aandoeningen, alsmede het aantal mensen met meerdere chronische 
aandoeningen, toe zal nemen in de komende jaren. Een belangrijke oorzaak hiervoor is de 
vergrijzing in de populatie. Dit brengt een extra druk op het zorggebruik met zich mee. 
Huisartspraktijken kunnen worden ondersteund bij het behouden van goede kwaliteit van 
chronische zorg of het verder verbeteren ervan met behulp van verschillende methoden. Zo 
kan audit en feedback bijdragen aan verbeteringen doordat het de mogelijkheid biedt het 
eigen handelen te evalueren. De NHG-Praktijkaccreditering maakt ook gebruik van een vorm 
van audit en feedback, ingebed in een 3-jarige cyclus waarin ook verbeterplannen ontwikkeld 
worden op basis van de audit en feedback. 
 
Het is belangrijk dat de validiteit en betrouwbaarheid van de instrumenten, die gebruikt 
worden om de chronische zorg te evalueren, afdoende zijn om de scores juist te kunnen 
interpreteren en er zinvolle conclusies aan te kunnen verbinden. De meetinstrumenten die 
gebruikt worden binnen de NHG-Praktijkaccreditering om de kwaliteit van de chronische zorg 
in kaart te brengen, zijn in eerder onderzoek al gevalideerd op inhoud en klinische relevantie. 
Andere aspecten van betrouwbaarheid en validiteit zijn echter nog niet onderzocht.  
In dit proefschrift onderzoeken we de samenhang van de meetinstrumenten onderling, hun 
interne consistentie en de precisie van de scores op de indicatoren en benchmarks. Door ook 
te kijken naar de precisie van samengestelde indicatorscores diepen we dit onderwerp nog 
wat meer uit; hiermee krijgen we een beter beeld van de zeggingskracht van indicatoren 
gegeven de grootte van de dataset waarop deze indicatorscores gebaseerd zijn.  
Als we de betrouwbaarheid en validiteit van de meetinstrumenten onderzocht hebben is de 
volgende stap het kijken naar de effecten van accreditatie. In een volgende studie gaan we 
daarom in op het effect van de NHG-Praktijkaccreditering op processen en uitkomsten van 
zorg voor patiënten met diabetes, hart- en vaatziekten en COPD. Om een completer beeld te 
krijgen van de effecten van accreditatie onderzoeken we ook de meningen van huisartsen 
over de NHG-Praktijkaccreditering.  
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Om feedback correct te interpreteren is het van belang dat we op de hoogte zijn van factoren 
die de scores mogelijk kunnen beïnvloeden. Daarom bestuderen we tot slot de samenhang 
van patiëntkenmerken en organisatorische factoren met scores op het medisch handelen. 
Tabel 1 bevat de onderzoeksvragen van dit proefschrift. 
 
Tabel 1. Onderzoeksvragen van de studies in dit proefschrift 
Hoofdstuk Onderzoeksvragen 
Hoofdstuk 2 In hoeverre voldoet het medisch handelen onderdeel van het visitatie instrument accreditatie 
(VIA) aan 4 criteria betreffende betrouwbaarheid en validiteit? 
 1. Correlatie tussen de verschillende indicatorsets 
 2. Interne consistentie binnen elke indicatorset 
 3. Betrouwbaarheid van de indicatorscores 
 4. Betrouwbaarheid van de benchmarks 
Hoofdstuk 3 Wat is de relatie tussen de steekproefgrootte en de precisie? 
 Kan het creëren van een samengestelde indicatorscore leiden tot een grotere precisie? 
 Hoeveel indicatoren zijn er minimaal benodigd om een zekere mate van precisie te bereiken? 
Hoofdstuk 4  Wat is het effect van de NHG-Praktijkaccreditering op het medisch handelen in de praktijk wat 
betreft diabetes, COPD en hart- en vaatziekten? 
Hoofdstuk 5 Wat is de opinie van de deelnemende huisartsen over de NHG-Praktijkaccreditering? 
Hoofdstuk 6 Welke patiëntkenmerken zijn geassocieerd met medisch handelen scores? 
Hoofdstuk 7 Welke organisatorische factoren hangen samen met medisch handelen scores op het gebied 
van diabetes? 
 
In hoofdstuk 2 beschrijven we een studie waarin we vier verschillende criteria over de 
betrouwbaarheid en validiteit van het instrument hebben onderzocht: de correlaties tussen 
verschillende indicatorsets, de interne consistentie van elke set, de betrouwbaarheid van de 
scores en de betrouwbaarheid van de benchmarks waarmee de scores vergeleken worden. 
We voerden een observationele studie uit die gebaseerd was op data uit het elektronisch 
patiënten dossier (EPD) van 82 praktijken die deelnamen aan de NHG-Praktijkaccreditering. 
De dataverzameling betrof diabetes (9 indicatoren), COPD (5 indicatoren), astma (4 
indicatoren), hart- en vaatziekten (8 indicatoren), griepvaccinatie (1 indicator), baarmoeder-
halskanker screening (1 indicator) en antibiotica prescriptie (1 indicator). De resultaten tonen 
aan dat de correlaties tussen deze 7 indicatorsets laag waren, wat suggereert dat het 
onderdeel medisch handelen van het VIA-instrument een relatief breed beeld schetst waarin 
verschillende aspecten gerepresenteerd worden. Verder bleek dat de interne consistentie van 
de sets met meer dan 1 indicator adequaat was, wat een indicatie is dat elke set een coherent 
onderliggend concept meet. Wat betreft de betrouwbaarheid van de scores vonden we dat 
voor een maximale foutenmarge van 10% (dat wil zeggen dat de werkelijke onderliggende 
waarde ergens tussen de +10 en -10 punten van de gemeten score af ligt) de score gebaseerd 
moet zijn op gegevens van 96 patiënten. Om deze foutenmarge te verkleinen naar 5% steeg 
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het aantal benodigde patiënten naar 384 patiënten. Een steekproef van 233 praktijken was 
voldoende om benchmark scores te kunnen berekenen met een foutenmarge van maximaal 
5%. Aangezien praktijken voornamelijk geïnteresseerd zijn in die scores waarin ze ver afwijken 
van de benchmark, om vast te stellen op welke punten ze zich het beste kunnen richten om 
de zorg te verbeteren, is een foutenmarge van 10% rond de eigen score en 5% rond de 
benchmark acceptabel. Wanneer de scores echter gebruikt worden voor andere doeleinden, 
bijvoorbeeld om een ranglijst te maken van de praktijkscores, dan worden de eisen die 
gesteld worden aan de scores wat betreft betrouwbaarheid strikter en is de huidige 
steekproefgrootte niet afdoende. 
 
In hoofdstuk 3 onderzochten we een mogelijke oplossing voor het relatief hoge aantal 
benodigde patiënten voor het berekenen van scores met een acceptabele foutenmarge. We 
evalueerden precisie, wat we definiëren als de mate waarin de geschatte score de 
onderliggende werkelijke populatie score weet te benaderen. Over het algemeen kan een 
betere precisie worden bereikt door een grotere steekproef te nemen om scores te 
berekenen. Echter, het aantal patiënten dat meegenomen kan worden in een steekproef 
wordt in de dagelijkse praktijk gelimiteerd door tijdsbelasting van dataverzameling, maar ook 
door de prevalentie van de betreffende aandoening. We onderzochten de precisie van losse 
indicatorscores en vergeleken de resultaten met de precisie van een samengestelde score 
waarin scores van meerdere indicatoren over één aandoening samengenomen werden. We 
onderzochten ook hoeveel scores op indicatoren er minimaal samengenomen moesten 
worden om een acceptabele mate van precisie te bereiken. We voerden een descriptieve 
statistische studie uit op basis van medische dossier data van 455 Nederlandse 
huisartspraktijken die deelnamen aan de NHG-Praktijkaccreditering. We namen indicatoren 
mee op het gebied van diabetes, hart- en vaatziekten en COPD; we berekenden losse scores 
per indicator en een samengestelde score per aandoening. Alle berekeningen werden gedaan 
op praktijkniveau (de indicatorscore betrof het percentage patiënten in de praktijk waarbij 
aan de indicator voldaan was). Uit de resultaten bleek dat voor losse scores gegevens van 96 
patiënten benodigd waren om een precisie van 10% te behalen. Als de losse scores 
samengenomen werden in een score per aandoening bleek een steekproefgrootte van 43 
(diabetes) tot 89 (hart- en vaatziekten) voldoende om een vergelijkbare precisie te bereiken. 
De verschillen in het benodigde aantal patiënten per aandoening werden veroorzaakt door I) 
de mate van spreiding tussen de scores binnen een aandoening, II) de mate waarin de 
gemiddelde indicatorscores in de buurt kwamen van de maximum/minimum score van 
100%/0% en III) de correlaties tussen de losse scores die in de samengestelde score 
meegenomen werden. Verder vonden we dat het benodigde aantal patiënten om een score te 
berekenen nog verder daalt als we accepteren dat voor een klein deel van de praktijken 
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(bijvoorbeeld 10%) de nagestreefde mate van precisie niet bereikt wordt. Ook bleek dat met 
een samengestelde score die gebaseerd is op een relatief klein aantal indicatoren (5 tot 7) 
dezelfde mate van precisie bereikt kan worden als met een samengestelde score die 
gebaseerd is op een groter aantal indicatoren. We concluderen daarom dat met het 
berekenen van een samengestelde score gebaseerd op een klein aantal indicatoren een 
voldoende mate van precisie bereikt kan worden. Echter, welke mate van precisie gewenst is 
hangt af van de onderliggende doelen voor het meten van kwaliteit. Statistisch gezien kan 
een hogere precisie bereikt worden door indicatoren te selecteren die onderling minder sterk 
met elkaar samenhangen en waarvan de gemiddelde scores dichter bij het maximum of 
minimum (100%/0%) liggen. Anderzijds is het voor een meetinstrument juist belangrijk dat 
gemiddelde scores niet dicht bij het maximum liggen, zodat er voldoende ruimte is voor 
praktijken om te verbeteren. Daarnaast geeft men juist de voorkeur aan indicatoren die 
onderling sterker met elkaar samenhangen als het gaat om het samenstellen van een 
indicatorset met een hoge validiteit. Het is daarom van belang om bewuste keuzes te maken 
die gebaseerd zijn op het doel van de meting en op alle aspecten gerelateerd aan het meten 
en het berekenen van scores. Precisie moet vooral hoog zijn als de metingen gebruikt worden 
voor externe verantwoording of in een pay-for-performance systeem. Voor het in kaart 
brengen van de stand van zaken voor intern gebruik, zoals het geval is in de NHG-
Praktijkaccreditering, is de huidige precisie van losse scores en samengestelde scores 
afdoende. 
 
In hoofdstuk 4 presenteren we een observationele cohortstudie waarin we de effecten van de 
NHG-Praktijkaccreditering op de kwaliteit van chronische zorg hebben onderzocht. Ondanks 
dat accreditatie wereldwijd wordt gebruikt om de kwaliteit van zorg vast te stellen en te 
verbeteren, is er vooral in de eerstelijnszorg weinig bekend over de effectiviteit ervan. De NHG-
Praktijkaccreditering hanteert een 3-jarige cyclus met uitgebreide metingen aan het begin 
van het 1e jaar. Een eerste cohort van 69 praktijken werd gevolgd gedurende het programma, 
met metingen aan het begin en na 3 jaar (de start van de volgende cyclus). Een tweede cohort 
van 69 praktijken werd gemeten tijdens hun start van deelname aan de NHG-
Praktijkaccreditering, in dezelfde periode als de nameting van het eerste cohort. Data werden 
retrospectief verzameld over het jaar voorafgaand aan de start. We evalueerden het effect van 
praktijkaccreditatie in een design met twee losse analyses. In de eerste analyse keken we naar 
verbeteringen in de tijd in het eerste cohort. In de tweede analyse keken we naar verschillen 
tussen het eerste en tweede cohort door de nameting van het eerste cohort te vergelijken met 
de startmeting van het tweede cohort. We namen metingen mee betreffende diabetes, COPD 
en hart- en vaatziekten. Uit de resultaten blijkt dat praktijken in het eerste cohort waren 
verbeterd wat betreft het meten van cholesterol, voetonderzoek en voorschrijven van lipide 
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verlagende medicamenten (diabetes), uitvoeren van een spirometrie (COPD) en het geven van 
advies om te stoppen met roken (COPD). Aangezien de nameting van het eerste cohort op 
deze indicatoren overeen kwam met de startmeting van het tweede cohort, is het onduidelijk 
of deze effecten toegewezen kunnen worden aan de NHG-Praktijkaccreditering. In vergelijking 
met het tweede cohort van nieuw startende praktijken, scoorden de praktijken in het eerste 
cohort beter op het bereiken van de cholesterol (diabetes) en bloeddruk (hart- en 
vaatziekten) streefwaarden; ook scoren ze beter op de registratie van rookgedrag en het 
meten van glucosewaarden (hart- en vaatziekten). Deze verschillen onderschrijven mogelijk 
de meerwaarde van de NHG-Praktijkaccreditering. Het bewijs voor de effectiviteit van de 
NHG-Praktijkaccreditering was niet zo sterk als van te voren verwacht door de deelnemers en 
andere betrokkenen. Mogelijk vormen de andere ontwikkelingen in de eerstelijnszorg 
gedurende de onderzoeksperiode, zoals de implementatie van zorggroepen, een 
gedeeltelijke verklaring voor deze bevindingen. Beide systemen vereisen dataverzameling en 
bieden feedback; de metingen betreffende diabetes, COPD en hart- en vaatziekten zijn bijna 
identiek. Uit onze studie blijkt dat de zorg voor chronische patiënten met de betreffende 
aandoeningen in de huisartspraktijk verbeterd is. Continue monitoring van zorg kan hebben 
bijgedragen aan praktijken om een goede kwaliteit van zorg te behouden ofwel verder te 
verbeteren in de verschillende aandachtsgebieden. 
 
Hoofdstuk 5 beschrijft een studie over de ervaringen van huisartsen met de NHG-
Praktijkaccreditering. Evaluatie van de opinie van deelnemers draagt bij aan het verkrijgen 
van inzicht in de onderliggende werkingsmechanismen van het programma en de effecten 
van accreditatie. We gebruikten een design met twee methoden; data van schriftelijke 
vragenlijsten werden gecombineerd met informatie uit interviews. Alle huisartsen namen deel 
aan de NHG-Praktijkaccreditering tussen 2006 en 2007 en namen ook deel in een pay-for-
performance studie. De vragenlijst bevatte open en gesloten vragen. We gebruikten een 
zogenaamde ‘framework’ benadering in de interviews; de belangrijkste thema’s en 
subthema’s van de vragenlijsten en interviews waren van te voren vastgesteld, maar een 
aantal subthema’s werden inductief afgeleid uit de data tijdens de analyse. De thema’s die 
aan bod kwamen waren: redenen voor deelname aan het programma, data collectie, inhoud 
van de meetinstrumenten, het schrijven van verbeterplannen, ondersteuning en behaalde 
winst voor de praktijk. De resultaten tonen aan dat de huisartsen vooral deelnamen aan de 
accreditatie omdat ze een interesse hadden in kwaliteitsverbetering en omdat ze inzicht 
wilden krijgen in hun handelen. Alhoewel ze positief waren over het verkregen inzicht in hun 
praktijkorganisatie en medisch handelen, vonden ze dat de dataverzameling over het 
medisch handelen te veel tijd kostte. Aangezien er niet uniform geregistreerd was, was 
extractie van de data uit de elektronische dossiers lastig. Wat betreft de inhoud van de 
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meetinstrumenten was men over het algemeen positief. Wel gaf men aan dat de nadruk in de 
meetinstrumenten niet zozeer zou moeten liggen op de details, maar meer op de 
onderliggende processen. Verder gaven huisartsen aan dat ze meer ondersteuning zouden 
willen krijgen bij het schrijven van de verbeterplannen. In het algemeen vonden we dat 
huisartsen bereid zijn om deel te nemen aan een accreditatie, maar het proces moet niet al te 
tijdrovend zijn en de instrumenten moeten goed geschikt zijn om kwaliteit van zorg te 
verbeteren en te borgen voor de toekomst. Er moet een goede balans gevonden worden 
tussen meetbaarheid en ervaren kwaliteit. Sommige huisartsen vonden dat de voordelen van 
accreditatie niet opwogen tegen de nadelen van het proces. 
 
Patiëntkenmerken kunnen mogelijk de scores op indicatoren gemeten in een 
accreditatieprogramma beïnvloeden. Hoofdstuk 6 richt zich op de relatie tussen 
patiëntkenmerken en het meten van processen en uitkomsten van diabeteszorg in de 
huisartspraktijk. Leeftijd, geslacht, etniciteit en andere sociaal-demografische kenmerken van 
de patiënt zijn geassocieerd met uitkomsten van diabeteszorg. Daarnaast kunnen ook 
verschillen in de ernst van de aandoening, gedefinieerd als multi-morbiditeit, de mate van 
controle op diabetes uitkomstmaten beïnvloeden. Om scores tussen praktijken goed te 
kunnen vergelijken met elkaar wordt gesuggereerd dat scores gecorrigeerd of gestratificeerd 
moeten worden voor dergelijke patiëntfactoren. De mate van associatie tussen factoren van 
multi-morbiditeit, andere case-mix factoren en metingen van processen en uitkomsten van 
zorg is echter niet bekend. Daarom onderzochten we in deze studie de associaties van 
verscheidene patiëntkenmerken (leeftijd, geslacht, BMI, woonomgeving) en drie 
aandoeningen die vaak als co-morbiditeit bij diabetes voorkomen (hart- en vaatziekten, 
COPD en angst/depressie) met processen en uitkomsten van diabeteszorg. We namen in 
totaal 6 maten mee wat betreft of HbA1c, systolische bloeddruk en LDL cholesterol gemeten 
waren en of de HbA1c, systolische bloeddruk en LDL cholesterol waarden binnen de 
streefwaarden lagen zoals beschreven in de richtlijnen. In de modellen over de processen van 
zorg (het meten van de betreffende waarden) vonden we middelmatige effecten, met een 
oppervlak onder de curve (AUC) variërend van 0.66 tot 0.76. Dit suggereert dat 
patiëntkenmerken wel enige invloed hebben op de scores op diabetes procesindicatoren. De 
belangrijkste factor die bijdroeg aan het gevonden effect was het aantal diabetes 
gerelateerde consultaties, als indicatie van de mate waarin de patiënt gebruik maakt van de 
aangeboden zorg (odds ratio tussen de 5.6 en 14.5). Effecten op de uitkomstmaten waren 
klein (AUC variërend van 0.57 tot 0.61). Bij een dergelijke AUC presteert het model niet veel 
beter dan kans niveau. De resultaten in deze studie bieden geen ondersteuning voor de 
suggesties in eerdere literatuur dat case-mix correctie of stratificatie nodig is. We concluderen 
daarom dat het wellicht meer van nut is voor gebruikers in de praktijk om niet te corrigeren 
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voor dergelijke factoren maar wel rekening te houden met een zekere foutenmarge rondom 
de scores. 
 
De effecten van praktijkaccreditatie op uitkomsten van zorg worden mogelijk beïnvloed door 
verschillen in praktijkorganisatie die gerelateerd kunnen zijn aan betere zorg. In hoofdstuk 7 
onderzoeken we welke organisatorische determinanten samenhangen met betere 
uitkomsten van diabeteszorg. Diverse organisatorische determinanten, die geassocieerd zijn 
met hoge kwaliteit van diabeteszorg en afgeleid zijn uit een review van trials, werden aan 
specifieke items van gevalideerde meetlijsten gekoppeld die gebruikt worden in de NHG-
Praktijkaccreditering. We gebruikten data van 362 praktijken die deelnamen aan de NHG-
Praktijkaccreditering tussen 2006 en 2009. We stelden 12 maten samen en berekenden een 
samengestelde score. Al deze maten werden onderzocht op hun associatie met 3 diabetes 
uitkomsten: HbA1c, totaal cholesterol en systolische bloeddrukwaarden. Uit de resultaten 
komt naar voren dat de meeste organisatorische determinanten breed geïmplementeerd 
waren in de deelnemende praktijken, wat suggereert dat de condities voor het leveren van 
hoge kwaliteit van diabeteszorg goed zijn. Een hogere score op de samengestelde maat van 
organisatorische determinanten was geassocieerd met betere waarden van systolische 
bloeddruk. Verder onderzoek naar de specifieke organisatorische determinanten liet zien dat 
er slechts 3 significante effecten waren van de in totaal 36 combinaties. Deze resultaten die 
gebaseerd zijn op routinematige zorg suggereren dat implementatie van een combinatie van 
organisatorische determinanten (in plaats van bepaalde losse organisatorische factoren) 
cruciaal is voor het bewerkstellingen van hoge kwaliteit van diabeteszorg.  
 
Hoofdstuk 8 bevat een algehele discussie over de studies in dit proefschrift. Ten eerste 
bespreken we verschillende aspecten rondom data verzameling en de methoden van de 
studies. Alle studies zijn gedaan met behulp van observationele data, die gebruikt kunnen 
worden om de bewijslast uit trials aan te vullen om zo de generaliseerbaarheid te vergroten. 
Er zijn echter ook een aantal beperkingen aan het gebruik van retrospectief verzamelde 
observationele data, waaronder het ontbreken van waarden en mogelijke selectiebias. Verder 
scoorden praktijken al relatief hoog op veel van de gemeten indicatoren van chronische zorg, 
waardoor de mogelijkheden om significante effecten te vinden wellicht wat ingeperkt werden.  
In de discussie komen verder drie verschillende aandachtsgebieden aan bod: (I) scores op 
indicatoren, (II) audit en feedback in accreditatieprogramma’s en (III) management van 
chronische zorg. Wat betreft de scores op indicatoren bediscussiëren we of we er goed aan 
doen de scores te corrigeren of stratificeren voor patiënt- en praktijkkenmerken. Aan de ene 
kant kan dit bijdragen aan een betere validiteit; aan de andere kant vonden we in onze 
studies slechts kleine associaties. Het is de vraag of voor een individuele praktijk de voordelen 
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van het corrigeren van scores opwegen tegen de nadelen (complexe rekenmethoden, lastige 
interpretatie van de scores). Verder suggereren we dat verdere analyses met Bayesiaanse 
statistiek mogelijk een interessante aanvulling kunnen vormen om scores op indicatoren te 
evalueren. Deze methode biedt een oplossing om in de statistiek en het meten ook 
verschillen in klinische relevantie voor diverse betrokken partijen mee te kunnen nemen.  
 
In accreditatieprogramma’s nemen audit en feedback een belangrijke plaats in. We 
bespreken dat de heterogene effecten op proces- en uitkomstmaten van chronische zorg die 
we in onze studies gevonden hebben overeenkomen met andere studies naar effecten van 
audit en feedback. Alhoewel accreditatie een geschikte methode kan zijn om kwaliteit te 
verbeteren, moet de moeite die het kost om data te verzamelen wel in evenwicht zijn met de 
voordelen van deelname aan accreditatie. Om bij te dragen aan het verhogen van de effecten 
van accreditatie, moeten we de NHG-Praktijkaccreditering continu aanpassen, het 
verzamelen van data moet verder gefaciliteerd worden en we moeten meer aandacht 
besteden aan bestaande belemmerende en bevorderende factoren om te veranderen. De 
NHG-Praktijkaccreditering is sinds de uitvoer van de studies in dit proefschrift ook continu in 
ontwikkeling om op de genoemde punten verder te verbeteren. 
Aangezien er een toenemende vraag is naar het openbaar maken van informatie over 
kwaliteit van zorg, bespreken we dat het publiek ontsluiten van gegevens of het koppelen van 
een financiële bonus aan kwaliteitsdata (pay-for-performance) mogelijk de effecten op de 
uitkomst kan vergroten. Er kunnen echter ook meerdere onbedoelde gevolgen zijn, zoals 
‘gaming’ en een gebrek aan verbeteringen op gebieden waar geen beloning aan gekoppeld is. 
Ook zijn er verschillende beperkingen op het gebied van validiteit en precisie, aangezien de 
eisen die aan de meetinstrumenten gesteld worden een stuk strikter worden bij gebruik voor 
externe verantwoording.  
 
Wat betreft management van chronische zorg bespreken we de relatie tussen de richtlijnen en 
de gemeten scores op indicatoren, de interpretatie van de scores en of de meegenomen 
indicatoren een goede afspiegeling vormen voor de gehele chronische zorg. De indicatoren 
die gebruikt worden in de NHG-Praktijkaccreditering zijn afgeleid van richtlijnen; echter, het is 
niet wenselijk dat artsen gaan streven naar 100% behandelen volgens de richtlijnen. Er zijn 
verschillende redenen om af te wijken van de richtlijn. Niet alle richtlijnen zijn gebaseerd op 
even sterk wetenschappelijk bewijs en in individuele gevallen kan het afwijken van de richtlijn 
baat hebben voor de patiënt. Bovendien worden de richtlijnen continu aangepast naarmate 
de bewijslast groeit en verandert. Op elk moment in de tijd kan het meest recente bewijs 
mogelijk nog niet geïmplementeerd zijn in de richtlijnen. Dit vereist dat huisartsen zich flexibel 
opstellen en bereid zijn om hun handelen aan te passen. Het is ook van belang om de 
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instrumenten die gebruikt worden in een accreditatieprogramma continu aan te passen. Het 
kan een uitdaging zijn om scores juist te interpreteren; het is verstandig om de scores op 
indicatoren puur te zien als een indicatie. Wellicht is het nodig om regelmatig de beperkingen 
van indicatoren en hun scores uit te leggen aan de relevante betrokken partijen. In de 
toekomst kunnen we het meten van chronische zorg aanvullen door ook rekening te houden 
met aspecten zoals tijdigheid en door het toevoegen van indicatoren over geïndividualiseerde 
zorg en uitkomsten van kwaliteit van leven. 
 
We concluderen dat het accreditatieprogramma een geschikt instrument kan zijn om 
kwaliteit te verbeteren. Het is van belang om te streven naar een optimale balans tussen het 
creëren van accurate en betrouwbare indicatorscores versus een acceptabele werkbelasting 
om de data te verzamelen. Het gebruik van het huidige programma voor interne evaluatie 
wordt aangeraden; na verdere evaluatie zou het programma in zijn geheel mogelijk ook 
geschikt kunnen zijn voor externe verantwoording. 
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De afgelopen jaren heb ik me telkens geconcentreerd op de berg werk die nog voor me lag; nu 
ligt deze achter me en is het tijd om terug te kijken. Zonder de hulp van mijn promotieteam, 
collega’s, familie en vrienden was dit proefschrift er niet geweest. Ik wil jullie dan ook graag 
bedanken. 
 
Als eerste Jozé Braspenning. Ik vond het erg fijn dat je mij vanaf het begin af aan begeleid 
hebt, ik heb veel van je geleerd. In overlegmomenten bleek regelmatig dat we inhoudelijk wel 
op één lijn zaten, maar dat we nogal konden verschillen in onze benadering. Waar het voor 
mij logischer was om eerst de beren op de weg af te handelen om uiteindelijk tot een 
conclusie te komen, heb jij me geleerd meer te denken vanuit de kern en vanuit de 
boodschap die je over wilt brengen. Ook als mijn perfectionisme me weer eens in de weg zat 
bij het schrijven wist me je goed verder te helpen. Ik heb veel gehad aan de gesprekjes die we 
onderweg in de trein hadden; hartelijk dank voor de goede begeleiding.  
Ook Michel Wensing wil ik hartelijk danken, ik had me geen betere promotor kunnen wensen. 
Je bijdrage in de overlegmomenten was altijd to-the-point en nuttig: met je helikopterview 
wist je goed aan te geven welke lijn we het beste zouden kunnen volgen. Ook in het 
schrijfproces heb ik veel aan je gehad. Mijn tweede co-promotor was René Wolters. Toen ik je 
vroeg of je in mijn promotieteam zou willen zitten twijfelde je; ik ben erg blij dat je 
toegestemd hebt. Niet alleen vanwege je achtergrond als huisarts (de enige in mijn 
promotieteam in een onderzoek waarin de huisartsenzorg centraal stond) maar ook als 
onderzoeker met een eigen mening heb je veel bijgedragen; ik heb dat erg gewaardeerd. Ook 
dank ik jullie alle drie voor de prettige samenwerking; jullie vulden elkaar onderling goed aan 
en vormden een fijn team.  
 
Dit proefschrift had niet tot stand kunnen komen zonder de medewerking en financiële steun 
van het NHG, dank voor de fijne samenwerking en support. Ook de mensen van het NPA wil ik 
hartelijk danken voor hun medewerking om de data voor deze studie aan te leveren. Het was 
nogal eens puzzelen hoe we de data ook bruikbaar konden maken voor de wetenschap; met 
name Adri aan het Rot wil ik hartelijk danken voor alle uurtjes werk en de altijd weer 
verhelderende telefoontjes.  
 
The first international article I wrote was the article on the precision of composite scores. We 
took quite some time to fine-tune the message of this article and perform all necessary 
calculations, but we got there in the end. David Reeves, I would like to thank you for your 
invaluable help in the analyses; thank you for all your time and efforts, also in the writing 
process. I still remember the various phone-calls and our meeting in Manchester. It was really 
stimulating to meet in person and work on the article together. You were very kind to 
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introduce Remco Feskens and myself to the University of Manchester, your colleagues and the 
local Indian cuisine. Also, I would like to thank Stephen Campbell. Your knowledge of 
developments in science and practice was crucial in choosing which direction to take with 
this article. I really appreciated your important contribution during the whole process. It was 
an honor and a great pleasure to work with you both.  
 
Ook alle anderen die hebben meegeschreven aan de artikelen in dit proefschrift wil ik graag 
bedanken. Margriet Bouma, hartelijk dank voor je rol in het schrijven van de artikelen, maar 
ook als aanspreekpunt binnen het NHG. Mede dankzij jouw inzet heb ik al die jaren onderzoek 
kunnen doen voor het NHG en heeft het kunnen uitmonden in een promotie, dat waardeer ik 
enorm. Het contact was altijd erg prettig; de overlegmomenten lichtelijk chaotisch en met 
veel te veel te bespreken in korte tijd, maar wel heel leerzaam. Ik heb veel gehad aan het NHG 
als directe link met beleidsvorming voor de praktijk. Pieter van den Hombergh, het was erg 
leuk om jouw promotiewerk verder uit te kunnen bouwen en daar ook zo af en toe met jou 
over te kunnen sparren. Je enthousiasme werkte absoluut aanstekelijk. Al moest ik er wel 
even aan wennen dat ik ook op zondagochtend gebeld kon worden voor een inhoudelijke 
discussie… Gelukkig gebeurde dat niet te vaak. Dank voor de fijne samenwerking! 
Remco Feskens, naast een waardevolle co-auteur was je ook een gezellige reisgenoot en 
kamergenoot, dank daarvoor. Het was erg handig iemand met zoveel kennis over statistiek 
naast me te hebben zitten toen ik net tot over mijn oren in een statistisch artikel zat; ook je 
ervaring met schrijven heeft me goed op weg geholpen. Wim de Grauw, dank voor je bijdrage 
aan het artikel over de organisatorische determinanten in de diabeteszorg. Je duidelijke visie 
leverde interessante discussies op bij het interpreteren van de gevonden resultaten. De 
samenwerking tussen IQ healthcare en de afdeling eerstelijnsgeneeskunde vond ik erg 
waardevol. Femke Atsma en Birgit Jansen, hartelijk dank voor jullie werk aan het artikel over 
de invloed van patiëntkenmerken op de diabeteszorg. Het heeft mij veel hoofdbrekens 
gescheeld om de data van LINH te kunnen gebruiken voor dit artikel met jullie hulp. Femke, 
dank voor het uitvoeren van de analyses en je deskundige input. Het was een plezier om met 
jullie samen te werken. Ook de overige co-auteurs, Kirsten Kirschner, Jako Burgers, Kees in ‘t 
Veld en Richard Grol wil ik graag bedanken voor de fijne samenwerking en hun waardevolle 
bijdrage aan de artikelen in dit proefschrift.  
 
Ik wil graag alle medewerkers van IQ healthcare danken voor de fijne sfeer, leuke gesprekken 
en stimulerende vergaderingen. Ik ga niet iedereen bij naam noemen, maar een aantal 
mensen wil ik toch speciaal bedanken. Jolanda van Haren, ik heb altijd veel aan je gehad als 
aanspreekpunt op de afdeling, maar vooral in de laatste periode heb je me enorm geholpen 
met de praktische zaken rondom mijn proefschrift. Hartelijk dank voor je uitgebreide werk 
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aan het vertalen van een hoofdstuk, het samenstellen van het proefschrift, de lay-out en de 
vele organisatorische regeldingetjes. Heel fijn!  
Ik heb bij IQ ook een leuke tijd gehad in de werkgroep communicatie en kennisgroep 
indicatoren. Het was een plezier om met jullie samen te werken; ik vond het heel fijn op die 
manier ook wat voor de afdeling te kunnen betekenen. Ook naast het werk was IQ een leuke 
afdeling. Ik heb genoten van het zanggroepje tijdens de lunchpauzes. Lianne en Nicky, zingen 
was één van de overeenkomsten die we hadden, maar ook de stimulerende gesprekken met 
jullie heb ik altijd erg gewaardeerd. Het bowlen/paintballen/film kijken maakte ook dat je je 
collega’s nog eens op een andere manier leerde kennen, dit was altijd erg gezellig.  
Ook de bedrijfsuitjes waren doorgaans erg geslaagd, met als persoonlijk hoogtepunt het jaar 
waarin we ‘Wie is de Mol’ deden en ik de beste mol van de afdeling bleek te zijn; ik wist niet 
dat ik het in me had. Ik herinner me verder nog goed het weekendje skiën met Kirsten, Renate, 
Linda, Selma, Lianne en Lucy, dat was erg geslaagd, ik heb ervan genoten. Ook de ISQua en 
Wonca congressen in Genève, Parijs en Malaga waren een geweldige ervaring, dank aan alle 
collega’s die deze reizen mede zo aangenaam gemaakt hebben. 
Door de jaren heen heb ik verschillende kamergenoten gehad: Marije, Anouk, Gijs, Remco, 
Nancy, Wytske en Lydia. Jullie waren geweldige kamergenootjes om mee te sparren en lief en 
leed te delen. Hartelijk dank voor alles! Gijs en Wytske, super dat jullie mijn paranimfen wilden 
zijn! Aan alle andere collega’s, te veel om iedereen bij naam te noemen: hartelijk dank 
allemaal voor de gezellige tijd die ik bij IQ gehad heb!  
 
Marianne Gullberg, jou wil ik hier graag bedanken omdat je in zekere zin de aanstichtster van 
mijn wetenschappelijke carrière bent geweest toen ik nog als onderzoeksassistent bij het Max 
Planck Instituut werkte. Je grote enthousiasme voor onderzoek en enorme kennis werkte 
zeker aanstekelijk. Ik heb nu mijn ‘driver’s license’ binnen! 
 
Op donderdagavond is het altijd weer een plezier de frustraties van die week er even uit te 
slaan tijdens het volleyen. Ik waardeer jullie vriendschap enorm, de leuke gesprekjes in de 
kleedkamer en de gezelligheid tijdens het sporten. Ook op de Veerkracht heb ik leuke mensen 
om me heen, fijn dat we elkaar hebben leren kennen. Verder wil ik hier nog het oude clubje 
van manege Neerbosch noemen: super leuk dat we nog altijd zo nu en dan bij elkaar komen 
om weer bij te praten, ik hoop dat we dat nog lang volhouden. 
Dieke, dank voor je fijne ondersteunende mailtjes vanuit Noorwegen, altijd weer fijn even van 
elkaar te horen! En tot slot Elodie: je bent een geweldige vriendin, ik waardeer je enorm. Het is 
erg fijn om samen goede gesprekken te hebben met een theetje op de bank; super dat je er zo 
voor me bent. We moeten nodig weer eens afspreken voor een spelletjesavond! 
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Lieve familie, dank voor alles. Ik stel ons prettige contact erg op prijs, dank voor jullie 
interesse! Het is heel fijn om te merken dat jullie er altijd voor ons en voor elkaar zijn. Lieve 
Jaap en Greet, pap en mam, ik waardeer het enorm dat jullie al mijn hele leven achter me 
staan in alles wat ik doe, er voor me zijn en van me houden zoals ik ben. Ik zou me geen 
betere ouders kunnen wensen, ik hou van jullie!  
 
En tot slot mijn lieve man, vriend, steun en toeverlaat: Sander. Ik ben zo blij met jou! We 
hebben geen woorden nodig om elkaar te begrijpen, je voelt het altijd precies aan hoe het 
met me is. Het is heel fijn om alles met je te kunnen delen. Ik zie er naar uit de rest van ons 
leven samen door te brengen, ik hou van je! 
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